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ABSTRACT 
 
IDENTIFICATION OF THE ROLE OF THE NUCLEAR MATRIX PROTEIN 
C1D IN DNA REPAIR AND RECOMBINATION 
 
 
TUBA ERDEMIR 
P.hD in Molecular Biology and Genetics 
Supervisor: Dr. Uğur Yavuzer 
April 2002, 120 pages 
 
 
The nuclear matrix protein C1D is an activator of the DNA dependent protein 
kinase (DNA-PK), which is essential for the repair of DNA double-strand breaks 
(DNA-DSBs).  C1D is phosphorylated very efficiently by DNA-PK, and its mRNA 
and protein levels are induced upon γ-irradiation, suggesting that C1D may play a 
role in repair of DNA-DSBs in vivo. In an attempt to identify the possible biological 
functions of C1D and the nuclear matrix, two approaches were employed.  One of 
the strategies was to apply yeast-two hybrid system to screen for polypeptides that 
interact with C1D. This screening revealed a number of cDNA clones that encode 
mainly proteins involved in recombination, DNA repair and transcription.  Among 
the identified proteins, TRAX (Translin Associated protein X) was chosen for further 
analysis.  Although, the biological function of TRAX remains unknown, its bipartite 
nuclear targeting sequences suggest a role for TRAX in the movement of associated 
proteins including Translin, into nucleus. After cloning the full-length TRAX ORF 
into bacterial and mammalian expression vectors, the specificity of the interaction 
between C1D and TRAX was confirmed both in vivo and in vitro conditions. 
Notably, it was shown that C1D and TRAX interact in mammalian cells only after γ-
irradiation.  In addition, it was demonstrated that the induced interaction of TRAX 
and C1D is not due to the alterations in their subcellular localizations but possibly 
through post-translational modifications in response to γ-irradiation.  
The second strategy was identification of the S. cerevisiae C1D homolog.  
Because of the high homology between yeast and mammalian C1D proteins, S. 
cerevisiae was used as a model organism to reveal the function of Yc1d.  YC1D gene 
was knocked-out in yeast and the phenotypic and functional consequences of 
disruption of the YC1D gene was analyzed.  It was found that yc1d mutant strain was 
slightly sensitive to γ-irradiation and was defective in DNA-DSB repair, thus, raising 
the possibility that yeast C1D and human C1D might be functional homologs. 
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ÖZET 
NÜKLEER MATRİKS PROTEİNİ C1D’NİN DNA TAMİR VE 
REKOMBİNASYONDAKİ ROLÜNÜN BELİRLENMESİ 
 
TUBA ERDEMIR 
Doktora  Tezi, Moleküler Biyoloji ve Genetik Bölümü 
Tez Yöneticisi: Dr. Uğur Yavuzer 
Nisan 2002, 120 sayfa 
 
Nükleer matriks proteini C1D, DNA çift sarmal kırıklarının (DNA-DSBs) 
tamiri için gerekli olan, DNA-PK’nın aktivatörüdür.  C1D’nin DNA-PK tarafından 
fosforlanması ve mRNA ile protein miktarının γ-radyasyonu sonucunda artması, in 
vivo koşullarda C1D’nin DNA-DSB’in tamirinde rol alabileceğini göstermektedir. 
C1D’nin ve nükleer matriksin olası biyolojik fonksiyonlarını tanımlamak amacıyla 
iki yaklaşımda bulunuldu.  Birinci strateji, C1D ile etkileşen polipeptidleri maya-ikili 
hibrid sistemini uygulayarak taramaktı.  Bu tarama sonucunda rekombinasyon, DNA 
tamiri ve  transkripsiyonda rol alan proteinleri kodlayan bir grup cDNA klonu açığa 
çıkarıldı. Bulunan proteinler arasında TRAX (Translinle etkileşen X proteini), daha 
detaylı olarak incelenmek üzere seçildi.  TRAX’ın biyojik fonksiyonu bilinmemesine 
rağmen,  içerdiği ikili çekirdek hedefleme dizini sayesinde, aralarında Translin’in de 
bulunduğu proteinleri, hücre çekirdeğine taşıdığı düşünülmektedir.  TRAX 
cDNAsının proteine kodlanan kısmının tümü, bakteri ve memeli ekspresyon 
vektörlerine klonlandıktan sonra, TRAX ve C1D arasındaki etkileşimin özgün olup 
olmadığı hem in vivo  hem de in vitro koşullarda doğrulandı.  Özellikle, memeli 
hücrelerinde C1D ve TRAX’ın  ancak γ-radyasyonu sonrasında etkileşimde 
bulundukları gösterildi.  Buna ek olarak, γ-radyasyonuna bağlı olarak oluşan TRAX 
ve C1D arasındaki bu etkileşimin, bu proteinlerin hücre içi lokasyonlarını 
değiştirmelerine değil, fakat oluşan olası bir post-translasyonel  degişimden 
kaynaklandığı gösterildi.  
 İkinci strateji C1D’nin S.cerevisiae  homoloğunu tanımlamaktı. Maya ve 
memeli C1D’si arasındaki yüksek benzerlikten ötürü, Yc1d’nin fonksiyonunu 
tanımlamak amacıyla,  S.cerevisiae model organizma olarak kullanıldı. YC1D  geni 
maya genomundan yok edilerek, bunun fenotipik ve fonksiyonel sonuçları araştırıldı. 
yc1d  mutant maya neslinin  γ-radyasyona  karşı hafif bir duyarlılık göstermesi ve  
DNA-DSB tamirinde kusurlu olması, maya ve insan C1D’sinin fonksiyonel olarak da 
homolog olabileceklerini düşündürmektedir.   
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CHAPTER 1 
 
 
1.1.  DNA DAMAGE 
 
DNA damage can be defined as any modification of DNA that alters its coding 
properties and leads to blockage of essential cellular processes such as transcripton 
and replication.  Cellular responses to unrepaired DNA damage may include acute 
cytotoxicity, programmed cell death, mutation fixation, and increased recombination 
leading to genomic instability.  Damage to genomic DNA occurs spontaneously and 
can be further enhanced by environmental mutagens such as ultraviolet (u.v.) light 
from the sun, inhaled cigarette smoke, or incompletely defined dietary factors.  Large 
proportions of DNA alterations are caused by spontaneous damage, which occur with 
an estimated rate of 1-3x104 per cell per day.  DNA damaging agents of different 
types produce different kinds of lesions in DNA. Types of DNA damage can be 
divided into two main groups; 
 
• Single base modifications: These are some minor base modifications or base 
replacements that might simply alter the coding sequence.  This simple base 
substitution includes deamination, depurination, reaction of reactive oxygen 
species (ROSs), nucleotide analog incorporation, alkylation, insertion and 
deletions. 
 
• Damage that involve more than one base or, result in damage to the DNA 
backbone: These are types of DNA damage that may distort DNA structure and 
interfere with replication or transcription.  Ultraviolet light-induced thymine 
dimers, intrastrand and interstrand cross-linking between two bases, single strand 
or double strand breaks are also examples for this type of DNA damage.
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If left unrepaired, DNA damage can have serious consequences for cells, causing 
mutations, which may lead to cancer formation or improper functioning of the 
encoded proteins.  Therefore, for the faithful reproduction and preservation of the 
genomic integrity, damaged DNA must be repaired.  Since there are many different 
types of DNA damage, it is not surprising that the repair system employs many 
different protein complexes.  Approximately more than 100 genes participate in 
various aspects of DNA repair, even in organisms with very small genomes.  As a 
result of analysis of the human genome sequence, considering evolutionary 
relationships and common sequence motifs in DNA repair genes, 130 human DNA 
repair genes have been identified (Wood et al., 2001) . 
According to the mechanisms they employ in repairing different types of 
damage, they can be grouped into three.  
 
• Direct reversal of DNA damage: It is the simplest way to correct the damage. 
There are two well-studied proteins in this type of repair.  One of them is 
cyclobutane pyrimidine dimers (CPD) photolyase, which reverts the covalent 
linkage of pyrimidine dimers in a light dependent reaction.  CPD photolyases are 
found in bacteria, fungi, plants, and many vertebrates, but not in placental 
mammals.  The other one is alkyl transferase that removes the methyl group 
from O6-methylguanine.  Alkyl transferase is present in all living organisms. 
 
• Excision repair: In cases where damage is present in just one strand, the damage 
can be accurately repaired by cutting the damaged DNA and replacing it with 
newly synthesized DNA using the complementary strand as a template.  There 
are three types of excision repair.  First one is mismatch repair, which repairs 
mismatched nucleotides and small loops.  Second one is base excision repair that 
removes incorrect bases such as uracil or damaged bases like 3-methyladenine 
and the last one is nucleotide excision repair which removes bulky DNA adducts 
such as thymine dimers and 6-4 photoproducts.  After the removal of the 
damaged region; DNA is repaired and re-ligated by proteins common to all three 
types of excision repair mechanisms. 
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• Double strand break repair: Among the other forms of DNA damage, double 
strand breaks (DSBs) are potentially the most dangerous, since they can lead to 
broken rearranged chromosomes, cell death, or cancer.  Eukaryotes have evolved 
specific mechanisms to repair DSBs by either homologous recombination (HR), 
which requires the presence of homolog sequences or non-homologous end 
joining (NHEJ) by which the two ends of a DSB are joined by a process that is 
independent of DNA sequence homology (Nickoloff and Hoekstra, 1998). 
 
 
1.2.  DNA DOUBLE-STRAND BREAKS (DNA-DSBs) 
 
DSBs are generated by exogenous agents such as ionizing radiation (IR) and 
certain chemotherapeutic drugs, or by spontaneously generated ROSs and 
mechanical stress on the chromosomes.  They can also be produced when DNA 
replication forks encounter DNA single-stranded breaks or other types of lesions.  
They can occur at the termini of chromosomes due to defective metabolism of 
telomers.  Additionally, they are generated to initiate recombination between 
homologous chromosomes during meiosis and also during V(D)J recombination, 
which is a process necessary for lymphocyte development (Critchlow and Jackson, 
1998; Jackson and Jeggo, 1995; Khanna et al., 2001). 
The presence of an unrepaired DSB will activate the DNA-damage response 
systems of a cell to arrest its progression through the cell cycle thereby, preventing 
possible chromosome loss or transmission of damaged DNA to the next cellular 
generation.  The cell cycle checkpoints are believed to prevent the replication of 
damaged DNA (G1/S and intra S checkpoints) or segregation of damaged 
chromosomes (G2/M checkpoint).  Once the damage is repaired, the cell cycle 
resumes.  However if the level of DNA damage is beyond repair, DSBs can lead to 
programmed cell death (apoptosis).  If a cell with an unrepaired DSB persists to 
divide, the broken chromosome ends can lead to chromosomal fragmentations, 
translocations and deletions, all of which can lead to carcinogenesis through 
activation of oncogenes, inactivation of tumour suppressor genes or loss of 
heterozygosity (Critchlow and Jackson, 1998; Kanaar et al., 1998).  Notably, a large 
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proportion of cancers of lymphoid origin exhibit chromosomal rearrangements 
involving the immunoglobulin or T-cell receptor loci, indicating that they have arisen 
through inappropriate resolution of DNA DSBs corresponding to V(D)J 
recombination intermediates (Khanna and Jackson, 2001) .  
  
 
1.3.  PATHWAYS OF DSB REPAIR 
 
To overcome deleterious effects of DSBs eukaryotes have evolved two main 
repair pathways, nonhomologous end joining (also called illegitimate recombination) 
(NHEJ) and homologous recombination (HR).  Both mechanisms operate in all 
eukaryotic cells but the relative contribution of each mechanism varies.  HR pathway 
requires extensive regions of DNA homology and repairs DNA accurately using 
information on the undamaged sister chromatid or homologous chromosome.  On the 
contrary, DNA end-joining pathway uses no, or extremely limited sequence 
homology to rejoin juxtaposed ends in a manner that may not be error free.  It seems 
that mammalian cells prefer NHEJ whereas HR is more common in the budding 
yeast Saccharomyces cerevisiae.  One possible explanation for this preference in 
mammalian cells might be misalignment of repetitive DNA sequences that could lead 
to deletions and translocations.  In addition to these two main mechanisms, DSBs can 
also be repaired by single strand annealing (SSA), which, can be considered as a sub-
pathway of HR.  In SSA; resection and annealing of short regions of complementary 
sequence initiates repair by SSA pathway in which ligation is preceded by the 
trimming of non-complementary single strand DNA tails (Karran, 2000). 
 
 
1.3.1.  Homologous Recombination 
 
 The yeast S.cerevisiae has been very useful in identification of genes required 
for DSB repair by HR.  In S.cerevisiae, HR is performed by RAD52 epistasis group 
of proteins which have been identified mainly by yeast genetics using ionizing 
radiation hypersensitive mutants (Orr-Weaver and Szostak, 1985).  Most of the 
  6
functional homologues of them have been isolated from mammalian species.  
According to the proposed model for HR (Figure 1) (Kanaar et al., 1998; Khanna and 
Jackson, 2001); DSBs generated by DNA damaging agents is processed to a single 
stranded region with 3’-overhang by an exonuclease and then Rad51 protein 
associates with 3’ ssDNA-end and searches for the homologous duplex DNA to 
catalyse strand exchange in a reaction, which generates a joint molecule between 
homologous damaged and undamaged duplex DNA.  In addition to Rad51 this step 
requires the coordinated action of Rad52, Rad54, Rad55/57 and the single strand 
binding protein RPA. DNA synthesis, requiring a DNA polymerase, its accessory 
factors and a ligase, then restores the missing information (Karran, 2000) . 
 
Figure 1: Pathways of DSB repair, (Karran, 2000) 
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Similar to yeast Rad51, mammalian Rad51 protein polymerizes on DNA to 
form nucleoprotein filaments that searches the homologous DNA and like yeast 
homologs, human Rad52 and Rad54 facilitate Rad51 strand invasion activity (Kanaar 
et al., 1998).  Mammalian Rad51 also interacts with Brca1 and Brca2 proteins 
(products of breast cancer genes) (Haber, 1999), which are supposed to act as protein 
scaffolds to coordinate the actions of the HR machinery (Khanna and Jackson, 2001).  
Another protein that has been linked to HR in mammals is the protein kinase ATM, 
which is deficient in the cancer prone, radiosensitive, and the neurodegenerative 
syndrome ataxia telangiectasia (A-T).  Upon IR, ATM phosphorylates proteins 
involved in HR such as Brca1 and c-Abl besides its other targets.  The c-Abl tyrosine 
kinase modulates Rad51 strand exchange activity through phosphorylation (Khanna 
and Jackson, 2001; Rotman and Shiloh, 1999).   The helicases defective in the human 
cancer predisposition and developmental disorders, Werner syndrome (WS) and 
Bloom syndrome (BS) have also been implicated in regulating HR through their 
ability to suppress NHEJ (Karow et al., 2000) 
 
 
1.3.2.  Single-Strand Annealing (SSA) 
 
This pathway can be considered as a subpathway of HR and it doesn’t 
involve formation and resolution of Holliday junctions.  However, SSA relies on 
regions of homology with which to align the strands of DNA to be joined. 
S.cerevisiae genes, which define SSA, belong to the Rad52 epistasis group of HR. 
The hRad50, hMre11 and Nbs1 define the human SSA pathway.  Mre11 has several 
activities, the most important of which may be 3-5’ exonuclease activity which may 
remove damaged DNA to expose short lengths of single-stranded DNA.  If a sister 
chromatid is available, then single stranded overhangs may initiate rejoining by 
homologous recombination.  Alternatively, sites of limited homology within the 
resected region may anneal to begin repair by SSA.  The single-stranded tails created 
by resection and annealing of overlapping ends are trimmed before ligation, which 
leads to loss of one of the intervening DNA (Fig 1) (Karran, 2000). 
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1.3.3. Non-Homologous End Joining 
 
In contrast to HR, NHEJ is achieved without the need for extensive homology 
between DNA ends to be joined (Figure1).  Many of the proteins involved in NHEJ 
have been identified in several ways such as biochemical fractionation of extracts 
capable of end joining reactions, genetic and biochemical analysis of the proteins 
required for DSB repair during V(D)J recombination and genetic analysis in yeast, 
rodent, and human cell lines.  According to these analyses, DNA dependent protein 
kinase (DNA-PK) is found to be a key component of the NHEJ (Jeggo, 1997; Lees-
Miller, 1996).  DNA-PK is an abundant nuclear serine/threonine kinase that is 
activated in vitro by DNA double strand breaks and certain other discontinuities in 
the DNA double helix (Dvir et al., 1993; Gottlieb and Jackson, 1993). 
 Recently, several other yeast NHEJ components have been identified 
including the nuclease complex containing Rad50p, Mre11p, and Xrs2p (Boulton 
and Jackson, 1998; Milne et al., 1996).  Most DNA DSBs are not blunt ended but 
have single-strand overhangs, which must be trimmed by exonucleases and/or 
endoucleases before rejoining.  In yeast, Mre11p, Rad50p and Xrs2p complex seems 
to be involved in this trimming process.  Mammalian cells have homologues of 
Rad50p and Mre11p but a different protein, Nbs1, seems to replace Xrs2p (Maser et 
al., 1997).  Nbs1 (also called Nibrin) is a protein whose deficiency leads to a rare 
human genetic disorder called Nijmegan breakage syndrome (NBS) (Baumann and 
West, 1998; Carney et al., 1998).   It is supposed that Nbs1 regulates function of 
Rad50p and Xrs2p through signaling the existence of DNA damage to the cell cycle 
checkpoint machinery.  Repair by NHEJ is completed by the DNA ligase IV/ 
XRCC4 complex, of which yeast homologous are Lig4p and Lif1, respectively 
(Baumann and West, 1998; Featherstone and Jackson, 1999). 
 
 
1.4. ROLE OF DNA-PK AND ITS COMPONENTS IN NHEJ 
 
DNA-PK consists of the heterodimeric Ku proteins, of 70- and 80- kDa and a 
large catalytic domain of 470-kDa, termed DNA-PKCS (catalytic subunit).  
  9
According to biochemical studies, the ser/thr kinase catalytic activity of DNA-PK 
was shown to be triggered upon association with DNA ends through its DNA 
targeting component, Ku 70/80 (Dvir et al., 1993; Gottlieb and Jackson, 1993).  
Although weak, DNA-PKCS possesses an intrinsic DNA-end binding activity that is 
greatly stimulated and stabilized by Ku complex (Hammarsten and Chu, 1998). 
DNA-PKCS doesn’t appear to have significant homology to other characterized 
proteins.  However, the C-terminal region of DNA-PKCS falls into 
phosphatidylinositol-3 kinase (PI3K) family and more specifically, DNA-PKCS is 
most related to a subgroup of proteins in this family, which includes ATM, ATR, and 
TRRAP.  These proteins have been shown to be involved in controlling transcription, 
cell cycle, and/or genome stability in organisms ranging from yeast to man (Hartley 
et al., 1995; Poltoratsky et al., 1995).  Interestingly, they all have serine/threonine 
kinase activity rather than lipid kinase activity (Smith et al., 1999).  DNA-PK also 
has an intrinsic phosphorylation activity.  Autophosphorylation has an important role 
in regulation of DNA-PK activity by affecting dissociation of DNA-PKCS from the 
Ku complex and results in inhibition of DNA-PK catalytic function (Chan and Lees-
Miller, 1996).  Upon activation, DNA-PKCS phosphorylates a variety of proteins in 
vitro including itself, Ku complex, Sp1, c-Jun, c-Myc, p53, Hsp90, the RNA 
polymerase II subunit, RPA, XRCC4 and a recently identified nuclear matrix protein 
C1D (Anderson and Lees-Miller, 1992; Jackson, 1997; Leber et al., 1998; Lees-
Miller, 1996; Smith et al., 1999; Yavuzer et al., 1998). 
 Ku was initially characterized as an antigen present in the sera of patients with 
autoimmune diseases (Mimori et al., 1981).  Ku70 and Ku80 heterodimer binds, 
without sequence specificity, to a variety of DNA structures such as double stranded 
DNA ends, nicks, gaps, and hairpins, however, it doesn’t bind to closed circular 
DNA (Dynan and Yoo, 1998).  Another characteristic of Ku protein is its ability to 
translocate along the DNA molecules in an ATP independent manner (Paillard and 
Strauss, 1991).  This ability of Ku is supposed to function transporting DNA-PKCS to 
its physiologically relevant substrates.  The cloning of cDNAs and genes for Ku 
subunits from a variety of species indicates that both Ku70 and Ku80 exist in 
organisms ranging from yeast to man (Dynan and Yoo, 1998). 
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The role of DNA-PK complex in NHEJ became evident through genetic 
complementation studies of rodent mutants that were shown to be sensitive to 
ionizing radiation and defective in repair of DNA DSBs and site-specific V(D)J 
recombination (Jeggo, 1997).  Among the 11-complementation groups of IR-
sensitive cells that were initially defined, 4 were defective in NHEJ (IR4, IR5, IR6, 
and IR7).  It has been established that IR7 cells are deficient in DNA-PKCS, whereas 
IR5 and IR6 cells are deficient in the Ku80 and Ku70 respectively. Subsequent work 
showed that IR4 cells are defective in Xrcc4, a small protein that forms a tight and 
specific complex with DNA ligase IV (Smith et al., 1999).  In light of the above 
reports, proposed model is that Ku/DNA-PKCS complex binds to DSBs and facilitates 
the recruitment and activation of other NHEJ components such as Xrcc4 and DNA 
ligase IV (Figure 1).   
Mice deficient in various components of NHEJ have been generated to study 
NHEJ in mammals.  According to these experiments, deficiency of any components 
of DNA-PK leads to multiple defects, including growth retardation, hypersensitivity 
to IR and severe combined immunodeficiency (Scid) due to severely impaired V(D)J 
recombination, which is an essential process during mammalian lymphoid cell 
development (Smith et al., 1999).  
V(D)J recombination is a well characterized site-specific recombination in 
higher eukaryotes which occurs during the development of B and T cells.  In this 
process, an enormous repertoire of immnunoglobulin and T-cell receptor genes is 
produced by bringing together variable (V), diversity (D), and joining (J) sub-exonic 
gene segments in various combinations (Oettinger, 1999).  V(D)J recombination is 
initiated by the generation of blunt DNA-DSBs between recombination signal 
sequences and coding gene segments.  Subsequently, these intermediates are 
resolved by the ligation of pairs of coding ends to form coding joints, and pairs of 
recombination signal sequence ends to yield recombination signal sequence joints 
(Jeggo et al., 1995).  Since site specific DNA-DSBs are introduced during the 
process of V(D)J recombination, there is a mechanistic link between the repair of IR 
induced DNA damage and DNA DSBs formed during V(D)J recombination (Smith 
and Jackson 1999).  Indeed, DNA DSB repair mutants of IR4, IR5, IR6 and IR7 can 
not perform V(D)J recombination effectively (Jackson and Jeggo, 1995). 
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So far, no mutations for DNA-PKcs have been identified in any congenital 
human diseases, suggesting that defects in NHEJ are rare or cause embryonic 
lethality in humans.  However, DNA-PK deficiency leads to increased rates of 
neoplastic transformation in mice.  Mice mutant for DNA-PKCS and/or Ku70 have a 
high incidence of T-cell lymphomas and especially Ku70 knockout mice have 
increased rates of fibroblast transformation (Jhappan et al., 1997).  Fibroblasts from 
Ku80 knockout mice show chromosomal instability associated with chromosome 
aberrations, including breakage, translocations and aneuploidy.  Notably, loss of 
tumour suppressor p53 in Ku80 -/- mice induces early onset of lymphomas 
(Difilippantonio et al., 2000). Tumors obtained from Ku80 and p53 double mutants 
display a specific set of translocations including the immunoglobulin heavy chain 
IgH/Myc locus that is reminiscent of Burkitt Lymphoma (Difilippantonio et al., 
2000).  Combined DNA-PKCS and p53 deficiency also promotes similar 
chromosomal translocations (Vanasse et al., 1999).  These reports suggest that 
chromosomal rearrangements in the double mutant mice primarily result from an 
impairment in the normal NHEJ pathway for resolving V(D)J recombination 
intermediates, which leads to chromosomal translocations with oncogenic potential. 
Interestingly, a radiosensitive human cell line, MO59J, derived from glioma was 
found to be defective in DNA-PKCS expression and DNA-PK activity, indicating a 
role for DNA-PK in cancer formation (Lees-Miller et al., 1995).   
Besides being a DNA-damage activated protein kinase, DNA-PK could have an 
important role in DNA damage signalling.  It is hypothesised that DNA-PK 
activation in response to DNA damaging agents could trigger signalling pathways 
that result in apoptosis and cell cycle arrest.  Consistent with this idea, a gatekeeper 
protein p53 that controls cellular proliferation and apoptosis in response to 
perturbations in genomic DNA, is an in vitro substrate of DNA-PK.  DNA-PK 
phosphorylates p53 at serine 37 and 15 residues, and this has been reported to 
destabilise interactions between p53 and Mdm2, a protein that negatively regulates 
p53 in vivo by targeting it to ubiquitin mediated proteolysis (Kubbutat et al., 1997; 
Lees-Miller et al., 1990; Lees-Miller et al., 1992; Smith and Jackson, 1999). Two 
relatives of DNA-PKCS, ATM and ATR, proteins that have been reported to have a 
role in DNA damage signalling (Durocher and Jackson, 2001), also phosphorylate 
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p53 on serine 15 in vitro (Canman et al., 1998; Khanna et al., 1998).  All these 
reports suggest that DNA-PK may be involved in DNA damage signalling process 
through p53 phosphorylation that results in p53 protein stabilization.  
 
 
1.5.  NUCLEAR MATRIX INVOLVEMENT IN REGULATION OF DNA-PK 
AND DNA-DSB REPAIR 
 
It is clear that DNA-PK plays a key role in DNA DSB repair, however, the 
molecular mechanism it employs during this process is not precisely understood. 
Although several proteins have been found to act as DNA-PK substrates in vitro, 
physiological targets of DNA-PK and factors that regulate its activity are not yet 
known.  
In an attempt to identify these mechanisms, the yeast two-hybrid system was 
applied to screen a cDNA library to identify DNA-PKCS interacting proteins.  As a 
result of this screen, the nuclear matrix protein C1D was identified to interact 
specifically with DNA-PKCS (Yavuzer et al., 1998).  Moreover C1D mRNA and 
protein levels were found to be induced specifically upon γ-irradiation.  C1D can be 
phosphorylated by DNA-PK but is different from all other DNA-PK substrates in the 
sense that, it can activate DNA-PK in the absence of free DNA ends.  These findings 
suggested that C1D might act as an accessory protein to target DNA-PK to nuclear 
matrix constitutively.  In support of this model, Ku80 deficient xrs5 cells were 
reported to have nuclear matrix and envelope alterations compared to their wild type 
controls (Korte and Yasui, 1993; Yasui et al., 1991).  Recently, DNA-PK was shown 
to bind specific regions within matrix attachment regions (MARs) that exhibit a high 
binding affinity to nuclear matrix (Galande and Kohwi-Shigematsu, 2000).  These 
specific regions are called base unpairing regions (BURs) that represent a specialized 
DNA context with an unusually high propensity for base un-pairing under negative 
superhelical strain.  In addition to DNA-PKCS, poly (ADP-ribose) polymerase 
(PARP), Ku70/80, and HMG1 that has been shown to stimulate DNA-PK activity in 
vitro (Watanabe et al., 1994), were identified as BURs binding proteins (Galande and 
Kohwi-Shigematsu, 2000).  BURs were also found at major breakpoint region 
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(MBR) of the untranslated region of BCL2 gene, suggesting that the nuclear matrix 
plays a role in DSB repair and/or recombination (Ramakrishnan et al., 2000).  Taken 
together, there is enough evidence to support the idea that the activity of DNA-PK in 
vivo could be influenced by the nuclear matrix. As being a nuclear matrix protein, 
C1D stands as a good candidate to regulate the in vivo function of DNA-PK. 
 
 
1.6.  NUCLEAR MATRIX PROTEIN C1D 
 
 The ∼30,000 to 40,000 genes of a human being, encoded in 6x 109 base pairs 
of DNA of a total length of almost 2 meters, are packaged into a nucleus 6-8 
micrometers in diameter (Varga-Weisz and Becker, 1998). Several levels of DNA 
compaction exist in eukaryotic nucleus (Figure 2).  The DNA is packed into 
nucleosomes, which consist of a core of histones with 166 DNA base pairs wrapped 
around the core, and resulting chromatin is further compacted into 30 nm fibers 
(solenoids) and DNA loop domains.  These loop domains are anchored to the 
proteinaceous nucleoskeleton, also called nuclear matrix or scaffold through matrix 
attachment regions (MARs) (Laemmli et al., 1978; Paulson and Laemmli, 1977).  
Therefore, nuclear matrix organizes DNA into a dynamic conformation to perform 
complex nuclear processes such as heterogenous nuclear RNA (hnRNA) synthesis 
and processing, replication, DNA repair and recombination (Nelson et al., 1986).  
Nucleus is a complex organelle containing subnuclear domains that 
compartmentalizes different nuclear processes.  The nuclear matrix is the skeletal 
framework of the nucleus consisting of the nuclear-pore lamina, residual nucleoli, a 
network of proteins, DNA and RNA (Nickerson et al., 1995) (Figure 3).  NM 
proteins are non-histone proteins that comprise of 10-25 % of total nuclear protein 
(Berezney et al., 1995).  They are insoluble proteins with strong DNA affinity and 
they remain associated with genomic DNA, especially with highly repetitive DNA 
sequences, even after treatment of harsh denaturants (Werner and Neuer-Nitsche, 
1989).  Phosphodiester bonds between NM proteins and DNA was found to be 
responsible for this strong interaction (Juodka et al., 1991; Neuer et al., 1983).   
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Figure 2: The levels of DNA organization in eukaryotic nucleus 
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C1D is the first nuclear matrix protein characterized at the sequence level.  
The cDNA encoding C1D (human HC1D, X95592; 1995) was initially characterized 
in an assay to identify polypeptides released from rigorously extracted and nuclease 
treated DNA (Nehls et al., 1998).  
In an independent research, C1D was found to be associated with the 
transcriptional repressor RevErb and the nuclear corepressors N-cor and SMRT 
(Zamir et al., 1997) suggesting that it could also be involved in transcriptional 
repression, possibly by recruiting the receptors and repressors to the nuclear matrix  
C1D is physiologically expressed in 50 human cell tissues tested that points 
out its basic cellular function.  However, cellular C1D expression is tightly regulated 
since elevated levels of C1D protein, which was induced by transient vector 
dependent expression, results in apoptotic cell death in cell lines with functional p53 
(Rothbarth et al., 1999).  
All these findings suggest that C1D is a multifunctional protein required for 
the maintenance of the genomic integrity by regulating proteins involved in DNA 
Figure 3: Schemetic view of nucleus 
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repair, recombination or transcription.  If the damage is beyond repair, C1D then 
induces apoptosis thereby protecting the organism from the consequences of 
unrepaired DNA damage. 
Cellular proliferation and growth must be controlled tightly since loss of this 
control can lead to cell death or tumorigenesis.  Any changes in uncontrolled cellular 
proliferation are reflected by changes in complex nuclear processes such as 
transcription, DNA replication, DNA repair-recombination and apoptosis.  As 
nuclear matrix provides a platform for the assembly of protein machines involved in 
complex nuclear processes, components of the nuclear matrix could be important 
targets of tumorigenesis. Aberrant expression of nuclear matrix proteins in cancer 
cells (Yanagisawa et al., 1996) and tight association of nuclear oncoproteins with 
nuclear matrix (Deppert et al., 2000; Galande and Kohwi-Shigematsu, 2000) are the 
recent reports that postulate the importance of nuclear matrix in epigenesis of cancer. 
 The nuclear matrix protein C1D has been identified rather recently and the 
precise biological functions of this protein are not known yet.  However, recent 
findings suggest that C1D may play a role in maintenance of genomic integrity. We 
believe that the identification of biological function of C1D will provide important 
clues in understanding the role of nuclear matrix in etiology of cancer.  Therefore, 
the scope of this project is to identify the biological role of C1D in preservation of 
genomic integrity.   To achieve this aim, two strategies were employed; 
First strategy was to identify C1D interacting proteins through yeast two- 
hybrid screen and characterize the biological significance of these interactions.  The 
involvement of C1D in several nuclear processes indicates that it may be a multi-
functional protein.  Since protein-protein interactions are critical to virtually every 
cellular process and also for nuclear matrix associated processes, it is highly possible 
that C1D performs its functions through associating with other proteins apart from 
DNA-PK.  Identification of these proteins will not only provide important clues 
about the biological function of C1D protein, but also clarify functions of nuclear 
matrix as well.  
Second strategy was identification of the function of S.cerevisiae C1D by 
deleting the C1D gene and analysing the effects of this deletion. Because most of the 
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important genes and cellular events are highly conserved throughout evolution, the 
results obtained using S.cerevisiae will be relevant to the functions of human C1D. 
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CHAPTER 2 
 
 
2.1.  BACTERIAL STRAINS 
 
 
Strain Genotype Usage Source 
M15  
(pREP4) 
F-, NalS, StrS, rif8, lac-, ara-, 
gal-, mtl-, recA+, uvr+ 
purification of recombinant 
proteins with pQE vectors 
QIAGEN 
DH5α F- supE44 hsdR17 recA1 
gyrA96 endA1 thi-1 relA1 
deoR lambda- 
a recA- host for propagation 
and storage of plasmids 
Cold Spring 
Harbour Labs. 
HB101 F- supE44 lacY1 ara-14 
galK2 xyl-5 mtl-1 leuB6 
proA2 delta(mcrC-mrr) 
recA13 rpsL20 thi-1 lambda 
leu deficient strain used to 
rescue library plasmids 
D.E. Ish Horowicz 
 
M15 stain contains multiple copies of pREP4 (kanamycin resistance marker) 
plasmid, which carries the lacI gene encoding the lac-repressor (details could be 
obtained from QIAGEN catalogue). 
Table 1: List of E.coli strains used during the course of this study 
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2.1.1.    Growth and Maintenance of Bacteria 
 
Bacterial strains were stored in 50% glycerol at –700C for long-term storage.  
Strains grown in LB (with or without antibiotic) to mid-log phase or saturation was 
mixed with sterile glycerol with a ratio of 1:1, mixed to homogeneity, and stored at –
700C until required.   Bacteria was recovered by scraping a small amount of cells 
from the frozen stock with an inoculation loop and streaking onto a LB-agar plate 
(supplemented with the appropriate antibiotics if necessary).  
Liquid culture of plasmid carrying E.coli was performed in LB (5 g NaCl,  
10 g Bacto-tryptone, 5 g Yeast Extract, 1 ml of 1 M NaOH, ddH2O added to 1 L) 
with appropriate antibiotic selection.  Liquid cultures were constantly agitated in a 
rotary shaking incubator (~200 rpm) at 370C.  The specialised components of all 
media were obtained from Difco Laboratories Ltd. 
 
 
2.2. YEAST STRAINS 
 
 
Strain/Acc. 
No. 
Genotype Usage Source 
FY1679 Mata/α;ura3-52/ura3-52; 
trp1∆63/TRP1;leu2∆1/LEU2; 
his3∆200/HIS3; GAL2/GAL2 
Diploid wild type 
used to analyse 
function of Yc1d 
EUROSCARF 
FY1679-
08A 
Mata;ura3-52;leu2∆1;trp1∆63; 
his3∆200; GAL2 
Haploid wild type 
used to analyse 
function of Yc1d 
EUROSCARF 
YO1909 BY4741;Mata;his3∆1;leu2∆0; 
met15∆0;ura3∆0; 
YHR081w::kanMX4 
Haploid yc1d 
mutant used to 
analyse function of 
Yc1d 
EUROSCARF 
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Strain/Acc. 
No. 
Genotype Usage Source 
Y11909 BY4742;Matα;his3∆1;leu2∆0; 
lys2∆0;ura3∆0; 
YHR081w:kanMX4 
Haploid yc1d 
mutant used to 
analyse function of 
Yc1d 
EUROSCARF 
Y21909 BY4743;Mata/α;his3∆1/his3∆1; 
leu2∆0/leu2∆0;lys2∆0/LYS2; 
MET15/met15∆0;ura3∆0/ura30; 
YHR081w::kanMX4/YHR08w 
Heterozygous 
diploid 
(YC1D/yc1d) 
mutant used to 
analyse function of 
Yc1d 
EUROSCARF 
Y31909 BY4743;Mata/α;his3∆1/his3∆1;  
leu2∆0/leu2∆0;lys2∆0/LYS2; 
MET15/met15∆0;ura3∆0/ura30; 
YHR081w::kanMX4/YHR08w::k
anMX4 
Homozygote 
diploid mutant 
(yc1d/yc1d); used 
to analyse function 
of Yc1d 
EUROSCARF 
Y00870 BY4741;Mata;his3D1;leu2D0; 
met15D0;ura3ymr284w::kanX4 
Haploid yku70 
mutant used as a 
control for various 
yeast assays. 
EUROSCARF 
Y00540 BY4741;Mata;his3D1;leu2D0; 
met15D0;ura3YML032c::kanM4 
Haploid rad52 
mutant used as a 
control for various 
yeast assays. 
EUROSCARF 
W303 Matα;ade2-1;his3-11,15;leu2-
3,112;trp1-1;ura3 
Haploid wild type; 
used to knockout 
YC1D 
Soo-Hwang Teo 
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Strain/Acc. 
No. 
Genotype Usage Source 
yc1d Matα;ade2-1;yc1d::HIS3;leu2-
3,112;trp1-1;ura3 
Haploid yc1d 
mutant; used to 
analyse function of 
YC1D 
Constructed for 
this study 
Yc1d-yku70 
double 
mutant 
BY4741;Mata;yc1d::HIS3; 
leu2D0;met15D0; 
ura3ymr284w::kanMX4 
Haploid 
yc1d/yku70  double 
mutant; used to 
analyse function of 
Yc1d 
Constructed for 
this study 
AMR70 Matα;his3;lys2;leu2;URA3:: 
(lexAop)8-lacZ GAL4 gal80 
Yeast Two Hybrid 
Assay 
Hollenberg et al., 
1995 
L40 Mata;his3∆200;trp1-910; 
leu2-3,112; 
ade2;LYS2::(lexAop)4-
HIS3;URA3::(lexAop)8-lacZ 
GAL4 gal80 
Yeast Two Hybrid 
Assay 
Hollenberg et al., 
1995 
 
Table 2: List of S.cerevisiae strains used during the course of this study  
 
 
2.2.1.  Growth And Maintenance Of Yeast  
 
Yeast strains were stored in YPAD (10 g Yeast Extract, 20 g Peptone and 
0.1g Adenine dissolved in 900 ml ddH2O, sterilized by autoclaving, cooled to ~ 550C 
and 100 ml of 20% filter-sterilized glucose was added) rich medium with 50% 
glycerol and kept at –700C for long-term storage.  Transformed yeast strains were 
stored in the appropriate minimal YC (1.2 g Yeast Nitrogen Base without amino 
acids, 5 g Ammonium Sulfate, 10 g Succinic Acid, 6 g NaOH and 0.1 g of all amino 
acids apart from Histidine, Uracil, Tryptophane and Leucine dissolved in 900 ml 
ddH2O, and autoclaved) medium to keep selective pressure on plasmid. Yeast cells 
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were recovered by scraping a small amount of cells from the frozen stock with an 
inoculation loop and streaking them onto YPAD- or (appropriate YC) agar plates. 
Transformed yeast strains were plated on selective YC-agar (20 g agar was added to 
900 ml YC medium and sterilized by autoclaving) plates lacking specific amino 
acids that were expressed by yeast plasmid.  Yeast extract, Yeast Nitrogen Base and 
Peptone were purchased from DIFCO Laboratories Ltd. and the rest of the 
components of yeast media were purchased from SIGMA. 
Liquid cultures of yeast were prepared by inoculating one large colony per 5-ml 
medium and incubating the culture at 300C for 16-18 hr with shaking at 230-270 
rpm.  For mid-log phase liquid culture, enough volume of overnight culture was 
inoculated into fresh medium to give an OD600 of 0.2-0.3 and the culture was 
incubated at 300C for 3-5 hours with shaking till it reached to an OD600 of 0.5-0.8.  
The density of cells in a culture was determined by measuring its optical density 
(OD) at 600 nm using spectrophotometer (Beckman Instruments Inc., CA, USA). 0.1 
OD600 value corresponds to 0.5x107 and 0.25x107 cells/ml for haploid and diploids 
strains, respectively. 
 
 
2.3. MAMMALIAN CELLS 
 
COS7 cells derived from kidney of SV40 transformed African green monkey 
was used (ATCC CRL-1651).  They were maintained at DMEM (SIGMA) 
supplemented with 10% Foetal Calf Serum, 1% Streptomycin/Penicillin (both from 
SIGMA) and 2% Fungiozone (GIBCO).  The cells were kept in air supplemented 
with 5% CO2 in a humidified incubator at 370C. 
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2.4. OLIGONUCLEOTIDES  
 
 
2.4.1. Synthesis of Oligonucleotides 
 
The oligonucleotides used for cloning and sequencing purposes were 
synthesized at the Beckman Oligo 1000M DNA Synthesiser (Beckman Instruments 
Inc. CA, USA) at Bilkent University, Department of Molecular Biology and Genetics 
(Ankara, Turkey).  The longer oligonucleotides used in yeast assays and knockout 
experiments were either purchased from IONTEK (Bursa, Turkey) or were provided 
by MCRI (Oxted, U.K.)   
 
 
2.4.2. List of Oligonucleotides Used in This Study 
 
• Sequencing Primers: 
TC187 pACT Forward Primer 
5’ TATCTATTCGATGATGAAGAT 3’ 
 
TC 238 T7-myc-pLink Forward Primer 
5′ CAG AAG CTG ATC TCC GAG 3′  
 
TC239 pGEXTK2 Forward Primer 
5’ CCAAAATCGGATCTGGTT 3’ 
 
TC241 pQE30 Forward Primer 
5′ GAA TTC ATT AAA GAG GAG AAA 3′ 
 
TC240 pCMV-HA Forward Primer 
5’ GACGTCCCTGATTATGCA 3’
 
 
• Primer pairs used for PCR and cloning  
Full-Length TRAX  
TC234 F 5′ AGACGTCGACAAGGATCC ATG AGC AAC AAA GAA GGA TCA 3′ 
 
TC235 R 5′ AGACGTCGACGGATCC CTA AGA AAT GCC CTC TTC 3′ 
 
 
N-Terminal TRAX  
UY29 R 5’AGACGGATCCCTCGAGTTAAGCTTCCACATATTCCTG 3’ 
SalI 
SalI 
BamHI 
BamHI 
BamHI XhoI 
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MutLZ TRAX 
UY30 R 5’AGACGGATCCCTCGAGTTAAGATCTAATTTCTGATTCAGTAAATAT 3’ 
 
UY31 F 5’AGACAGATCTGATGGTGTCAGACAAAAGATA 3’ 
 
 
 
Full-Length Translin  
TC236 F 5′ AGACGTCGACAAGGATCC ATG TCT GTG AGC GAG ATC TTC 3′ 
 
TC237 R 5′ AGACGTCGACGGATCC CTA TTT TTC AAC ACA AGC 3′ 
 
 
Full-Length Human C1D  
UY48 F5’ AGACAGATCTATGGCAGGTGAAGAAATTAATGAAGAC 3’ 
               
UY49 R 5’AGACAGATCTTTAACTTTTACTTTTTCCTTTATTGGCAAC 3’ 
 
 
 
• Primers Used in Yeast Based In-vivo Recombination Assay 
 
Oligonucleotide used for “GV256 Dead” 
 
5’ CTGACTGAGTGAAGATCTTCACTCAGTCAGGAGCT 3’ 
 
 
 
Primer pair used to amplify 800 bp region of LacZ  
 
 F 5’ AGACGGATCCTCCTTTGCGAATACGCCCAC 3’  
 
R 5’ AGACGAATTCTGTGAAAGAAAGCCTGACTG 3’  
 
 
 
 
 
 
 
SalI 
SalI 
BamHI 
BamHI 
Bgl II SacI 
BamHI XhoI Bgl II 
Bgl II 
Bgl II 
Bgl II 
STOP     STOP    STOP 
BamHI 
Eco RI 
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• Primers Designed to Knockout YC1D 
YC1D Disruption Cassette and PCR confirmation 
F5’CAAAGCGGCAACGTCATAACCTTGGTATTTATTGGGCAACGTTTTAAGAGCT
TGGTGAGC 3’ 
R5’CAAAAGTGTTCACTGCCAACTACAAGAATAGCATATACACATTCGAGTTCAA
GAGAAAAA 3’ 
R 5’CGGATCCCGTAGAAATGCTTTTGCCAAGG 3’ 
 
 
2.5.   RECOMBINANT DNA TECHNIQUES 
 
 
2.5.1. Polymerase Chain Reaction 
 
Target DNA sequences between a pair of oligonucleotide primers were 
amplified by using either thermostable DNA Polymerase of T. aquaticus (Taq)(MBI) 
or Pfu DNA polymerase (recombinant enzyme expressed and purified in bacteria, 
was a gift from Emine Ercikan Abali).  A typical 50 µl PCR reaction contained 10-
100 ng of target DNA, 16 pmol of each primer, 2mM of each dNTP (200mM) (MBI 
Fermentes; Cat. No.R0181), 3 mM MgCl2 (25 mM) (SIGMA), 1X Taq Pol buffer 
(SIGMA), and 0.5-1 units Taq DNA polymerase (SIGMA; Cat. No. D-4545).  In 
cases, where longer DNA segments (>1kb) were amplified, 1 µl Pfu DNA 
polymerase was used with 1X Pfu Buffer (10x; 20mM Tris-HCl (pH: 8.0, 100mM 
KCl, 60 mM (NH4)2SO4, 1 % Triton X-100, 100µg/ml nuclease free BSA).  The 
reaction was preheated to 94oC for 4 minutes and then subjected to 25-30 cycles of 
denaturation (0.5 min. at 950C), annealing (1-2 min. at 50C below the estimated Tm of 
the primers, which is generally between 48-550C) and synthesis (1-2 min. at 720C), 
in an automated thermal cycler (Perkin Elmer Gene Amp PCR System 9600).  The 
product was assessed by gel electrophoresis and EtBr staining. 
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The PCR product was purified either by phenol/chloroform extraction and 
ethanol precipitation (Ausubel et al., 1987) or by gel extraction kit (Nucleospin- 
Macherey-Nagel; Cat.No. 740590) according to manufacturer’s instructions.  The 
PCR products were digested with the appropriate restriction enzymes overnight and 
ligated into plasmids accordingly. 
 
 
2.5.2. DNA Purification From Agarose Gel 
 
The desired DNA bands were cut from the agarose gel under UV illumination 
and DNA was extracted from agarose gel slices by Gel extraction kit, Nucleospin 
extract (MN 740590), according to the manufacturer’s instructions. 
 
 
2.5.3. Quantification of DNA 
 
Concentrations and purity of nucleic acids were determined by measuring 
absorbency at 260nm and 280nm in a spectrophotometer (Beckmann PU640 
Instruments Inc., CA, USA).  The ratio between absorbance values at OD260 and 
OD280 was taken.  Nucleic acid samples displaying OD260 and OD280 values in the 
range of 1.8 to 2.0 are regarded as highly pure. The concentration of DNA was 
determined automatically by using oligo/DNA quantitation program of BECKMAN 
spectrophotometer.  
 
 
2.5.4. DNA Sequencing 
 
The automated sequencing of the constructs was carried out on a ABI Prism 377 
sequencer by Birsen Cevher at Bilkent University, Department of Molecular Biology 
and Genetics (Ankara, Turkey). 
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2.5.5.  Enzymatic Manipulation of DNA 
 
2.5.5.1.   Restriction Enzyme Digestion of DNA 
Restriction enzyme digests of DNA were performed in 20-50 µl reactions that 
contained 5-10 units of enzyme/1 µg of DNA with the appropriate buffer.  The 
digests were conducted at 370C for 1-5 hours, depending to the amount of DNA to be 
restricted.  Restriction enzymes were purchased from MBI, ROCHE and GIBCO.   
 
2.5.5.2.  Dephosphorylation of DNA Ends 
Shrimp Alkaline phosphatase (SAP- Roche, Cat. No. 1 758 250) was used for 
dephosphorylation of either staggered or blunt-ended DNA ends to prevent religation 
of plasmid DNA.  After digestion of vector DNA with appropriate restriction 
enzymes, up to 1pmol 5’-terminal phosphorylated DNA fragments (either 5’ 
protruding or 5’ recessive ends) were incubated with 1 unit of SAP at 37oC for 1 hr.  
SAP was inactivated at 65 oC for 15 min and used for ligation.  
 
2.5.5.3.  DNA Ligation 
The DNA to be ligated was purified by phenol extraction, ethanol 
precipitated and resuspended in ddH2O. The vector was dephosphorylated with SAP 
as mentioned above.  Prior to ligation, vector and insert concentrations were checked 
by agarose gel electrophoresis, and a 1:4 vector:insert ratio was maintained in the 
ligation reactions.  Ligations were performed in 15 µl reaction volumes containing 
0.1 µg plasmid DNA and a molar excess of insert DNA in the presence of 1-4 Weiss 
units of T4 DNA ligase (Roche: Cat. No. 481220) with standard ligation buffer 
supplied by the manufacturer.  The reactions were incubated either at room 
temperature for 4-6 hours or at 16oC overnight.   
 
2.5.5.4.  Repairing of 5’-Overhanging Ends to Generate Blunt Ends 
Klenow fragment was applied to convert 5’-extensions to blunt ends that 
were required in cloning experiments.  0.1-4 µg DNA was digested with restriction 
enzymes that produced 5’-overhangs, and was purified with phenol/chloroform 
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extraction followed by ethanol precipitation.  A 20 µl reaction contained 2 µl dNTP 
(0.5 mM each), 2 µl Klenow 10x buffer, 2 µl Klenow enzyme (STRATAGENE; Cat. 
No. 600071), 0.5 µl DTT (1 M stock), 0.5 µl BSA (10 mg/ml). The reaction was 
incubated at 370C for 1 hour and stopped by heating at 750C for 15 minutes. 
 
 
2.5.6. Preparation of Plasmid DNA 
 
2.5.6.1.  Introduction of Plasmid DNA into E.Coli Cells Using Cacl2 
A single colony of appropriate E.Coli strain was inoculated into 5 ml LB and 
the culture was incubated at 370C, 250 rpm overnight.  The saturated culture was 
diluted in 50 ml LB to an OD600 of 0.2-0.3 and grown at 370C incubator with shaking 
at 250 rpm until the OD600 reached to 0.6-0.7.  The cells were pelleted by 
centrifugation at 2500 g, at 40C for 10 minutes, resuspended in 40 ml ice cold 100 
mM CaCl2 and incubated on ice for 1 hour.  The cells were pelleted as above and 
resuspended in 2 ml ice cold CaCl2  (Maniatis et al., 1982).  The competent cells 
prepared by this method were either used immediately or stored at 40C overnight. 
DNA (less than 100 ng) was added to 150 µl competent cells in round bottom 
tubes, and incubated on ice for 30 minutes with occasional flicking.  The cells were 
then exposed to a 90 second heat shock at 420C, chilled on ice for 1-2 minutes, 800 
µl LB was added and incubation continued at 370C for one hour.  The culture was 
then pelleted, resuspended in 100 µl LB, and was spread on L-agar plates 
supplemented with 50 µg/ml ampicillin and/or 25 µg/ml kanamaycin and incubated 
overnight at 370C.   
 
2.5.6.2. High Efficiency Transformation with Quick and Simple Method  
A single colony of appropriate E.coli strain was inoculated into 5 ml LB and 
culture was incubated at 370C shaker at 250-rpm overnight. 250 ml of SOB (0.5% 
bacto-tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 
mM MgSO4, sterilised by autoclaving) was inoculated with appropriate E.coli strain, 
grown to an OD600 of 0.6 at 18-250C shaker at 250 rpm.  The culture was chilled on 
ice for 10 minutes, centrifuged at 2500 g for 10 minutes at 40C.  The pellet was then 
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resuspended in 80 ml of ice-cold TB (10 mM Pipes, 55 mM MnCl2, 15 mM CaCl2, 
250 mM KCl, pH 6.7, sterilised by filtration through 0.45 µm filter, stored at 40C), 
and incubated on ice for 10 minutes.  The mixture was pelleted as above, 
resuspended gently in 20 ml TB and 7% DMSO was added, mixed gently and 
incubated on ice for 10 minutes.  Aliquots of this mixture were then immediately 
chilled in liquid nitrogen, and stored in liquid nitrogen for up to 6 months without a 
significant loss in transformation efficiency. 
For transformation with supercompetent cells, an aliquot was thawed at room 
temperature.  200 µl of the cells was dispersed to round bottom tubes and mixed with 
plasmid DNA (less than 100 ng) and the mixture was incubated on ice for 30 
minutes.  The cells were then exposed to a 30-second heat shock at 42oC, chilled on 
ice for 1-2 minutes, 800 µl SOC (SOB with 20 mM glucose) was added and 
incubation continued at 37oC for one hour with vigorous shaking at 250 rpm.  The 
culture was then pelleted, washed with 1 ml LB and centrifuged again, resuspended 
in 100 µl SOC, and was spread on L-agar plates supplemented with 50 µg/ml 
ampicillin and/or 25 µg/ml kanamaycin and incubated overnight at 37oC (Inoue et 
al., 1990). 
 
 
2.5.7. Plasmid DNA Purification  
 
 2.5.7.1. Small Scale Isolation (Alkaline Lysis Miniprep) 
Small-scale preparation of plasmid DNA was performed by standard methods 
based on NaOH/SDS cell lysis and potassium acetate precipitation of cellular debris 
(Maniatis et al., 1982). 
Cells were harvested by centrifugation (13,000 rpm, 1 minutes, at room 
temperature) from a 1.5 ml overnight culture of bacteria carrying the plasmid of 
interest.  Following resuspension of the bacterial pellet in 100 µl solution I (50 mM 
glucose, 25 mM Tris-Cl, pH 8.0, 10 mM EDTA), 200 µl solution II (200 mM NaOH, 
1% SDS) and 150 µl solution III (3M potassium acetate, 11.5% acetic acid glacial) 
was added, mixed and then protein was extracted with an equal volume of 
  31 
phenol:chloroform 1:1.  The phases were separated by centrifugation (13,000 rpm, 5 
minutes at room temperature) and the DNA was precipitated from the aqueous phase 
by addition of 1 ml cold absolute ethanol.  After washing once with 70% ethanol, the 
pellet was dried and resuspended in 30 µl ddH2O including 10µg/ml DNase-free 
RNase A to destroy the RNA in the product.   
 
 2.5.7.2.  Medium Scale Isolation 
Cells were grown in 30-50 ml LB (containing appropriate antibiotic) 
overnight to saturation and plasmid DNA was isolated by using Nucleobond Ax100 
Midi Prep kit (MN 740573), according to the manufacturer’s instructions. 
 
 
2.5.8.  Expression Vectors and Cloning Strategy 
 
 The way the constructs that were prepared and used during this study have 
been summarized in the table below. The maps of plasmids used in cloning are 
available in Appendix section. 
 
Vector Digest Insert Digest Construct Usage 
pQE30-XhoI 
 
C1D-SalI pQE30-C1D Bacterial expression, 
purification 
pBTM116- 
XhoI 
C1D-SalI pBTM116-C1D Yeast expression 
 TRAX-SalI pBTM116-TRAX Yeast expression 
 Translin-SalI pBTM116-Translin Yeast expression 
 mutLZ-TRAX-SalI pBTM116-mutLZ-
TRAX 
Yeast expression 
 N-TRAX- 
XhoI –SalI  
pBTM116-N-TRAX Yeast expression 
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Vector Digest Insert Digest Construct Usage 
pACT2-XhoI C1D-SalI pACT-C1D Yeast expression 
 TRAX-SalI pACT2-TRAX Yeast expression 
 Translin-SalI pACT2-Translin Yeast expression 
 MutLZ-TRAX- SalI pACT2-mutLZ-
TRAX 
Yeast expression 
pACT2-BamHI C-TRAX-BamHI pACT2-C-TRAX Yeast expression 
pEYFP-BamHI TRAX-BamHI pEYFP-TRAX Subcellular 
localization 
pECFP-BamHI Translin-BamHI pECFP-Translin Subcellular 
localization 
pdsRed1-BglII C1D-BglII pDsRead1-C1D Subcellular 
localization 
T7-myc-pLink-
BamHI 
TRAX-BamHI T7-myc-pLink-
TRAX 
in vitro transcription 
and translation 
 Translin- 
BamHI 
T7-myc-pLink-
Translin 
in vitro transcription 
and translation 
T7-pLink- 
BamHI 
TRAX-BamHI T7-pLink-TRAX in vitro transcription 
and translation 
 Translin-BamHI T7-pLinkTranslin in vitro transcription 
and translation 
T7-myc-pLink-
BamHI 
mutLZ-TRAX- 
BamHI 
T7-pLink-mutLZ-
TRAX 
in vitro transcription 
and translation 
pCMV5’2N3-XhoI C1D-SalI pCMV5’1N3-C1D Expression in 
mammalian cells 
pEGFP-N2- 
EcoRI-BamHI 
TRAX- 
EcoRI-BamHI 
pEGFP-N2-TRAX Expression in 
mammalian cells 
pGV256 ‘Live’ 
- Sac I 
 
Double stranded 
oligonucleotide with 
‘STOP’ codons-SacI 
pGV256-‘Dead’ Expression in yeast 
cells for 
recombination assay 
 
 
 
Table 3: The way the constructs that were prepared during the course of this study 
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2.5.8.1.  Linker Scan and Deletion Mutagenesis 
Linker Scan Mutagenesis method (Ausubel et al., 1987) was applied to 
introduce mutations into the putative leucine zipper motif of TRAX within an 
otherwise intact protein.  MutLZ-TRAX was generated in two steps.  First, the region 
between amino acids 1-194 was isolated by PCR with mismatch primers (TC234/ 
UY30) placing Sal I-Bam HI sites at the 5’ end and a Bgl II site at the 3’ end.  The 
region between amino acids 194-272 was then amplified via PCR, using primers (UY 
31/TC235) that place a Bgl II site at the 5’ end and Sal I-Bam HI sites at the 3’ end.  
The two PCR fragments were digested with Sal I-Bgl II and cloned in a triple 
ligation into the Xho I site of pACT.  This construct produced a mutant TRAX where 
Bgl II site is inserted, which changes the 194th amino acid leucine to arginine and 
preceding lysine to serine. The whole fragment was then cut out with BamHI and 
cloned into T7-Myc-plink, it was transcribed and translated in vitro using TnT 
Coupled Reticulocyte Lysate System (PROMEGA; Cat. No. L4610) to confirm that 
it gives a similar size product to wild type TRAX.  
N- terminal region of TRAX between nucleotides 131-550 (including LZ 
region) was isolated by PCR with TC234 and UY29 primers placing Sal I to 5’ end 
and Xho I to 3’end. Then, this construct was cloned into XhoI site of pACT2.   
 
 
2.5.8.2.   Construction of “pGV256 Dead” 
The oligonucleotide that contains a unique restriction enzyme site (Bgl II) in 
the middle, which is preceded by ‘STOP’ codons (“TGA” in three different reading 
frames, see section 2.4.2) was designed as a self-annealing primer and a Sac I 
restriction half-site was placed at the 3’-end. To obtain double-stranded 
oligonucleotide, 10 ng of primer was incubated at 950C for 2 minutes, 700C for 10 
minutes, followed by at 370C for 10 minutes and finally, incubated at room 
temperature for an additional 10 minutes.   As shown below, after hybridization the 
double-stranded oligonucleotide has a Bgl II site in the middle, flanked by “STOP” 
codons (indicated in bold) in different reading frames, with a Sac I site at both ends 
mimicking the digested sequence. 
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   5’ CTGACTGAGTGAAGATCTTCACTCAGTCAG GAGCT 3’ 
3’  TCGAGGACTGACTCACTTCTAGAAGTGAGTCAGTC 5’ 
 
 
Nascent synthetic oligonucleotides lack a 5’ phosphate group and thus cannot 
be directly ligated to other DNA, such as plasmids or other oligonucleotides, 
therefore it is necessary to phosphorylate with T4 polynucleotide kinase.  In a typical 
reaction 100 ng of oligonucleotide was phosphorylated in a 50 µl volume containing 
5 µl 10X kinase buffer, 2 mM ATP, and 1 µl T4 polynucleotide kinase.  The reaction 
was incubated at 370C for 1 hour and phosphorylated oligonucleotide was recovered 
by phenol:chloroform extraction and ethanol precipitation.  Next, the 
pGV256’Live’plasmid was digested from the unique Sac I site within the LacZ 
coding sequences and the phoshorylated oligonucleotide was ligated as described in 
2.5.5.3. The ligation product was then transformed into the bacterial strain DH5α and 
transformed cells were plated on X-gal (25 µg/ml), IPTG (0.1 mM) and ampicillin 
(50 µg/ml) containing LB agar plates to select white colonies harbouring plasmid 
with a disrupted LacZ (pGV256 Dead).  The clones were further confirmed by 
isolating the DNA and digesting with  Bgl II and Bam HI restriction enzymes, which 
give a ∼2250 bp fragment.   
 
 
2.6. YEAST TECHNIQUES 
 
 
2.6.1. Yeast Two-Hybrid Screen 
 
The yeast two-hybrid screen was performed as described previously using a 
B-lymphocyte cDNA library in pACT (Harper et al., 1993) and full-length C1D in 
fusion with the DNA-binding domain of bacterial LexA protein (DBD-C1D) 
(Yavuzer et al., 1998).  The yeast strains and the control plasmids (DBD-Lamin and 
Bgl II Sac I 
Sac I 
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DBD-Daughterless) were kindly provided by S. Hollenberg.  S. cerevisiae L40 
(MATa trp1 leu2 his3 LYS2::lexA-HIS3 URA3::lexA-lacZ) was grown at 300C in 
YPAD medium and was transformed with DBD-C1D.  Human B-lymphocyte cDNA 
library was then transformed into this strain using large scale transformation (lithium 
acetate method).  Double transformants were plated on selective medium lacking 
Trp, Leu, His, Lys and Ura and were grown at 300C for 3 days.  Colonies were 
transferred on Whatman 40 filters to test for β-galactosidase activity using X-gal (5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside).  Positive clones were rescued and 
tested for specificity by mating analysis or retransforming into L40 together with the 
control plasmids mentioned above.  For the mating assay, DNA from positive clones 
was extracted using glass beads and then transformed by electroporation into the 
bacterial strain HB101, which has a defect in the leuB gene that can be 
complemented by LEU2 from yeast and therefore provides selection of the library 
plasmids.  The transformants were plated onto M9 medium containing ampicillin and 
proline and incubated at 370C for 24 hours.  DNAs of 5 colonies from each plate 
were then isolated by the alkaline lysis method and transformed into the yeast strain 
AMR70 (MAT α, his3 lys2 trp1 leu2 URA3::lexAop)8-lacZ) and were mated with the 
L40 strain carrying the bait plasmid.  The details of this screen including large-scale 
library transformation, elimination of false positives and database search has been 
written in MSc thesis of Bleda Bilican (Bilican, 1999).  
 
 
2.6.2. Two-Hybrid Assay 
 
S.cerevisiae L40 strain was used in yeast two-hybrid assays. L40 can detect 
weak LexA activators as histidine prototrophs without the use of 3-aminotriazole (3-
AT).  The expression of the LacZ and HIS3 coding sequences are driven respectively, 
by minimal GAL1 and HIS3 promoters fused to multimerized LexA binding sites.   
The LexA DNA binding domain fusion vector pBTM116 poly-stop, was modified by 
U. Yavuzer from the original plasmid constructed by S. Fields. It carries the TRP1 
gene and has a polylinker downstream of LexA coding sequence.  
  36 
The Gal4 activation domain fusion vector pACT (Kindly provided by S. Elledge), 
carries the LEU2 gene and contains NLS-Gal4-linker unit driven by the ADH 
promoter.  The cDNAs of proteins to be analysed are cloned into one of these 
plasmids in fusion with DBD or AD.  They were then transformed into yeast as 
described below and  β-galactosidase activity was measured as in 2.6.4 or 2.6.5. 
 
 
2.6.3. Small Scale Yeast Transformation 
 
10 ml YPAD was inoculated with a yeast colony and culture was incubated 
overnight at 300 C.  Then saturated culture was diluted to an OD600 of around 0.2-0.3 
in 50 ml YPAD and incubated an additional 2-4 hours till mid-log phase.  Cells were 
centrifuged at 2500 rpm for 5 minutes at room temperature and cell pellet was 
resuspended in 40 ml TE.  Cells were re-centrifuged at the same speed and cell pellet 
was resuspended in 2 ml of 100 mM LiAc (LiAc/ 0.5XTE, filter sterilized) and 
incubated at room temperature for 10 minute. 1 µg plasmid DNA and 100 µg 
denatured salmon sperm DNA (SIGMA) were distributed to tubes and 200 µl yeast 
suspension was added on them and all the ingredients of tube were mixed well.   700 
µl of 100 mM LiAc/40% PEG-3350/ 1XTE was added to tubes and tubes were 
incubated at 300 C for 30 minutes on a rotating wheel.  After incubation, 88 µl 
DMSO was added, heat shock was applied at 420 C for 7 minutes. Cells were 
centrifuged for 10 sec, supernatant was discarded and pellet was resuspended in 1 ml 
TE.  One more time, cells were collected by centrifuge and pellet was resuspended in 
50-100 µl TE.  Cells were plated on selective plates and incubated at 300C incubator 
for 3 days till colonies were detected. 
 
 
2.6.4.  Colony -Lift β-Galactosidase Assay Using X-gal as a substrate   
 
Colonies were transferred on to nitrocellulose filter (HYBOND C; 
Amersham).   Filter was removed and was placed, colony side-up, in an aluminium 
boat floating in liquid nitrogen and then was immersed into the liquid nitrogen for 30 
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seconds. After allowing enough time for the filter to thaw at room temperature, it 
was transferred to a petri dish containing one Whatman filter circle (100mm) soaked 
in 1.5 ml Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4 
and β-Mercaptoethanol (2.7 ml/lt) that was added freshly to the buffer) and 150 µl 
X-gal (SIGMA, 50 mg/ml).  The dish was covered, fixed and plates were incubated 
in a 300C incubator for 2-3 hours till blue colour appeared.   Depending to the 
strength of protein-protein interactions, the time for the blue colonies appearing 
varied from 30 minutes-3 hours. 
 
 
2.6.5.  Liquid Culture Assay Using ONPG as a Substrate 
 
For quantification purposes, liquid cultures were assayed for β-Galactosidase 
activity using ONPG (o-nitrophenyl β-D-galactopyronoside) as a substrate.  The 
detailed protocol for this assay can be found in CLONTECH- Matchmaker library 
manual.  Briefly, a yeast colony was grown at 300C to mid-log phase (OD600) and the 
exact OD600 was recorded. 1.5 ml of culture was placed to three eppendorf tubes and 
cells were centrifuged at max-speed for 30 seconds, supernatant was removed and 
cell pellet was resuspended in 1 ml Z buffer. 0.1 ml of suspension was removed to a 
new tube and the cells were lysed by 3 freeze-thaw cycles.  700 µl of Z buffer and 
160 µl of ONPG (4 mg/ml) was added to 100 µl of lysate and incubated at 300C till a 
yellow colour appeared.  The reaction was stopped by addition of 400 µl 1 M 
Na2CO3  and OD420 of the samples were read.  β-galactosidase units were calculated 
according to the formula: 1000 x OD420/ (t x V x OD600) where “t” is elapsed time (in 
minutes) of incubation and “V” is 0.1 ml x concentration factor. 
 
 
2.6.6. Extraction of Yeast Proteins 
 
 5 ml of appropriate yeast medium was inoculated with a very small mass of 
yeast colony from a plate and incubated overnight to give an OD600 of 0.5-2.0.  1 
OD600 units of cells were transferred to a tube containing 1 ml of 50 mM Tris (pH 
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7.5) on ice.  Cells were centrifuged and cell pellet was suspended in 15 µl ESB (2 % 
SDS, 80 mM Tris pH:6.8, 10 % Glycerol, 1.5 % DTT and 0.1 mg/ml Bromophenol 
blue).  After boiling of cell suspension at 1000C for 3 minutes, the glass beads (425-
600 microns, Acid washed SIGMA, Cat. No.G-8772) were added and cell-glass bead 
suspension was mixed by vigorous vortexing for 2 minutes.  Finally 35 µl of ESB 
was added to the sample, briefly vortexed and boiled for additional 1 minute. Tubes 
were briefly centrifuged and 5-20 µl of supernatant was loaded on a SDS gel to 
analyse protein expression. 
 
 
2.6.7.  Colony- PCR  
 
  A small glob of yeast cells were suspended in 30 µl of sterile ddH2O (fewer 
cells is better than too many).  10 µl of yeast cell suspension was added to the 40 µl 
PCR reaction mix including 50 pmol of each primers, 2 mM of each dNTP (200 
µM), 2 mM MgCl2 (25 mM), 1xTaq Buffer and 2 units of Taq Polymerase.  PCR 
was carried out for 30 cycles under the following conditions; denaturation at 940C for 
4 minutes, annealing at 500C 1 minute, extension at 720C for 2 minutes and final 
extension at 720C for 10 minutes.  An aliquot of PCR product was analysed by 
agarose gel electrophoresis to verify amplification.  
 
 
2.6.8.  In vivo Plasmid-based Repair Assay  
 
3 µg of S.cerevisiae-E.coli shuttle plasmid, pRS313 (HIS3 reporter) was 
linearized with different restriction endonucleases (10 unit from each) to produce 5’- 
(BamHI digest), 3’- overhanging ends (SacI and PstI digests) or blunt ends (SmaI 
digest).  Linearized plasmid was then purified from the agarose gel using gel 
extraction kit (see section 2.5.2) and 100 ng of the linearized and supercoiled 
versions of the plasmids were transformed into yeast strains in parallel by using 
small scale yeast transformation (see section 2.6.3).  Transformed yeast cells were 
plated on histidine deficient YC agar plates and incubated at 300C for 3-4 days until 
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yeast colonies appeared.  NHEJ efficiency of yeast strain was determined by 
counting the number of colonies harbouring re-ligated plasmid on each plate and 
normalizing the potential minor differences in transformation efficiencies between 
various yeast strains with the supercoiled version of the same plasmid.   For NHEJ 
accuracy assays, SacI-linearized and supercoiled forms of  “pGV256 Live” was used.  
  
  
2.6.9.  In vivo plasmid-based Homologous Recombination Assay 
 
Initially, 5 µg ‘pGV256 Dead’ plasmid (URA3) was linearized with Bgl II 
and was purified from the agarose gel by gel extraction kit.  A 800 bp region of LacZ 
coding sequences encompassing the region where the ‘STOP’ codons were 
integrated was amplified by PCR from the ‘pGV256 Live’ plasmid using ‘LacZ 
forward and reverse primer pair.  Amplified LacZ fragment (10 ng) was transformed 
into the recipient yeast strain together with the Bgl II-digested linear ‘pGV256 Dead’ 
plasmid (90 ng) by using small yeast transformation. Transformed yeast cells were 
plated on uracil deficient YC agar plates and incubated at 300C for 3-4 days.   After, 
the colonies appeared, colony lift β-Galactosidase assay using X-gal as a substrate  
was performed and number of colonies were counted.   The ratio of blue colonies 
over the total number of colonies on plates reflects HR for that particular yeast strain. 
 
 
2.6.10.  HO Endonuclease Sensitivity Assay  
 
The pCHOL(LEU2), that expresses homothallic switching (HO) 
endonuclease under the control of GAL I promoter was kindly provided by Allison 
Rattray, Fred Hutchinson Cancer Research Centre, U.S.A.  This plasmid was 
transformed into the appropriate yeast strains and the transformants were grown to 
mid log phase (OD600: 0.5-0.8), washed two times with ddH2O and resuspended in 
YC-Leu minus liquid medium containing either glucose (2%) or galactose (2%) as 
carbon source.  Samples were taken at various time points, the number of cell 
determined by measuring OD600 and cells were plated on non-selective YPAD plates.  
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The survival rate was calculated as the proportion of colony forming units to total 
cells and was normalized to the number of colonies before galactose induction 
(Downs et al., 2000). 
 
 
2.6.11.  Phenotype analyses 
 
  Mid-Log phase liquid yeast cultures were prepared by inoculating one large 
colony per 5-ml medium and incubating the culture at 300C for 16-18 hr with 
shaking at 230-270 rpm. The culture was then diluted in TE six times by serial 10-
fold dilutions.  Aliquots (5 µl) of each dilution was spotted on YPAD plates with or 
without MMS (0.01 %, SIGMA) and were then incubated at 300C for 3-4 days to 
analyse sensitivity towards MMS.  To analyse temperature sensitivity of yeast 
strains, serial dilutions of yeast strains spotted on YPAD plates were incubated either 
at 300C or 390C for 3 days.  For u.v. and γ-irradiation sensitivity, serial dilutions of 
yeast strains spotted on YPAD plates in duplicates were exposed to either u.v. 
irradiation at 100 j/m2 (UV Stratalinker 1800, STRATAGENE) or 50 Gy of gamma 
(Cs137) source, followed by incubation at 300C for 3-4 days.  The photos of the plates 
were captured with Biorad Multi Analyst Software.  As we don’t have a gamma 
(Cs137) source at Bilkent University, irradiation experiment was performed at Marie 
Curie Research Institute by U.Yavuzer. 
 
 
2.7.  CELL CULTURE TECHNIQUES 
 
 
2.7.1. Maintenance and Subculturing of Cells 
 
COS7 cells were grown as monolayers in culture flasks or petri dishes in a 
medium mentioned in section 2.3. Cells were subcultured twice a week using 
Trypsin/EDTA (BICHROM, Cat. No. L2143) for detachment. The medium was 
aspirated and Trypsin/EDTA solution was added to the petri dish or culture flask and 
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was incubated at 370C for 30 seconds. After removal of Trypsin/EDTA solution, the 
flask was kept at 370C incubator for an additional 10 minutes. Then cells were 
detached by tapping flask/petri dish gently and the cells were collected in 10 ml 
growth medium. Cell suspension was centrifuged at 2000 rpm for 5 minutes at 40C 
and the pellet was resuspended in fresh medium and diluted to a concentration of 
2x105cells/ml and placed into a new culture dish.   
 
2.7.1.1.   Cryopreservation of Cells 
Pre-confluent cells were trypsinized, pelleted and resuspended in freezing 
medium (DMEM including 10 % DMSO and 5% FCS).  1 ml of cells (approximately 
3-5x106 cells) was delivered into each freezing vial and vials were placed into –800C 
freezer overnight.  Next day, vials were transferred into a liquid nitrogen chamber 
quickly. 
 
2.7.1.2.  Thawing of Frozen Cells 
Frozen cells were thawed quickly in a 370C water bath and directly 
transferred into growth medium.  Cells were collected at 2000 rpm for 5 minutes at 
40C.  Pellet was resuspended in growth medium and transferred to medium in flask. 
 
2.7.1.3.    Estimation of Cell Number by haemocytometer Counting 
 Cells were trypsinized and resuspended in growth medium. Using pasteur 
pipette, 1 ml from cell suspension was taken into an eppendorf and 10 µl was 
delivered into each side of the cover-slipped haemocytometer by capillary action. 
Cells in the middle square were counted in both chambers (up and down), mean 
value of number of cells was taken and multiplied by 1x104 to give the number of 
cells per millilitre in the sample counted (Spector et al., 1997) 
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2.7.2.  Transient Transfections  
 
2.7.2.1. Transfection Using FuGENETM 6  
FuGENE 6 Transfection Reagent (Roche, Cat.No. 1814443) is a multi-
component lipid based transfection reagent that complexes with and transports DNA 
into the cell during transfection. It provides very high transfection efficiency, 
demonstrates no cytotoxicity and requires minimal optimization compared to other 
methods employed for mammalian cell transfections.  
The day before transfection, COS7 cells were plated into 35 mm 6-well plates 
at a density of 3x104.  Transfections were performed using FuGENE 6 transfection 
reagent with 0.5 µg of DNA according to the manufacturer’s instructions.  Cells were 
harvested 24 hours after transfection for the following immunoprecipitation 
experiment. 
 
 
2.8.  BIOCHEMICAL TECHNIQUES 
 
 
2.8.1.  Immunoprecipitation 
 
 This technique was used to analyse the protein/protein interactions in 
mammalian cells.  The plasmids expressing the desired proteins were initially 
transfected into the mammalian cells as described above and the protein complexes 
were purified by the aid of antibodies and interactions were detected by 
immunoblotting using the corresponding antibodies.  
 
2.8.1.1. Cell Lysis and Sample Preparation 
24 hours following transfection, tissue culture plates were placed on ice, 
growth medium was removed, and cell monolayer was washed twice with ice cold 
PBS. Cell lysis buffer, NET-N, [150 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl pH 
8.0, 0.5% NP40, 10 % Glycerol, and 1x CompleteTM protease inhibitor (ROCHE, 
Cat. No. 1873580) was added to the monolayer (0.3 ml for a 35-mm dish, 0.6 ml for 
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a 60-mm dish, or 1 ml for 100-mm dish) and then cells were incubated on ice for 30 
minutes with occasional agitation.  The cells were scraped to one side of the dish 
with a rubber policeman and transferred into a fresh eppendorf. Samples were 
centrifuged for 10 minutes 12,000xg at 40C and supernatants were transferred to a 
fresh tube.  
 
2.8.1.2. Antibody Incubation and Purification of Cellular Proteins 
The supernatant, which is the total cell lysate, was removed into a new tube 
and was incubated with either anti-GFP (Clontech) or anti-HA monoclonal antibody 
(Roche) for 2 hours on a rotating wheel.  Meanwhile, 50 µl of the homogenous 
protein A/G agarose suspension (25 µl bed volume) (Protein A-Agarose, Roche, Cat. 
No. 1719408; Protein G-Agarose, Roche, Cat. No.1719416) per sample was washed 
three times with 0.5 ml of NET-N lysis Buffer (10 minutes washing followed by 5 
minutes centrifugation at 2500 rpm to remove supernatant).  After 2 hours incubation 
period, the cell lysate/antibody mix was added onto the equilibrated beads and was 
incubated for further 2 hours.  The beads were collected at the end of the incubation 
by centrifugation at 2500 rpm for 5 minutes and the supernatant was removed.  Then 
the beads were washed four times with 0.5 ml of Lysis buffer as described before.  
After the last wash, supernatant was discarded and the beads were resuspended in 20 
µl of 2x SDS Loading Buffer.  The samples were boiled for 5 minutes, centrifuged at 
full speed for 5 minutes and then loaded on to SDS-PAGE gel.   
 
 
2.8.2.  Immunoblotting 
 
Following SDS-PAGE, proteins were transferred from the gel onto a 
nitrocellulose membrane by Mini Trans-Blot Electrophoretic Transfer Cell (BIO 
RAD, Cat. No. 170-3930).  Nitrocellulose membrane (Schleicher & Schuell, Protran 
BA 85 Cellulosenitrate, Cat. No. BB0451-1) and the filter paper (3MM Whatman) 
were cut according to the dimensions of the gel. The nitrocellulose paper was soaked 
in ddH2O and wetted by capillary action from the bottom.  The gel, nitrocellulose 
membrane, filter papers and filter pads were equilibrated in transfer buffer (For 
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proteins with a molecular weight 80 kDa-400 kDa; 50mM Tris, 380 mM Glycine, 
20% Methanol, 0.1% SDS (10% stock), and for proteins ≤80 kDa; 25 mM Tris, 192 
mM Glycine, 20% Methanol) for 15 minutes to 1 hour depending on gel thickness. 
Then the transfer stack was prepared in the following order starting from the side that 
would face the cathode: one pre-wetted fiber pad, one sheet of 3 MM Whatman 
paper, the gel, pre-wetted nitrocellulose membrane, one sheet of Whatman paper and 
finally the second fiber pad. The transfer stack was then placed into the tank filled 
with transfer buffer and transfer was performed at 100V for 1 hour for proteins with 
molecular weights smaller than 150 kD and at 40V for 3 hours for bigger proteins. 
After the transfer, the membrane was washed twice with TBS-T (TBS + 0.5% 
Tween-20), and incubated in 50 ml of blocking solution (10% non-fat dry milk in 
TBS-T) with continuous shaking for 1 hour at room temperature or overnight at 40C.  
The membrane was briefly rinsed using two changes of washing buffer then washed 
once for 15 minutes and twice for 5 minutes with fresh changes of the washing buffer 
at room temperature. While membrane was being washed, primary antibody was 
diluted to 1/1000-5000 in 2.5% non-fat dry milk in TBST (TBS with 0.2% Tween 
20). The membrane was incubated in diluted primary antibody for 1 hour at room 
temperature or overnight at 40C. Membrane was washed as indicated previously. 
HRP (Horse raddish peroxidase) conjugated secondary antibody was diluted to 
1/10,000 in 2.5 % non-fat dry milk in TBST and the membrane was incubated in 
diluted secondary antibody for 1 hour at room temperature. Membrane was washed 
as indicated previously.  
For detection ECL (Enhanced ChemiLuminescence; Amersham Pharmacia 
Biotech, Cat. No. RPN2106) was carried out according to the manufacturer’s 
instructions.  
The complete removal of primary and secondary antibodies from membrane 
is possible. The membrane could be stripped of bound antibodies and re-probed 
several times using different antibodies. For this purpose, the membrane was 
submerged in stripping buffer (100 mM 2-mercaproethanol, 2% SDS, 62.5 mM Tris-
HCL pH 6.7) and incubated at 500C for 30 minutes (For more stringent conditions 
temperature can be increased up to 700C). The membrane was washed twice for 10 
minutes in TBST at room temperature using large volumes wash buffer. The 
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membrane was blocked in blocking reagent for 1 hour and immunoblotting was 
performed as described above. 
 
 
2.8.3.  In Vitro Transcription and Translation 
 
The in vitro transcription and translation of target proteins were carried out 
with the TnT Coupled Reticulocyte Lysate Kit (Promega), according to the 
manufacturer’s instructions using radioactively labelled methionine (S35).  Samples 
were resolved on a SDS-PAGE gel.  Following electrophoresis, the proteins were 
fixed by using a fixing solution [isopropanol:water:acetic acid (25:65:10)] for 30 
minutes and then the gel was soaked in Amplify solution (Amersham) for 15-30 
minutes.  The gel was then dried under vacuum at 700C for 1 hour. Dried gel was 
exposed to X-ray film and stored at –800C overnight. After exposure, the film was 
developed using Hyper Processor (Amersham). 
 
 
2.8.4.  Ni-NTA Pull Down Assays 
 
His-tagged C1D (pQE-C1D) and His-tagged hepatitis-C virus core protein, 
p16 (kindly provided by Mehmet Ozturk) were expressed in E.coli, purified under 
denaturing conditions and immobilized on Ni-NTA beads according to the 
manufacture’s instructions (Qiagen).  The details of these protocols can be found in 
MSc thesis of Dilhan Oncel (Oncel, 2001).  10 µg of radiolabelled in vitro 
transcribed and translated protein product and the immobilized fusion proteins were 
incubated in 200 µl binding buffer (20% Glycerol, 100 mM NaCl, 0.1xTE pH 8.0, 
0.1% NP-40, 1 mM DTT, 30 µg BSA) at room temperature for 20 minutes followed 
by four washes using wash buffer (20% Glycerol, 100 mM NaCl, 0.1xTE pH 8.0 and 
0.5% NP-40).  The beads were then resuspended in 20 µl of 2xSDS sample buffer, 
boiled, centrifuged at 13,000 rpm for 5 minutes and loaded on 10% SDS-PAGE.  The 
gel was dried and visualized by autoradiography.  
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2.9.  GEL ELECTROPHORESIS 
 
 
2.9.1.  Agarose Gel Electrophoresis 
 
DNA fragments were separated by gel electrophoresis using agarose at 
concentrations of 0.8-2.0% w/v in 1x TBE buffer.  Samples were mixed with loading 
dye (8% deionised formamide, 1xTBE and 0.1% bromophenol blue) and the samples 
were loaded onto the gel and electrophoresis was performed at 100V.  When the run 
was complete, the gel was stained in 1x TBE containing 0.1% EtBr for 5 minutes and 
rinsed with dH20.  DNA fragments were visualised by using UV transilluminator.  
The gel photos were captured with BioRad Multi-Analyst Software running on a PC 
and a hardcopy was produced by Lexmark Optra laser printer. 
 
 
2.9.2. Denaturing Discontinuous Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
 
Electrophoretic separation of proteins under denaturing conditions was 
performed as described in Current protocols (Ausubel et al., 1987).  Resolving gels 
were made up to the required concentration, 5-15%, from a 40% acrylamide stock 
solution (38% acrylamide, 2% bisacrylamide, Severn laboratories).  The 
electrophoresis apparatus (Mini-Protean 3, BioRad) was assembled according to 
manufacturer’s instructions.  Acrylamide stock solution (to the desired gel 
percentage) and 1x Lower Buffer solution (4xTris-Cl/SDS pH 8.8; 1.5 M Tris-HCl 
containing 0.4 % SDS) were mixed in ddH2O and 10% ammonium persulphate and 
TEMED (20 µl and 5 µl, respectively, for a 5 ml solution) were added and stirred 
gently. Immediately the mixture was poured into the gap between the glass plates so 
that sufficient space is left for the stacking gel and water saturated isobutanol was 
added slowly to cover the top with a layer. After the polymerisation, the isobutanol 
layer was removed, rinsed with water several times. The stacking gel was prepared 
by mixing 3.9% acrylamide, 1xUpper Buffer (4x Tris-Cl/SDS pH 6.8; 0.5 M Tris-Cl 
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containing 0.4 % SDS), 20µl of 10% ammonium persulphate, and finally 5 µl of 
TEMED (for 5 ml) in ddH2O and was poured onto the top of the resolving gel.  The 
comb was immediately inserted into the stacking gel avoiding the formation of 
bubbles.  After the stacking gel polymerised, the comb was carefully removed and 
the wells were rinsed with the SDS running buffer (25 mM Tris, 192 mM Glycine 
0.1 % SDS) remove any unpolymerised acrylamide.  The samples were mixed with 
appropriate volume of 2x SDS loading buffer (For 10 ml final volume; 2.5 ml 4x 
Tris.Cl/SDS, pH 6.8, 2 ml glycerol, 0.4 g SDS, 0.2 ml 2-BME or 0.31 g DTT, 0.1 mg 
bromphenol blue), boiled at 100oC for 5 minutes to denature proteins, centrifuged at 
full speed for 5 minutes, and then loaded on to gel.  Gels were run at 70V until the 
samples left the stacking gel.  As the samples entered to the resolving gel the voltage 
was raised to 100V. After the electrophoresis, gel was carefully removed and stained 
in Coomassie Brilliant Blue (0.25% Coomassie Brilliant Blue G250, 45% methanol, 
10% acetic acid) for 20 minutes, and destained in a solution of 30% methanol, 10% 
acetic acid, and 60% deionised distilled water for 1-4 hours. Alternatively gels were 
subjected to electrophoresis for the purpose of immunoblotting. 
 
 
2.10.  MICROSCOPY AND MICROPHOTOGRAPHY 
 
Vectors expressing C1D, TRAX, and Translin in fusion with GFP and 
various GFP variants were transiently transfected into COS7 cells as described in 
section 2.8.4. 24 hours after transfection, the expression of the fusion proteins were 
examined in the control and γ-irradiated living cells for 24 hours.  Florescence 
microscopy was performed on a Zeiss Axiovert 135TV microscope equipped with a 
CCD camera (Hitachi Denshi, Ltd) and appropriate filter sets, and the images were 
processed by using OpenLab software (Improvision).  All the expression plasmids 
were constructed at Bilkent University, however, as we do not have a flourescence 
microscope equipped with different filter sets and also a γ-irradiation source, the 
microscopic analyses and γ-irradiation experiments were performed at Marie Curie 
Research Institude by U.Yavuzer and B. Bilican. 
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 2.11.  RADIOCHEMICALS 
 
 [35S]methionine and [γ-32P]ATP were   supplied by Amersham International 
and DuPont NEN. 
 
 
  2.12.  EQUIPMENT 
 
The following equiments were routinely used during this study: Automatic 
pipettes (Rainin), filter and 3MM paper (Whatman), GeneAmp PCR System 9600 
(Perkin Elmer), heating blocks (Stuarts Scientific), benchtop centrifuge (Heraus 
Instruments), Avanti J-25I centrifuge (Beckman), gel tanks for agarose (E-C 
Apparatus Corporation), Mini-PROTEAN 3 Cell (BioRad), spectrophotometer 
DU640 (Beckman), power supply PAC 300(BioRad), pH meter (Beckman), UV 
transilluminator (Herolab), Slab Gel Drier (Savant), Mini Trans-Blot (Biorad). 
 
 
2.13.  STANDARD SOLUTIONS AND BUFFERS 
 
Dithiothreitol (DTT), 1 M 
1.545 g DTT was dissolved in 10 ml ddH2O, store at –20oC 
 
EDTA (ethylenediamine tetraacetic acid), 0.5 M pH 8.0 
186.1 g Na2EDTA.2H2O was dissolved in 700 ml ddH2O, pH adjusted to 8.0 with 10 
M NaOH, volume completed to 1 liter 
 
Ethidium Bromide, 10 mg/ml 
0.2 g was dissolved in 20 ml ddH2O 
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NaCl, 5 M 
29.2 g was dissolved in 100 ml ddH2O 
 
NaOH, 10 M 
200 g NaOH was dissolved in 500 ml ddH2O 
 
Sodium Acetate, 3 M 
40.8 g sodium acetate.3H2O was dissolved in 60 ml ddH2O. After pH adjustment to 
4.8-5.2 with 3 M acetic acid, volume was completed to 100 ml. 
 
 Tris-Cl, pH 8.0 
121 g Tris base was dissolved in 800 ml ddH2O. After  pH was adjusted to 8.0 by 
adding 58.4 ml 0.1 M HCl, volume was completed to 1 liter.   
 
Phosphate-Buffered Saline (PBS) 
 
Working Solution, ~pH 7.3:                            10x Stock Solution (1lt): 
137 mM NaCl                                                  80 g NaCl 
 2.7 mM KCl                                                   2 g KCl 
 4.3 mM Na2HPO4.7H2O                                 11.5 g Na2HPO4.7H2O 
 1.4 mM KH2PO4                                             2 g KH2PO4  
 
Tris Buffered Saline (TBS) pH 8.0, 1 lt 
2.42 g Tris base (20 mM) 
8 g NaCl (137 mM) 
3.8 ml HCl 
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TBE Buffer:  
Working Solution:                                          10x Stock Solution (1lt): 
 45 mM Tris-borate                                         108 g Tris Base 
   1 mM EDTA.                                                 55 g  Boric Acid 
                                                                          40 ml 0.5 M EDTA, pH 8.0 
 
 
TAE Buffer: 
Working Solution                                           50x Stock Solution (1lt) 
0.4 M Tris acetate                                           2 M Tris Base (242 g) 
0.001 M EDTA                                               57.1 ml Glacial Acetic Acid 
                                                                        50 mM EDTA 
 
1x TE: 
10 mM Tris, pH 8.0 
1 mM EDTA, pH 8.0  
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CHAPTER 3  
 
IDENTIFICATION OF C1D INTERACTING PROTEINS 
 
 
3.1.  IDENTIFICATION OF C1D INTERACTING PROTEINS USING YEAST 
TWO HYBRID SCREEN 
 
This assay relies on two fundamental properties of eukaryotic transcription 
factors.  They typically have modular structure with at least two discrete domains; a 
DNA binding domain (DBD) and an activator domain (AD). These two domains 
need not to be covalently linked and can be brought together by interaction of any 
two polypeptides.  The application of this system requires two constructs: a DBD 
fused to a bait protein, X, and AD domain fused to a prey protein, Y.  These two 
hybrids are expressed in a yeast recipient cell containing one or more reporter genes. 
If the X and Y proteins interact, they built a functional activator by bringing the 
activation domain in close proximity with the DNA binding domain which can be 
detected and/or selected by expression of reporter genes (Fields and Song, 1989). 
The yeast two hybrid assay is explained schematically in figure 4. 
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 In order to identify the interacting proteins with C1D, yeast two hybrid 
screen was performed. For this purpose, a human B-lymphocyte cDNA library in 
fusion with an AD was screened using C1D expressed in yeast in fusion with a DBD.  
As a consequence we identified 80 positive cDNAs that were grouped into five.  One 
group was comprised of C1D itself that can be accepted as a positive control for this 
screen since C1D homodimerisation has been reported previously (Yavuzer et al., 
1998).   The second group of cDNAs encode the most intriguing protein in our 
screen, Translin associated factor X, TRAX (Aoki et al., 1997). TRAX has been 
shown to form a stable complex with Translin protein that is supposed to be a 
recombination hot spot binding protein seen in many chromosomal translocations. 
Other identified C1D interacting proteins were; ERCC1 that is involved in nucleotide 
excision repair, SL1 which is a transcription factor of RNA polymerase 1, and 
eIFp40 protein that is involved in translational initiation.  The summary of yeast two 
hybrid results is presented in Figure 5.  The detail of how this screen was performed 
has been written in MSc thesis of Bleda Bilican (Bilican, 1999).  
 
 
Figure 4: Yeast Two Hybrid Assay 
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3.2.  FEATURES OF TRAX 
 
TRAX stands for Translin Associated protein X, and it was identified as an 
interacting protein with Translin in a yeast two hybrid screen (GenBank accession 
no. X95073,(Aoki et al., 1997)).  TRAX encodes a 33 kDa protein and exhibits 28 % 
homology to Translin. The biological functions for either of the proteins are not 
known yet.  Interestingly, Translin was identified as binding to consensus sequences, 
ATGCAG and GCC(A/T)(G/C)(G/C)(A/T), found at the breakpoint junctions of 
various chromosomal translocations seen in many lymphoid malignancy and solid 
tumours (Aoki et al., 1995; Chalk et al., 1997).   Both Trax and Translin are highly 
conserved throughout evolution and beside mammals, they are found in various 
species such as Xenopus laevis, Arabidopsis thaliana, Drosophila, and S.pombe 
Figure 5: Summary of Yeast Two Hybrid Screen using C1D as bait 
1x108 Transformants were analysed 
3x103 were His+ 
280 Transformants were LacZ+, His+ 
120 Real Positives were obtained 
80 of them sequenced 
   C1D         TRAX      ERCC1       SL1        eIFp40    
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(Devon et al., 2000).  All these evidence suggest that TRAX and Translin should 
have important biological functions and possibly play a role in genesis of cancer.   
Therefore, it was decided to analyse the TRAX/C1D interaction further and 
decipher the biological consequences of this interaction.  Although, Translin was not 
amongst the proteins identified that were found to interact with C1D in our yeast 
two-hybrid screen, it was included in some of the assays as it binds to TRAX with a 
very strong affinity. 
 
 
3.3.  C1D AND FULL LENGTH TRAX INTERACT IN YEAST 
SPECIFICALLY 
 
Clone 41, the longest cDNA clone that was found to interact with C1D 
specifically, was first aligned against the full-length TRAX protein using ClustalW 
program.  As seen in figure 6, this cDNA encodes only a partial region of TRAX 
protein.  
 
 
 
 
Figure 6: Alignment of Clone41 Against full length TRAX 
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5
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In order to confirm that the full length TRAX also interacts specifically with 
C1D as does the library clone, the full-length open reading frame of TRAX was 
isolated by RT-PCR and cloned into the yeast expression plasmid, pACT.  These 
plasmid enables TRAX to be expressed in yeast as an activation domain tagged 
fusion protein (AD-TRAX).  AD-TRAX was then transformed into L40 together 
with plasmids expressing the lexA DNA binding domain (DBD) alone, DBD-Lamin, 
DBD-Daughterless, or DBD-C1D and the level of activity from the integrated LacZ 
reporter was determined using the ONPG assay.  As seen in figure 7, TRAX interacts 
specifically with DBD-C1D since no interaction is detected with DBD-alone and 
DBD fused to heterologous proteins such as DBD-Lamin and DBD-Daughterless. 
 
 
 
 
 
 
 
 
Figure 7: C1D and TRAX interact specifically in yeast 
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3.4.  ANALYSIS OF TRAX AND C1D INTERACTION IN VITRO 
 
 For in vitro studies, cDNA encoding the full-length C1D protein (16 kDa) 
was cloned into bacterial expression plasmid pQE and was expressed in E.coli as a 
His-tagged fusion protein. Hepatitis C virus core protein, HCV-core (kindly provided 
by M. Ozturk), which has a similar size to C1D, was also expressed in bacteria and 
used as a control to verify the specificity of interaction.  Both C1D and HCV-core 
proteins were purified from bacteria under the same denaturing conditions using 6-1 
M urea gradient and were immobililized on Ni-NTA column.  The immobilized 
fusion proteins were then incubated with the in vitro transcribed and translated 
TRAX and pull-down assays were performed.  As shown in Figure 8, a substantial 
proportion of input TRAX  (1/10th) is bound by C1D (Lane 3), whereas no 
interaction is observed between TRAX and pQE alone (Lane 2) or HCV-core protein 
(Lane 4), demonstrating that TRAX and C1D also interact specifically in vitro.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: C1D and TRAX interact in vitro.   IVTT TRAX was incubated with the 
indicated fusion proteins immobilized on Ni-NTA coulmn 
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3.5.  MAPPING THE INTERACTION DOMAINS OF TRAX 
 
 
3.5.1.  Constructing the LZ Mutant Form of TRAX and in vivo/in vitro 
expression studies 
 
TRAX encodes a 33 kDa protein (290 amino acid) that contains a bipartitate 
nuclear targeting motif between the amino acids 11-27 and a putative leucine zipper 
(LZ) motif between the amino acids 73-108 in its N-terminal region.  Translin and 
TRAX share 28% identity at the protein level with a conservation of 38% in the C-
terminal region of TRAX (Aoki et al., 1997).  The leucine zipper motifs are involved 
in protein-protein interactions. In order to analyse the importance of LZ motif of 
TRAX in protein-protein interactions, a mutant TRAX cDNA was constructed 
(mutLZ-TRAX) where the LZ motif has been mutated within otherwise intact protein 
(Figure 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Leucine Zipper Motif 
11   27  73          108            180            264          290 
F LLHRITSAPDMEDILTESEIKLDGVRQKIFQVAQEL  
F LLHRITSAPDMEDIFTESEISRDGVRQKIFQVAQEL  
NTD 38 % Identity to Translin 
TRAX 
mutLZ-TRAX 
Figure 9. Domains of TRAX. N-terminus of TRAX contains a Nuclear Targeting Domain (NTD)
and putative Leucine Zipper (LZ) motif and C-terminus shows high identity to Translin.  In order 
to obtain LZ motif mutant TRAX (mutLZ-TRAX), by linker scan mutagenesis, the third leucine 
(L) was replaced by phenyalanine (F) and fourth leucine and preceding lysine (K) were replaced 
by arginine (R) and serine (S), respectively. 
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     The mutLZ-TRAX was initially cloned into T7pLink and in vitro transcribed and 
translated under the control of T7 promoter.  As shown in figure 10, mutLZ-TRAX 
(Lane 3) exhibits a similar size to the wild type TRAX (Lane 2), indicating that the 
mutations introduced into a certain region within an otherwise intact protein did not 
cause truncations.    
 
 
 
mutLZ-TRAX was then subcloned into the yeast expression plasmid, pACT2 
and expressed in yeast in fusion with an activation domain.  This particular plasmid 
also contains an HA epitope enabling the detection of expressed proteins in yeast.  
As controls, wild type TRAX (AD-TRAX) and pACT2 plasmid on its own were also 
introduced into yeast in parallel with mutLZ-TRAX.  The lysates from each 
transformed strain was prepared and subjected to SDS-PAGE followed by probing 
with an antibody raised against HA-epitope.  As expected, mutLZ-TRAX was 
detected as a protein with a similar size to the wild type TRAX (Figure 11, Lanes 1 
and 2) and no such protein was detected in lysates obtained from pACT2 transformed 
1 2  3     
Figure 10: The IVTT of mutLZ-TRAX gives a similar size protein 
product to the wild type protein  
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or non-transformed yeast strains (Lanes 3 and 4).  Therefore, mutLZ-TRAX is 
expressed in vivo as well and the mutations we have introduced did not have any 
effect in overall structure of the protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.2.  TRAX Interacts with C1D through Its Putative Leucine Zipper Region 
 
For mapping the interaction domains of TRAX, yeast two-hybrid assay was 
performed.   To this end, plasmids expressing the wild type and two mutant forms of 
TRAX (N-terminal region TRAX containing the LZ motif and mutLZ-TRAX) in 
fusion with an activation domain were introduced into the yeast strain L40 together 
with the plasmid expressing DBD-C1D and β-Galactosidase activity was determined 
using ONPG as a substrate. 
In accordance with the previous yeast two hybrid assay result (Figure 7), a 
significant activity was detected between TRAX and C1D, whereas a rather low level 
of β-galactosidase activity was detected with mutLZ-TRAX and C1D (Figure 12, 
Figure 11: Verification of mutLZ-TRAX and TRAX expression in the yeast strain L40 
by immunobloting.  
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Lane 1 and 3), demonstrating that the putative leucine zipper domain of TRAX is 
essential for its interaction with C1D.  Interestingly, the N-terminal region of TRAX 
containing an intact LZ region (N-Ter) interacted with C1D as strongly as the wild 
type TRAX (Lane 2), further confirming the requirement of the putative leucine 
zipper region for interaction between TRAX and C1D.  
 
 
 
 
 
 
 
 
 
 
                                 
           
           
           
           
           
           
3.5.3.  LZ Region of TRAX is Also Important For Interaction With Translin 
 
Although TRAX was initially identified as a Translin interacting protein, the 
interaction domains are not known yet.  According to our results (Figure 12), LZ 
motif of TRAX is particularly important for TRAX/C1D interaction.  Since TRAX 
also interacts with Translin, it was important to determine whether LZ motif is also 
critical for TRAX/Translin interaction.  In order to determine the regions of TRAX 
that are responsible for TRAX/Translin interaction, AD fusions of TRAX, mutLZ-
TRAX, and N-TRAX were expressed together ywith DBD fusion of Translin in the 
yeast strain L40 and the level of interaction among them was determined by  
Figure 12: The putative Leucine zipper region of TRAX is essential for TRAX/C1D 
interaction  
      1                  2                 3 
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β-galactosidase activity.   As seen in figure 13 (Lane 1), TRAX/Translin interacted 
very strongly, (almost 10-fold stronger than TRAX/C1D interaction), however the 
disruption of LZ region of TRAX abolished this interaction (Lane 2).  Unlike the 
C1D/TRAX interaction which is mainly governed through the N-terminal region of 
TRAX containing an intact LZ, TRAX/Translin interaction is likely to require the 
full-length TRAX protein as the N-terminal mutant TRAX did not interact with 
Translin (Lanes 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.4. C1D and Translin Compete with Each Other In Binding to TRAX 
 
According to our yeast two hybrid results (Figure 12 and Figure 13), TRAX 
interacts with both C1D and Translin through its LZ region.  It was important to 
determine whether these three proteins form a complex or C1D and Translin would 
compete with each other to bind to TRAX.  To determine the relative interaction 
among them, His-tagged C1D was immobilized on Ni-NTA beads and incubated 
with the in vitro transcribed and translated (IVTT) TRAX and Translin either alone 
(Figure 14, Lanes 3 and 4) or together (Lanes 5,6, and7).  
Figure 13: Translin requires the full-length TRAX with intact LZ for interaction. 
 1               2                3 
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Similar to our previous Ni-NTA pull down assay result (Figure 8), a substantial 
amount of TRAX was found to bind C1D (Figure 14, Lane 3), whereas binding of 
Translin to C1D was barely detectable (Lane 4).  When TRAX and Translin were 
incubated simultaneously with immobilized C1D, the binding of TRAX to C1D was 
similar to the levels obtained when TRAX was incubated with C1D alone (Lane 5).  
By contrast, when TRAX and Translin were pre-incubated for 1 hour and then added 
to immobilized C1D, only small amount of TRAX was found to bind C1D (Lane 6).  
When TRAX was incubated with C1D for 1 hour prior to the addition of Translin, 
 
Figure 14: In vitro competition assay 
Lane 1: TRAX input 
Lane 2: Translin input 
Lane 3: TRAX incubated with immobilized C1D  
Lane 4: Translin incubated with immobilized C1D  
Lane 5: Simultaneous (S) incubation of immobilized C1D with TRAX (T) and 
Translin (t)     
Lane 6: Pre-incubation of TRAX (T) and Translin (t) before addition on to 
immobilized C1D 
Lane 7: Pre-incubation of immobilized C1D (C) with TRAX (T) before addition of 
Translin (t) 
Lane 8: Incubation TRAX and Translin with The plasmid expressing His only (pQE) 
as a negative control   
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binding of TRAX to C1D was increased almost twofold with respect to its binding 
without pre-incubation in the absence of Translin (compare lanes 3 and 7).  As both 
C1D and Translin require LZ region of TRAX to bind (Figure 12 and 13), these 
results would suggest that C1D and Translin bind to TRAX in a mutually exclusive 
manner. 
 
 
    3.6.  TRAX-C1D INTERACT IN MAMMALIAN CELLS 
 
After demonstrating the interaction between C1D and TRAX in yeast and in 
vitro, mammalian cells were tested for interaction between these two molecules. C1D 
is an insoluble protein and it remains associated with DNA even after treatment with 
harsh denaturants (Nehls et al., 1998), rendering it impossible to perform 
immunoprecipitations using an antibody raised against the endogenous C1D protein. 
To overcome this limitation, COS7 cells were transiently transfected with a vector 
expressing HA epitope-tagged version of C1D protein (HA-C1D). Transfection of 
cells with C1D-expressing plasmids enables the production of sufficient soluble C1D 
and thus allows co-immunoprecipitation assays to be performed (Yavuzer et al., 
1998).  In agreement with this, when lysates from HA-C1D transfected cells were 
immunoprecipitated using an anti-HA antibody, followed by immunoblotting with an 
antibody against C1D, both the SDS-resistant dimeric (32 kDa) and monomeric (16 
kDa) forms of C1D were readily detectable (Figure 15, Lane 1). To analyse the 
C1D/TRAX interaction, COS7 cells were co-transfected with vectors expressing 
HA-C1D and YFP-tagged TRAX (YPP-TRAX) and the lysates were 
immunoprecipitated with an anti-GFP antibody, which recognizes the YFP peptide.  
The immunoprecipitates were then subjected to immunoblotting with anti-C1D 
antibody.  However, it was observed that C1D did not interact with TRAX under 
these conditions (Figure 15, Lane 2). 
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3.6.1.  TRAX and C1D Interaction is γ-Irradiation Inducible In Mammalian 
Cells 
 
It was previously shown that mRNA and protein levels of C1D are induced 
upon γ-irradiation, a type of DNA-damage that induces double strand breaks (DSBs) 
in the DNA (Yavuzer et al., 1998).  It was possible therefore, that C1D could 
perform its functions after being activated by such a stimulus.  To demonstrate this, 
COS7 cells were transiently transfected with vectors expressing HA-C1D, YFP-
TRAX or both.  Untransfected cells were also included as controls. 24 hour 
following transfections, 20 Gy of γ-irradiation was applied to a set of transiently 
transfected cells and after incubating for an additional hour, lysates were prepared 
from unirradiated (Figure 16, lanes 1,2) and irradiated cells (lanes 3-6).  In both 
HA-C1D 
YFP-TRAX
16 kDa 
32 kDa 
Figure 15: In mammalian cells TRAX and C1D don’t interact under 
normal conditions.  Plasmids used in transfections are indicated on 
the right hand side.  Antibodies used for immunoprecipitation are as 
indicated.  Western blot was performed by anti-C1D antibody. The 
upper band detected above C1D dimer is as a non-specific band. 
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+ 
+ 
+ 
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unirradiated and irradiated cells, C1D monomers and dimers were detected in 
immunoprecipitations using anti-HA antibody followed by immunoblotting with 
anti-C1D (Figure 16, lanes 1 and 4).  As expected and in agreement with previous 
experiments (Figure 15, lane 2), when HA-C1D and YFP-TRAX were co-transfected 
and immunoprecipitated with anti-GFP antibody and probed with anti-C1D antibody, 
C1D did not interact with TRAX in unirradiated cells (Lane 2).  However, in lysates 
obtained from irradiated cells, 32 kDa SDS-resistant homodimer, but not the 16kDa 
monomer of C1D, was detectable (Lane 3).  Since, C1D was not detected in lysates 
from untransfected or YFP-TRAX expressing cells (Lanes 6 and 5), it was concluded 
that C1D and TRAX interact in mammalian cells as well, however only in response 
to γ-irradiation. 
 
 
  
 
 
 
 
Figure 16: C1D and TRAX interact in mammalian cells in response to γ-irradiation.  
Plasmids used in transfections are indicated on the right hand side.  Antibodies used for 
immunoprecipitations are as indicated.  Western blot was performed by anti-C1D antibody. 
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3.6.2.  C1D and TRAX Interact Only In Response to DNA Damaging Agents 
Inducing DNA-DSBs 
 
Since γ-irradiation specifically induces DSBs formation in the DNA, It was 
important to determine whether C1D/TRAX interaction would be induced by other 
DNA damaging agents, such as ultra violet (u.v.) irradiation that induces thymine 
dimers which are mainly repaired by nucleotide excision repair (NER) pathway.  To 
test this,  COS7 cells were again transiently transfected with vectors expressing HA-
C1D, GFP-TRAX or both and 50 j/m2 u.v. irradiation was applied to a set of 
transfected cells 1 hour before harvesting. The lysates were prepared from 
unirradiated (Figure 17, lanes 1 and 2) and u.v. irradiated cells (Lanes 3-7) and were 
immunoprecipitated using antibodies against GFP or HA-epitope. As controls, 
lysates from untransfected and HA-C1D or GFP-TRAX transfected cells were also 
immunoprecipitated using the same antibodies (Fig. 17, lanes 4-7).  The 
immunoprecipitates were then blotted with an anti-C1D antibody (Figure 17, upper 
panel).  As expected, anti-HA antibody immunoprecipitated the 32 kDa dimeric form 
of C1D in cell lysates from HA-C1D transfected cells (Lane 1). Due to usage of a 
low percentage gel, the 16 kDa monomeric form was not visible in this particular 
experiment.  However, C1D was not detectable when cell lysates from GFP-TRAX 
and HA-C1D transfected cells were immunoprecipitated with an anti-GFP antibody 
(Lane 2).  In contrast to γ-irradiation, treatment of these double transfected cells with 
u.v. irradiation did not induce interaction of TRAX with C1D (Lane 3).  
To confirm that the lack of interaction between C1D and TRAX upon u.v. 
irradiation is not due to absence of TRAX expression, the blot was stripped and re-
probed with an antibody raised against the GFP peptide (Figure 17, lower panel).  A 
protein of ~60-kDa, which is the expected size for GFP-TRAX protein, was detected 
in all cell lysates from GFP-TRAX transfected cells (Lanes 2, 3, and 7) but not in 
cell lysates from untransfected or HA-C1D transfected cells (Lanes 1,5, and 6). 
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3.7.  SUBCELLULAR LOCALIZATION OF C1D, TRAX AND TRANSLIN IN 
MAMMALIAN CELLS 
 
The data presented so far demonstrates that TRAX interacts specifically with 
both C1D and Translin, however C1D and Translin compete with each other for 
binding to TRAX.  Thus, the three molecules can not form a complex, and in 
mammalian cells TRAX interacts with C1D only in response to γ-irradiation.  In 
order to demonstrate the biological reason for this, the subcellular localizations of 
these three molecules were examined and the effects of γ-irradiation on the 
subcellular distribution of TRAX, C1D and Translin were analysed. To this end, 
these proteins were expressed in COS7 cells as fusions with different GFP variants 
either alone or combination and the expression patterns were determined in the living 
cells.  Thus, Translin was expressed as a CFP fusion protein (CFP-Translin), TRAX 
as YFP-TRAX and C1D as RFP-C1D giving cyan, green or red colours with the 
appropriate filters.  All the expression plasmids were constructed at Bilkent 
Figure 17: TRAX and C1D don’t interact in mammalian cells in response to u.v.  
irradiation 
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University, however, as we do not have a fluorescence microscopy equipped with 
different filter sets, the microscopic analyses were performed at Marie Curie 
Research Institute by U.Yavuzer and B. Bilican.  
First the subcellular localization of each protein was analysed.  In agreement 
with previous results (Chennathukuzhi et al., 2001; Kasai et al., 1997).  CFP-Translin 
was found to be cytoplasmic in over 90 % of the cells examined (Figure 18Aa, B). In 
around 6 % of the cells however, CFP-Translin exhibited both nuclear and 
cytoplasmic localization (Figure 18B).   γ-Irradiation or other DNA damaging agents 
did not cause any alteration in its subcellular localization in agreement with previous 
observations (Chennathukuzhi et al., 2001).  In contrast, YFP-TRAX was localized 
to nucleus in all cells examined, whereas C1D was observed in a diffuse nuclear 
(predominantly)/cytoplasmic staining pattern as observed using anti-C1D antibody 
(U. Yavuzer unpublished data) (Figure 18A b and c respectively and figure 18B).  As 
with Translin, localization of TRAX and C1D did not change following γ-irradiation 
(Figure 18B).   
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Since, in 6% of the cells Translin exhibited nuclear/cytoplasmic localization 
when expressed alone, we wanted to see whether an alteration would occur in its 
nuclear localization when expressed together with C1D or TRAX.  To constitute a 
basal level for the percentage of cells exhibiting nuclear Translin in double 
transfections, Translin was co-expressed with a plasmid expressing YFP only and 
was found to show nuclear/cytoplasmic localization in around 10 % of the cells 
(Figure 19B).   A different picture emerged with TRAX or C1D double transfections: 
Co-expression of Translin with TRAX resulted in almost 3.5-fold increase in the 
proportion of cells in which Translin was observed to be nuclear/cytoplasmic (34 %) 
 
Figure 18: (A) Subcellular localization of Translin, TRAX and C1D when they were expressed 
alone.  (B) Summary of the results demonstrating the percentage of nuclear/cytoplasmic and   
nuclear localizations of Translin, TRAX and C1D before and after γ-irradiation 
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co-localizing with TRAX, and a striking alteration in the location of TRAX, with 
around 58 % of cells expressing TRAX both in cytoplasm and nucleus (compared to 
100 % when expressed alone).  In 42% of the cells TRAX was solely cytoplasmic 
and colocalized with Translin.  Importantly, in these cells where TRAX was solely 
cytoplasmic, Translin was never found to be nuclear.  In Figure 19A d-f, a 
representative area where three cells are shown, of which two of the cells contain 
both TRAX and Translin.  In one of the cells, TRAX and Translin are co-localized to 
cytoplasm whereas in the other, a diffuse nuclear/cytoplasmic staining pattern is 
observed.  The third cell expresses TRAX only and as expected, when Translin is not 
co-expressed, TRAX is solely nuclear.  This single TRAX expressing cell in this 
particular area also acts as an internal control demonstrating that the filters used to 
detect YFP or CFP are highly specific.  These alterations in the compartmentalization 
of TRAX and Translin presumably reflect interactions between these two proteins 
and indicates that the relative expression levels of these proteins is important in 
determining their subcellular localization.  γ-irradiation did not cause a significant 
alteration in the subcellular localizations of TRAX and Translin.  On the contrary 
when TRAX was expressed with C1D, neither C1D nor TRAX changed their 
localizations either before or after γ-irradiation and TRAX stayed in the nucleus 
(Figure 19Aa) whereas C1D showed its usual nuclear/cytoplasmic staining pattern  
(b), co-localizing with TRAX in the nucleus (c).  Co-expression of Translin and C1D 
(Figure 19A g-i) resulted in a slight increase in the proportion of cells containing 
nuclear Translin (19%) however; once again γ-irradiation did not have any effect on 
the subcellular localizations of either Translin or C1D.  These results demonstrate 
that γ-irradiation does not effect the localization of the TRAX, Translin or C1D, 
however, the otherwise nuclear TRAX changes its localization when Translin is co-
expressed and stays in the nucleus when C1D is co-expressed.  
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Figure  19: (A) Effect of TRAX-C1D, TRAX-Translin and C1D-Translin coexpression on 
expression pattern of TRAX, C1D and Translin (B) Summary of the results demonstrating the 
percentage of % Nuclear/Cytoplasmic and % Nuclear localizations of Translin, TRAX and C1D 
before and after γ-irradiation 
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In cells triple transfected with YFP-TRAX, CFP-Translin and RFP-C1D 
expression vectors, we were not able to detect any significant alteration in the 
subcellular localizations of TRAX or Translin compared to TRAX/Translin double 
transfected cells (Figure 20B).  In other words, C1D over expression did not cause an 
overall alteration in the localization of TRAX or Translin. In figure 20A a-c, a group 
of cells of which two were triple transfected are shown.   C1D again exhibits a 
nuclear (predominantly)/cytoplasmic staining (c), whereas TRAX is solely nuclear in 
one of these cells (a, upper cell) and nuclear/cytoplasmic in lower cell.  Translin on 
the other hand, is also nuclear/cytoplasmic in the lower cell, but is mainly 
cytoplasmic in the upper cell and therefore does not co-localize with TRAX.  In the 
bottom, left hand side a third cell (a and b) which only expresses nuclear/cytoplasmic 
TRAX and Translin, and fourth cell (b) expressing Translin only, again acting as 
internal controls demonstrating that the different filter used for GFP, YFP or DsRed 
kare specific.  Although in a few cells expression of C1D appears to maintain TRAX 
in the nucleus while Translin was mainly cytoplasmic, the majority of cells showed a 
nuclear/cytoplasmic staining, making it difficult to determine whether TRAX was 
complexed with Translin or C1D.  However, we noted a slight increase in the 
percentage of cells experessing nuclear TRAX or Translin after irradiation in the 
presence of C1D compared to no increase in the double transfected cells (Figure 
20B).   
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In conclusion, in vitro and in vivo experiments in yeast and mammalian cells 
suggest that the nuclear matrix protein C1D interacts with TRAX in response to 
DNA damage and possibly could inhibit TRAX/Translin complex formation by 
masking the Translin binding site.  This, as a consequence may inhibit binding of  
TRAX/Translin to DNA and prevent any unwanted TRAX/Translin based 
recombination events, which may lead to translocations seen in many types of cancer 
(for details please see the ‘Discussion’ section).  Although, these experiments give 
important clues about the biological function of C1D, they do not provide any direct 
evidence.  Therefore, it was decided to use S. cerevisiae, since this organism has 
served as a useful tool for analyzing mammalian gene function and deducing 
biological processes in human cells. 
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CHAPTER 4 
 
 
4.1.  IDENTIFICATION OF S.CEREVISIAE HOMOLOG OF C1D 
 
In light of the evidence presented in the previous chapter and also the published 
work on C1D show that C1D is regulated in response to γ-irradation and suggest that 
C1D might play a role in DNA repair and recombination.  The easiest way of 
demonstrating this directly would be via the usage of S. cerevisiae, since it is rather 
cheap and easy to combine genetics and biochemistry to identify the function of a 
given gene using this organism.  Indeed, many disease genes and most of the genes 
involved in the repair of damaged DNA in mammalian cells were initially 
characterized in yeast.    
There are at least two distinct pathways in eukaryotes to repair DNA-DSBs; 
HR and NHEJ (Haber, 1999).  In mammals, the NHEJ pathway appears to be the 
major pathway, whereas yeast cells mostly rely on HR.   
In eukaryotic organisms, RAD52 epistasis group of genes is identified to 
encode proteins that participate in HR.  Many members of this group were initially 
identified in S.cerevisiae as mutants sensitive to γ-irradiation.  They include RAD50, 
RAD51, RAD52, RAD54, RAD55, RAD57, MRE11 and XRS2.  Mutants in this group 
have defects in the repair of DNA-DSBs by HR (Paques and Haber, 1999).  
Genetic and biochemical studies have shown that end-joining in yeast and 
mammals requires the same core set of proteins, the DNA end binding subunits of 
DNA-PK, Ku70 and Ku80 as well as DNA Ligase IV and its associated factor 
XRCC4 (called YKU70, YKU80, LIG4 and LIF, respectively, in S.cerevisiae) 
(Boulton and Jackson, 1998; Schar et al., 1997; Teo and Jackson, 1997; Wilson et al., 
1997).   RAD50, MRE11 and XRS2 gene products have also been implicated in NHEJ 
pathway.  Interestingly, this complex has been shown to play important roles both in 
NHEJ and HR (Boulton and Jackson, 1998; Moreau et al., 1999). 
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In this section, I will present the data towards identification of the yeast 
homolog of C1D and the assays that were used to decipher the biological function of 
yeast C1D in DNA repair and recombination.  It is important to keep in mind that, 
although many human genes may have homologs in yeast, this doesn’t mean that 
they are functionally similar.  Therefore, it was important to determine whether 
human and yeast C1D perform the same functions in an organism. 
Initially, a BLASTP search was performed and it was seen that the S.cerevisiae 
YHR081W gene encodes a hypothetical protein exhibiting 25% and 27% identity to 
mouse (acc. no. CAA648444) and human (acc. no. CAA64845) C1D, respectively.  
This gene is referred to as YC1D from now on.  Since the role of YC1D in HR and 
NHEJ was decided to be analysed, it was important also to obtain mutant strains for 
RAD52 and YKU70 as both genes are the best-studied examples for each type of DSB 
repair.  Therefore, haploid and diploid mutant strains for YC1D, YKU70 and RAD52 
genes were purchased from EUROSCARF (description of the strains can be found in 
Chapter 2) and both phenotypic and functional assays were performed.  
 
 
4.2. PHENOTYPIC ANALYSIS OF YC1D MUTANT STRAIN 
 
 4.2.1.  yc1d Mutant Strain is Temperature Sensitive 
 
 To address the function of Yc1d, the phenotypic consequences of deleting the 
YC1D gene in haploid and diploid strains were examined.  Previous findings about 
the function of human C1D protein suggest that C1D could be a multi functional 
protein involved in preservation of genomic integrity by assisting factors involved in 
DNA repair, recombination, transcription and apoptosis. Therefore, if yeast C1D and 
human C1D are orthologs, absence of Yc1d could result in deficiency of preservation 
of genomic integrity, which would be manifested by some phenotypic features, such 
as growth retardation, high sensitivity to increased temperature and DNA damaging 
agents. These types of phenotypic analyses are routinely applied for the identification 
of the yeast proteins involved in chromosome metabolism, cell cycle checkpoint, 
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DNA repair/recombination, DNA replication and chromatin remodelling (Bennett et 
al., 2001).  
 The yc1d haploid and homozygote or heterozygote diploid mutant strains were 
initially analysed for temperature sensitivity. Both MATa and MATα type haploid and 
homozygote diploid strains deleted for YC1D gene were temperature-sensitive for 
growth at 390C (Figure 21B).  On the contrary, the heterozygous diploid strain, 
YC1D/yc1d, did not show any defect for growth at the restricted temperature, 
suggesting that the temperature sensitive phenotype is a direct consequence of Yc1d 
deficiency. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21:  yc1d mutant strain is temperature sensitive.  Aliquots (5µl) of serial 10-fold 
dilutions of yeast cultures were spotted onto YPED medium and were grown for 3 days at 
300C or 390C, as indicated. 
Cells plated 
wt (Mat a/α) 
wt (Mat a) 
yc1d (Mat a) 
yc1d (Mat α) 
YC1D/yc1d (Mat a/α) 
yc1d/ yc1d (Mat a/α) 
30oC 
39oC 
wt (Mat a/α) 
wt (Mat a) 
yc1d (Mat a) 
yc1d (Mat α) 
YC1D/yc1d (Mat a/α) 
yc1d/ yc1d (Mat a/α) 
A 
B 
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4.2.2. yc1d Mutant Strains are Slightly Sensitive to γ-Irradiation 
 
Next, the sensitivity of yc1d mutant strains to variuos physical and chemical 
DNA damaging agents, such as u.v. irradiation, methyl methane sulfonate (MMS) 
and γ-irradiation were examined.  As mentioned before, u.v. irradiation induces 
thymidine dimers which are mainly repaired by nucleotide excision repair (NER), 
whereas  MMS and γ-irradiation, induce DNA-DSBs that are repaired by  either 
homologous recombination (HR) or non-homologous end joining(NHEJ).  Although 
previously it was reported that the yku70 mutant strain is resistant towards MMS, u.v. 
and γ-irradiation (Boulton and Jackson, 1996), in our experimental conditions we 
were able to detect a very slight sensitivity of yku70 mutant strain towards MMS 
(Figure 22A).  Interestingly, yc1d haploid mutant strain  was resistant to both u.v. and 
MMS (Figure 22A and B).  However, unlike the yku70 mutant strain,  both mating 
type yc1d mutants were slightly sensitive towards γ-irradiation (Figure 22C). As a 
control, a rad52 mutant strain was also included in these assays and as reported 
before, it was found to be sensitive to MMS and γ-irradiation, however only slightly 
sensitive towards u.v. treatment (Bennett et al., 2001). 
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No-MMS 0.01% MMS 
Figure 22: yc1d mutant strain is not sensitive to either MMS or UV radiation, however is slightly 
sensitive to γ-irradiation 
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4.3.  IDENTIFICATION OF THE FUNCTION OF YC1D GENE 
 
4.3.1. YC1D Is Involved In DSB Repair 
 
Human C1D has been found to interact with proteins involved in DNA DSB 
repair and recombination.  In addition, YC1D deletion causes S. cerevisiae cells 
sensitive to high temperatures and to a slight extent, to γ-irradiation.  Therefore, it is 
likely that Yc1d may be involved in repair of DNA double-strand breaks. In order to 
examine this, a plasmid-based repair assay was employed to assess the efficiency of 
DNA DSB repair.  This assay was previously used to analyse the role of Yku70 in 
NHEJ (Boulton and Jackson, 1996).  Briefly, a S. cerevisiae-E.Coli shuttle plasmid 
was linearized within its multiple cloning site using restriction enzymes that produce 
5’- and 3’- overhanging or blunt-ends.  The linearized and the supercoiled versions of 
the same plasmid were then introduced into yeast strains in parallel and the 
transformants were plated onto selective medium.  Linearized plasmids can only be 
propagated in S.cerevisiae after they have been recircularized and ligated.  Therefore, 
by counting the number of colonies harbouring religated plasmid on each plate and 
normalizing to the efficiency of transformation with the supercoiled plasmid, the 
efficiency of ligation, thus NHEJ, can be measured.  In wild type strains both the 5’- 
and 3’-overhanging ends were religated efficiently, whereas as reported previously, 
the plasmids bearing two blunt termini (as generated by SmaI digest) were not 
(Boulton and Jackson, 1996).   We observed that yc1d mutant strain was defective in 
rejoining the 3’-overhanging (SacI and PstI digests) and blunt-ended (SmaI digest) 
plasmid DNA, however unlike yku70 mutant strains, yc1d mutant strains exhibited 
only a slight defect in repair of the 5’-overhanging ends (Figure 23A).   Moreover, 
introduction of a plasmid expressing wild type Yc1d into the yc1d mutant strain 
complemented the defect seen in the repair of 3’-overhanging ends in these mutant 
strains (Figure 23B).  
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Figure 23:  yc1d mutant strain is defective in NHEJ as demonstrated by a plasmid-
based in vivo DNA end joining assay.   A) Transformant yield of linearized plasmids
with the indicated restriction enzymes in wild type and different mutant backgrounds.
B) Transformant yield of SacI or PstI-linearized plasmid in yc1d mutant strain is
restored to wild type levels when a plasmid expressing Yc1d is introduced.  
A 
B 
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4.3.2. In The Absence of YC1D, Accurate End-joining Is Impaired 
 
Although the yc1d mutant strain is deficient in repair of 3’-overhanging ends, 
there is almost 20 % residual repair activity (Figure 23A).  It was important 
therefore, to analyse the transformants and determine whether the NHEJ has been 
performed accurately in the absence of YC1D.  For this purpose, again the plasmid-
based repair assay was performed with some modifications.  In this modified assay, a 
yeast episomal plasmid (pGV256 Live) expressing LacZ under the control of the 
constitutively active CYC (Cytochrome C) promoter was used.   When this plasmid is 
introduced into yeast, the colonies produce a blue colour in the presence of the 
substrate X-gal, due to the expression of β-galactosidase.  pGV256 Live was 
linearized using the unique SacI site that is found in the middle of the LacZ ORF, 
introduced into the wild type, yc1d and yku70 mutant strains and plated onto 
selective medium.  As described in the previous section, only the transformants 
harboring recirculized and ligated plasmids can grow on selective medium.  In this 
case, because the plasmid is linearized within the coding sequence of LacZ, re-
ligation will produce transformants, but only the colonies harbouring accurately re-
ligated plasmid will give blue colour in the presence of X-Gal.  Consequently, the 
ratio of number of blue colonies to the total number of transformants will give the 
efficiency of accurate repair.  
 The result showed that, yc1d mutant strain is defective in accurate repair of 
DNA ends, since only 50% of the transformants were accurately repaired, thus 
giving blue colour in the presence of X-Gal (Figure 24). The other half of the 
residual repair activity was governed by an error-prone pathway.  In agreement with 
a previous report, absence of Yku70 leads to error prone repair of DNA ends 
(Boulton and Jackson, 1996) and only 25% of the transformants were repaired 
accurately (Figure 24).  Therefore, although not to the extent of Yku70, Yc1d also 
acts as a barrier to error-prone DNA repair pathways.  
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4.3.3. Role of Yc1d in Homologous Recombination 
 
Since the repair of DSBs may also be performed by homologous 
recombination, the role of YC1D gene in recombination was assayed.  For this 
purpose a novel in vivo recombination assay was developed using the “pGV256 
Live” plasmid.  The schematic representation of this assay is shown in Figure 25.  
First, “pGV256 Live” was modified by inserting a double-stranded oligonucleotide 
into the unique SacI site within the LacZ coding sequences. This 21- bp 
oligonucleotide contains a unique restriction enzyme site (Bgl II) in the middle 
flanked by ‘STOP’ codons in different reading frames, thus disrupting the expression 
of LacZ (Figure 25B). We termed this plasmid “pGV256 Dead” as no β-
galactosidase activity is produced by the yeast transformants harbouring this plasmid. 
A 800 bp region of LacZ coding sequences encompassing the region where the 
‘STOP’ codons were integrated was amplified by PCR and introduced into the 
recipient yeast strain together with the BglII-linearized plasmid pGV256 Dead.  
Since there is no homology between the LacZ fragment and S.cerevisiae 
Figure 24: Accurate DNA-end joining is impaired in yc1d and yku70 mutant 
strains.   NHEJAJ0123045607
890
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Recovery 
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chromosomal sequences, the only way the plasmid can be propagated is either by re-
circularization and ligation of the plasmid, in which case there would be 
transformants but none of them will produce blue colour in the presence of X-gal 
(Figure 25C).  Alternatively, the 800-bp LacZ PCR fragment could be integrated into 
the plasmid by homologous recombination, which will manifest itself by production 
of blue colour (Figure 25D).  Therefore, the ratio of blue colonies over to the total 
number of colonies on a selective plate will directly reflect the efficiency of 
homologous recombination for those particular yeast strains. 
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Figure 25: Schematic view of in vivo homologous recombination assay 
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To validate this novel in vivo recombination assay, the rad52 mutant strain 
that was shown to be deficient in HR (Paques and Haber, 1999) and the yku70 
mutant strain which is mainly deficient in DNA end joining but not in HR (Lewis et 
al., 1999), were also analysed along with the wild type and yc1d mutant strains.   As 
expected, the in vivo recombination assay demonstrated that the yku70 mutant strain 
was able to perform HR as efficiently as the wild type strain, whereas the rad52 
mutant strain was completely defective in HR.  Notably, yc1d mutant strains 
exhibited a twofold reduction in HR compared to wild type strain (Figure 26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  In order to confirm the results obtained using this novel in vivo 
recombination assay, we also checked the same strains for growth in the presence of 
the homothallic switching (HO) endonuclease by using a galactose inducible 
construct.  This assay is based on expression of HO endonuclease from a plasmid 
with a galactose inducible GAL1-10 promoter, which leads to a site specific DSB at 
the MAT locus (Moore and Haber, 1996).  Since repair of HO endonuclease- induced 
DSBs is performed by HR, strains deficient in HR are not able to survive in growth 
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Figure 26: Analysis of yc1d role in HR recombination using our in vivo HR assay 
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medium containing galactose if they are carrying this construct (Lewis et al., 1999).  
Therefore, the survival rates of WT, rad52 and yc1d mutant strains harbouring the 
plasmid expressing galactose-inducible HO endonuclease were assessed by counting 
the number of colonies formed on galactose-containing medium. As seen in Figure 
27, survival of rad52 mutant strain was severely debilitated with respect to the wild 
type strain.  In accordance with our in vivo plasmid-based recombination assay, the 
yc1d mutant strain exhibited 57% efficiency in survival rate with respect to the wild 
type strain, which had a 82% efficiency.  Importantly, this reduction in survival rate 
was restored to wild type levels upon introducing into the yc1d mutant strain a 
plasmid expressing wild type Yc1d.   Therefore, we concluded that the assay we have 
developed is as efficient as the other assays measuring the recombination efficiency 
and that Yc1d also plays a role in homologous recombination.  
 
 
Figure 27: Survival of strains containing a plasmid with a galactose inducible HO-
endonuclease expressed relative to survival time at zero 
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4.4.  YKU70 AND YC1D ARE IN THE SAME EPISTASIS GROUP 
 
  The data obtained so far demonstrates that both the yku70 and yc1d mutant 
strains are not only phenotypically similar but both genes have similar effects in 
NHEJ. In addition and in contrast to YKU70, YC1D is also involved in HR.  It was 
important therefore to determine whether Yc1d and Yku70 belong to the same 
epistasis group.  In an attempt to analyse this possibility, the phenotypic and 
functional consequences of Yc1d deletion on a yku70 mutant background were 
analysed. 
 
 
4.4.1. Preparation of Yeast Strains Deleted for Both YC1D and YKU70 
 
To this end, gene knock out strategy was employed, which relies on deletion 
of the certain coding DNA sequence by transforming host organism with genetically 
engineered DNA molecule carrying appropriate selective marker.  Accordingly, DNA 
molecule used for this purpose is named gene disruption or gene replacement 
cassette.  Knocking out the gene of interest is based on the homologous 
recombination between homologous DNA sequences present on the disruption 
cassette and the host genome. The employment of S. cerevisiae for gene knockout 
strategy is particularly easy and well developed since the rate of homologous 
recombination is very high and the whole genome has been sequenced in April 1996. 
PCR mediated gene knockout strategy was applied to delete YC1D on a 
yku70 mutant background.  In this method, the PCR primers used had 5’-ends (~40 
nucleotides) that correspond to a region 200 bp upstream (forward primer) or 
downstream (reverse primer) of the open reading frame Yc1d.  The 3’-ends (~20 
nucleotides) of these primers contained sequences that anneal and allow the 
amplification of HIS3 as selectable marker.  Using these primers and a plasmid 
containing the open reading frame of his3 as a template, PCR was applied and the 
gene disruption cassette was obtained (Figure 28).  The gene disruption cassette was 
then introduced into the recipient yku70 mutant strain and transformed colonies were 
selected on histidine deficient selective plates.   
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Figure 28: Steps of PCR mediated gene knockout strategy 
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  Targeted integration of the cassette into the YC1D locus was confirmed by 
PCR using a forward primer that corresponds to a region 300 bp upstream of the 
open reading frame of Yc1d and a reverse primer (20 nucleotides) that  corresponds 
to the integrated His3.   By using these primers, the expected size PCR product will 
be obtained only if the disruption cassette has been integrated into the C1D locus.  
As anticipated, and shown in Figure 29, 1.02 Kb fragment was amplified from 
genomic DNA of yc1d-yku70 double mutant strains (Figure 29, lanes 1-4, 6) but not 
from yku70 mutant strain (Lane 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4.2. Phenotypic Analysis of yc1d/yku70 Mutant Strain 
 
4.4.2.1.  yc1d/yku70  mutant strain is also temperature sensitive  
After obtaining the yc1d-yku70 double mutant strain, the same set of 
phenotypic and functional analyses, which were previously applied to yc1d mutant 
strain were employed.   Initially temperature sensitivity of the yc1d-yku70 strain was 
analysed and compared with parental yc1d and yku70 mutant strains.  In accordance 
with a previous report, yku70 mutant strain shows high sensitivity for growth at 39oC 
M       1        2        3      4        5       6 
Figure 29: Confirmation of the integration of the disruption 
cassette into the YC1D gene loci in yku70 mutant background 
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(Boulton and Jackson, 1996) and as previously shown in Figure 21, yc1d mutant 
strain displays growth defect at this temperature (Figure 30).  It was observed that the 
yc1d-yku70 double mutant strain also displayed temperature sensitivity, exhibiting a 
growth arrest similar to yc1d or yku70 mutant strains at high temperatures (Figure 
30).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
4.4.2.2. yc1d-yku70 double mutant strain displayed no obvious sensitivity to DNA 
damaging agents. 
Then, we analysed the sensitivity of yc1d-yku70 double mutant strain to DNA 
damaging agents such as MMS, u.v. irradiation and γ-irradiation and compared 
sensitivity of this strain to the wild type and parental strains.   Neither yku70 nor yc1d 
mutant strains were sensitive towards u.v. treatment and so neither were the double 
Figure 30: The yc1d-yku70 double mutant strain is temperature sensitive 
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knock-out mutant strains (Figure 31B).   MMS treatment showed that the yc1d 
mutant strain was resistant to MMS, whereas the yku70 mutant strain exhibited a 
slight sensitivity as has been presented earlier in Figure 22.  The yc1d-yku70 double 
mutant strains were also slightly sensitive, however not any more than yku70 mutant 
strain (Figure 31A).  The response of the strains to γ-irradiation was potentially 
interesting (Figure 31C).  The yc1d haploid mutant strain exhibited a slight 
sensitivity to γ-irradiation with respect to the yku70 mutant strain as demonstrated 
previously in Figure 22.  Interestingly, the sensitivity of yku70/yc1d double mutants 
was similar to the yku70 mutant strain, suggesting that YKU70 gene might be 
involved in inhibition of homologous recombination.  Thus, the absence of Yku70 
restores the slight growth defect seen in Yc1d deficiency and when both genes are 
deleted, the mutant strain becomes resistant to γ-irradiation.  
 In conclusion, we were not able to detect dramatic alterations in responses of 
the yc1d/yku70 double mutants to different DNA damaging agents relative to the  
parental strains.  
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Figure 31: As yku70 and yc1d, yc1d-yku70 double mutant strain is not sensitive to MMS,  u.v.,
and γ irradiation 
No-γ 
wt 
yku70 (Mat a) 
yc1d (Mat a) 
yku70/yc1d (Mat a) 
yku70/yc1d (Mat a) 
yku70/yc1d (Mat a) 
C 
B 
A 
20 Gy 
  94 
4.4.3. Analysis of yc1d-yku70 Double Mutant for NHEJ  
 
Next, the yku70-yc1d double knockouts were analysed for their ability to join 
the DNA ends using the plasmid-based DNA repair assay.  As presented in section 
4.3.1, the efficiency of rejoining the 3’-overhanging DNA ends especially is severely 
debilitated in yc1d and yku70 mutant strains.  If YC1D and YKU70 genes are on the 
same pathway, then the disruption of both genes will accentuate the efficiency of 
repair.  Therefore, a plasmid that was digested with SacI or PstI to produce 3’-
overhanging ends was transformed into the yc1d, yku70 and yku70/yc1d mutant 
strains in parallel with the supercoiled form of the same plasmid and DNA end-
joining efficiency was assessed as described previously.  As shown in Figure 32, the 
double knockout mutant strains exhibited an even less efficiency of NHEJ with 
respect to the yc1d or yku70 mutant strains.  It was concluded therefore that, the 
YC1D and YKU70 genes are in the same epistasis group and possibly take part in the 
same pathway in NHEJ.  
 
 
 
 
Figure 32: Yku70 and Yc1d are involved in the same pathway to rejoin 3’-
overhanging ends 
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4.4.4. Analysis of yc1d-yku70 Double Mutant for HR 
 
Although Yku70 is mainly involved in NHEJ, we regularly observed a 1.5-
fold increase in the efficiency of HR in the yku70 mutant strain (Figure 26 and data 
not shown).   This finding suggests that the Yku70 has a slight inhibitory effect on 
HR.  Indeed, it was reported that in eukaryotes, Ku70 acts as a switch between NHEJ 
and HR repair pathways and induces NHEJ while repressing the other (Goedecke et 
al., 1999).  Using the in vivo plasmid-based recombination assay described in section 
4.3., it was demonstrated that the yc1d/yku70 double mutants are also 1.5-fold more 
efficient in HR with respect to the wild type strains (Figure 33). As presented before 
and as seen in Figure 33, yc1d mutant strain is defective in HR.  Although Yc1d is 
required for HR, obviously the repressive effect of YKU70 is dominant to YC1D.  
This result is in accordance with the γ-irradiation sensitivity of double knockout 
mutant strains shown in Figure 33.  Although the haploid yc1d mutant strain was 
slightly sensitive to γ-irradiation, the yc1d/yku70 double knockout mutants, similar to 
the yku70 mutants, exhibited resistance to this kind of damage. Therefore, it can be 
concluded that the functional effect of Yku70 in HR is dominant to the effect of 
Yc1d and that possibly these two proteins act on HR through different pathways.  
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Figure 33:  yku70-yc1d double mutant  strain, similar to yku70 mutant strain, 
exhibited 1.5 fold increase in HR 
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CHAPTER 5 
 
IDENTIFICATION OF C1D INTERACTING PROTEINS 
 
In human diploid nuclei, 6.6x109 base pairs (bp) of DNA are 
compartmentalized into chromosomes.  The resulting chromatin is further organized 
into looped domains by the dynamic binding of tethered bases to a network of 
intranuclear proteins, the so called nuclear matrix (NM) (Berezney et al., 1995).  The 
25 million nucleosomes in a mammalian nuclei are organized into about 60,000 
chromatin loops by periodic attachments to NM at positions separated on average by 
70 Kb (Gasser and Laemmli, 1986; Vogelstein et al., 1980).  Dynamic association 
between DNA loops and NM allows stringent regulations of replication, 
differentiation, gene expression, recombination and repair in response to functional 
requirements of the cell (Nickerson, 2001) .  
DNA sequences that exhibit high affinity binding to NM are called 
matrix/scaffold attachment regions (S/MARs) (Gasser and Laemmli, 1987).   MARs 
are found in exons, introns, centromers, telomeres and also at gene break point 
cluster regions (Bode et al., 2000).   Although MARs don’t have clear consensus 
sequences, they consist of a specialized AT rich DNA content which is prone to base 
unpairing when subjected to negative superhelical strain (Benham et al., 1997).  This 
unique sequence of MARs allow them to regulate DNA replication and transcription 
(Boulikas, 1995), DNA organization (Strick and Laemmli, 1995) and recombination 
(Sperry et al., 1989).  Arising evidence indicates that MARs are recombinogenic 
elements or in other words recombination hot spot regions.  For instance, they are the 
preferred targets for entry of retroelements and retrosposons (Baer et al., 2000; 
Mielke et al., 1996) and are sensitive to DNAses, topoisomerases and S1 nucleases 
(Boehm et al., 1989).   In addition to these findings, it was shown that MARs 
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associate with proteins involved in recombination and repair, such as, TOPO II, 
PARP, HMG-1 and DNA-PK (Ku70/Ku86 and DNA-PKCS) (Bode et al., 2000; 
Galande and Kohwi-Shigematsu, 2000), suggesting that MARs recruit DNA repair 
proteins to NM to perform their functions.  MARs were also identified at breakpoint 
junctions of many chromosomal translocations such as 11q23, 9p22, 4q21, 11q23, 
22q11, 8q24, 14q21 and 18q21 (Bode et al., 2000) .  
C1D is the first non-histone NM protein to have been characterized at the 
sequence level.  It was previously shown that protein and mRNA levels of NM 
protein C1D increase upon γ-irradiation.  In addition, C1D interacts with DNA-PK 
and is an efficient substrate for this kinase. The interaction between C1D and DNA-
PK is significant in the sense that C1D is the first substrate identified that is capable 
of activating DNA-PK in the absence of free DNA-ends (Yavuzer et al., 1998). 
Therefore, it is highly possible that upon activation by γ-irradiation, NM protein C1D 
through associating with chromatin loops, could recruit and activate DNA-PK to the 
site of MARs in response to DNA damage.  
In an attempt to identify proteins that interact with C1D, we have applied 
yeast two hybrid system to screen a human B-lymphocyte library.  As a result of this 
screen, Translin associating protein, TRAX was found to interact with C1D (Figure 
5).  Translin is a DNA binding protein that recognizes and binds specific consensus 
sequences found at the break point junctions in many chromosomal translocations 
including 1p32, 3q27, 5q31, 8q24, 9q34, 9q34.3, 10q24, 11p13, 11q13, 14q11, 
14q32, 17q22, 18q21, 19p13, and 22q11 (Aoki et al., 1995; Kasai et al., 1997). 
Interestingly, Translin binding consensus sequences resemble the recognition signal 
(Chi-χ) of the RecBCD recombinase of E.coli (Smith, 1994).  Similar to DNA 
structure of MARs, DNA region flanking the Translin binding consensus sequences 
exhibits non-B DNA structure that is sensitive to DNAaseI and TOPOII (Aoki et al., 
1995).  Of particular interest is the observation that many of the chromosomal 
translocations correlated with MARs including 22q11, 9q34, 14q21, 18q21, 8q24 
(Meuth, 1989; Sperry et al., 1989) coincides with Translin associated chromosomal 
translocations.  
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Beside Translin’s proposed role in recombination (Aoki et al., 1997), it also 
functions as a RNA binding protein that regulates mRNA transport (Wu and Hecht, 
2000) and translation (Han et al., 1995). 
To date, little is known about TRAX.  Both human and mouse TRAX can form 
heterodimers with Translin/TB-RBP (Aoki et al., 1997; Taira et al., 1998; Wu et al., 
1999).  Although TRAX alone doesn’t bind to DNA or RNA, TRAX/Translin 
heterodimer is capable of binding to DNA but not RNA (Chennathukuzhi et al., 
2001).   Therefore, TRAX enhances binding of Translin to DNA while decreasing its 
binding to RNA.  
Recently, DNA-PK was found to associate with major breakpoint region (MBR) 
of BCL2 gene in which 70% of translocations occur (Ramakrishnan et al., 2000).  In 
this region DNA-PK particularly shows binding affinity to unique octamer consensus 
sequence, which is termed as χ-sequence due to its high homology to prokaryotic 
recombination activator. Notably, this sequence was previously identified as Translin 
binding consensus sequence (Aoki et al., 1995).  
In accordance to these findings, as being a nuclear matrix protein C1D could 
regulate the activity of Translin-TRAX complex and DNA-PK by organising their 
association with chromatin.  Actually, our results give important clues about the 
molecular basis of NM associated regulation of DNA repair and recombination.  
To define the functional relationship between TRAX and C1D, the interaction 
between them was verified in vitro and in vivo conditions. (Figures 7 and 8).  The 
regions of TRAX responsible for TRAX-C1D and TRAX-Translin interactions were 
identified (Figures 12 and 13).   Although, the putative LZ region of TRAX is 
important for interaction with both C1D and Translin, C1D and Translin show 
different requirements for interaction with TRAX outside the LZ region. The N-
terminal region of TRAX that contains an intact LZ region is sufficient for its 
interaction with C1D (Figure 12), whereas Translin requires the full-length TRAX 
with an intact LZ region (Figure 13).  Consistent with this, C1D and Translin bind to 
TRAX in a mutually exclusive manner and TRAX preferentially binds to C1D when 
three of them are found together (Figure 14).  The most interesting finding is that, in 
mammalian cells C1D and TRAX interact in response to γ-irradiation (Figure 15).  
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Although the biological functions of these proteins are not yet clear, these findings 
suggest that both C1D and TRAX might play a role in the repair of DNA DSBs.  
Previous data demonstrated that Translin is primarily cytoplasmic in many 
cell lineages, whereas it is found in nucleus in haematopoietic cell lines (Kasai et al., 
1997).  Interestingly, however, treatment of non-haematopoietic cells with 
mitomycin C and etoposide, agents that induce DNA-DSBs, was reported to cause 
translocation of Translin into the nucleus (Kasai et al., 1997).  The subcellular 
localization of TB-RBP (mouse homolog of Translin) changes in meiotic and post-
meiotic cells (Gu et al., 1998; Morales et al., 1998), but agents causing DNA DSBs 
did not affect localization of TB-RBP (Chennathukuzhi et al., 2001).   In agreement 
with this latter study, and consistent with Translin containing a Rev-like nuclear 
export signal (Chennathukuzhi et al., 2001), Translin was located in the cytoplasm in 
all but around 6 % of cells where a nuclear/cytoplasmic expression pattern was 
observed (Figure 18Aa, B), and treatment of transfected COS7 cells with etoposide 
or γ-irradiation did not induce translocation of Translin  into nucleus (Figure 18B).  It 
is not clear at the moment why 6% of cells exhibit a different localization for 
Translin.  These cells may represent those that have just undergone mitosis and 
Translin gained access to DNA as the nuclear envelope has been broken down. 
In contrast to Translin and to a previous report indicating that mouse 
orthologue of human TRAX is predominantly a cytoplasmic protein 
(Chennathukuzhi et al., 2001), our results show TRAX is located in the nucleus in all 
cells examined (Figure 18Ab), consistent with TRAX containing a nuclear 
localization signal (Aoki et al., 1997).   However, co-expression of TRAX and 
Translin resulted in a different pattern of localization of both proteins. When TRAX 
and Translin were co-expressed, an increase in the number of cells with a nuclear 
Translin and a significant increase in the cells expressing cytoplasmic TRAX was 
detected (Figure 19Ad,e; 19B).  As TRAX and Translin interact with each other, co-
expression of these proteins could effect their subcellular localizations. Therefore, 
the relative expression levels of TRAX and Translin in a cell could affect ability of 
these proteins to traffic between nucleus and cytoplasm. In fact, this explains why the 
reported subcellular localizations of exogenously expressed TRAX or Translin differ 
in different cell types and conditions.  
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  According to our experiments, γ-irradiation didn’t have any significant effect 
in the subcellular localizations of TRAX, C1D or Translin.  Therefore the finding 
that the SDS-resistant homodimers of C1D and TRAX interact only after γ-
irradiation (Figure 16) may indicate that a post-translational modification is required 
for the interaction.  After DNA damage, damage sensor proteins such as DNA-PK 
and ATM, are activated and transmit the signal by phosphorylating the downstream 
effector molecules to activate cell signalling mechanisms for cell cycle arrest, repair, 
or apoptosis (Khanna and Jackson, 2001). Considering the previous report that shows 
phosphorylation of C1D by DNA-PK (Yavuzer et al., 1998), it is possible that γ-
irradiation activates DNA-PK and activated DNA-PK phosphorylates C1D, which in 
turn interacts with TRAX.  However, this doesn’t exclude the possibility that TRAX 
could be phosphorylated by DNA-PK or a related kinase in response to DNA-DSBs.  
In fact, mouse TRAX has been found to be phosphorylated in testis germ cell nuclear 
extracts where many DNA DSBs are found due to ongoing recombination events 
(Chennathukuzhi et al., 2001).  
  TRAX enhances Translin DNA binding while decreasing its RNA binding 
capacity (Chennathukuzhi et al., 2001).  Therefore, TRAX could regulate Translin 
function by adjusting its DNA-RNA binding ability.   One biological consequence of 
TRAX-C1D interaction could be to regulate the Translin-TRAX interaction.  
Because interaction with either C1D or Translin appears to require the putative LZ 
motif of TRAX (Figures 12 and 13), the increased expression of C1D that occurs in 
response to γ-irradiation (Yavuzer et al., 1998) (a signal that also triggers the stable 
interaction between TRAX and C1D) could result in C1D masking the Translin 
interaction site of TRAX and thereby preventing the Translin/TRAX complex 
formation and binding to DNA.  In fact, this possibility supports the proposed 
function of C1D in maintenance of genomic integrity, because increased C1D/TRAX 
interaction upon γ-irradiation might represent a mechanism to inhibit any unwanted 
Translin-mediated recombination events before the damaged DNA is repaired.  
Indeed, in our in vitro competition experiments, we showed that binding of C1D and 
Translin to TRAX is mutually exclusive.  Importantly, however, if TRAX binds to 
Translin first, then it is no longer available to bind to C1D.  Therefore, C1D may act 
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as a regulator of TRAX-Translin complex formation, rather than regulate association 
of any preformed TRAX-Translin complex.  
 Our studies using flourescently tagged proteins also failed to identify any 
dramatic changes in subcellular localization of TRAX, Translin or C1D when 
expressed in any combination in response to γ-irradiation.  This is in agreement with 
others (Chennathukuzhi et al., 2001) who also found no difference in the subcellular 
localization of Translin in response to DNA damaging agents. We suspect that the 
results may reflect the relative timing of expression of the proteins in transfected 
cells.  Thus, in the absence of γ-irradiation, C1D will not interact stably with TRAX 
and no significant effect of C1D on the subcellular localization of TRAX and 
Translin would be expected.  On γ-irradiation C1D would interact with TRAX, but 
this association will only inhibit the formation new TRAX-Translin complexes.  
Against the high background of preformed TRAX-Translin complexes it 
would be difficult to detect any change in overall localization of the florescent 
proteins before the overexpression of C1D eventually results in apoptosis.  
Nevertheless, we suspect that the interaction between C1D and TRAX will represent 
an important mechanism regulating the associations of TRAX and Translin and 
leading to alterations in the relative amounts of TRAX/Translin targeted to nucleus. 
C1D could also regulate the activity of Translin and DNA-PK in a cell cycle 
dependent fashion because it was reported that Ku complex (DNA targeting subunit 
of DNA-PK) and Translin bound to the same  consensus sequences, found at the 
Bcl2 breakpoint region, in a cell cycle dependent manner.   In G1 and early S phases, 
this sequence is occupied by the Ku complex, however in G2-M phase it is replaced 
by Translin (DiCroce and Krontiris, 1995).  In eukaryotes, DNA-DSB repair 
mediated by HR occurs mainly during late S and G2 phases of the cell cycle, when 
sister chromatids are present and other repair pathway, NHEJ is predominant in G1-
early S-phase (Hendrickson, 1997).  Therefore by regulating Translin and DNA-PK 
activities, C1D could assist DNA-DSBs repair pathways in a cell cycle dependent 
manner.   
Cancer susceptibility genes have been classified into two groups; gatekeepers 
and caretakers (Kinzler and Vogelstein, 1997).  Gatekeepers are genes that control 
cell proliferation and death, whereas caretakers are DNA repair genes whose 
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inactivation leads to genetic instability. Abrogation of both caretaker and 
gatekeeper’s function markedly increases cancer susceptibility.  Repair genes are 
caretakers of the genome when they fail to repair DNA damage, this leads to genetic 
instability, gross chromosomal rearrangements and accumulation of mutations that 
trigger cell cycle checkpoints resulting in permanent growth arrest or death of 
affected cells.  If this system is inactivated this leads to tumorigenesis. It has been 
previously shown that DNA-PK complex has a caretaker role in maintaining 
genomic stability. Considering previous reports and our results both C1D and 
Translin-TRAX complex could be caretakers. In this context, it is important to 
identify roles of these proteins in epigenesis of cancer.  We believe that analysis of 
the function of C1D, TRAX or Translin by mouse knockout models or analysis of 
expression pattern of these proteins in cancer cells will provide important clues about 
the role of nuclear matrix in tumorigenesis.  
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CHAPTER 6 
 
IDENTIFICATION OF S.CEREVISIAE HOMOLOG OF C1D 
 
There is no doubt that repair of the genotoxic lesions is critically important 
for prevention of genomic instability. Our published work (Chapter 3) and previous 
reports suggest that the nuclear matrix protein C1D could be a care-taker protein that 
is involved in maintenance of genomic integrity by regulating activity of proteins 
involved in DSB repair.  However, these results do not reveal the precise molecular 
mechanisms that C1D employs when performing its function.  Obviously, transgenic 
animal models that over express C1D or animals knocked out for C1D would be very 
useful to demonstrate the role of this nuclear matrix protein in important cellular 
processes.  These types of experiments require well-established animal house 
facilities and heavily depend on financial support.   Therefore, we decided to use a 
simpler organism, S.cerevisiae, to demonstrate the direct consequences of C1D 
deletion.   Since, yeast carries out all essential processes such as replication, cell 
cycle control, DNA repair and protein trafficking using proteins conserved among all 
eukaryotes including humans, it is accepted as a very useful in vivo test tube to 
analyse functions of genes from other organisms.   
The yeast C1D homolog, YC1D, exhibits 27% identity to human C1D.  
Therefore, the mutant strains deleted for YC1D were analysed to decipher the 
function of this gene.  In agreement with the proposed role for human C1D, the yc1d 
mutant strain is sensitive for growth at 390C (Figure 21), which is a common 
phenotype of mutant strains defective in preservation of genomic integrity (Boulton 
and Jackson, 1996; Hryciw et al., 2002; Peggie et al., 2002).  Moreover, the yc1d 
mutant strains were found to be slightly sensitive to γ-irradiation but not to other 
DNA damaging agents such as MMS or u.v., supporting the results obtained for 
human C1D.  In support of our findings on yc1d mutant strain, recently, it has been
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reported that some S.cerevisiae genes are only slightly sensitive to γ-irradiation, 
whereas exhibit resistance to all other DNA damaging agents (Bennett et al., 2001).  
In this study, a genome-wide screen of diploid mutants homozygous to deletions of 
3,670 nonessential genes revealed 107 new loci that have an effect on γ-sensitivity.   
Interestingly, about 90% of these were sensitive also to other DNA damaging agents.  
However, a group of diploid mutants containing 14 newly identified genes, amongst 
which YC1D (YHR081W) was also found, exhibited resistance to all DNA damaging 
agents but not to γ-irradiation.  Therefore, it can be concluded that the activities of 
both the human and yeast C1D are regulated by the presence of double-strand DNA 
breaks and that these two proteins could be functionally homologous.  One direct 
way of demonstrating that hC1D and YC1D are orthologs, would be to show that the 
human C1D complements the phenotypic defects in a yc1d mutant strain.  This 
approach was tried by expressing the hC1D under the control of a galactose inducible 
promoter in yc1d mutant strains.  However, because the promoter used for expression 
of hC1D is a heterologous one and does not resemble the native endogenous YC1D 
promoter, the over expressed protein was toxic to the cells and results were not 
informative (data not shown).  Therefore, this experiment should be repeated by 
integrating the hC1D coding sequences downstream of the native YC1D promoter.  
This approach will enable us to detect the effects of hC1D in yeast and therefore will 
be a direct way of showing that the function of C1D gene is evolutionarily 
conserved.  
Nevertheless, because the phenotype of yc1d mutant strain suggested a role 
for YC1D in DSB repair, the functional analyses were performed.  Since DSBs can 
be repaired both by NHEJ and HR, the effects of deletion of YC1D was analysed for 
both pathways.   The yku70 and rad52 mutant strains were analysed along with yc1d 
mutants since they are the best-studied examples of NHEJ and HR in S.cerevisiae.  
  Using the plasmid -based DNA repair assay, it was demonstrated that the 
yc1d mutant strains are defective in DNA-end joining to a similar extent as the yku70 
mutant strain (Figure 23).  The only difference between the yc1d and yku70 mutant 
strains was in the efficiency of repair of the 5’-overhanging ends.  Although still 
defective with respect to the wild type strains, the yc1d mutant strain was slightly 
more efficient than yku70 in repairing the 5’-overhanging DNA ends, suggesting that 
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the role of Yc1d in NHEJ is mainly in the 3’-end processing, an essential step in 
appropriate joining of DNA ends.  Moreover, our work has demonstrated that in the 
absence of Yc1d, around 50 % of 3’-overhanging ends are repaired inaccurately 
(Figure 24), indicating that another role of Yc1d in NHEJ is to repress the error-
prone double-strand break repair pathways.  This finding is yet another supporting 
evidence to the proposed role for C1D in maintenance of genomic integrity.  When 
NHEJ is impaired in S.cerevisiae, cohesive ends are repaired by error-prone 
pathways, which is highly mutagenic (Boulton and Jackson, 1996).  Thus, by 
inhibiting this pathway, Yc1d may prevent formation of mutations on the DNA.  
 In order to identify the function of Yc1d in HR, a novel in vivo recombination 
assay was developed.  This assay is easy to apply and quicker with respect to the 
other conventional assays used to measure the HR efficiency. Indeed, using this 
novel assay, a rad52 mutant strain was found to be defective in HR, whereas a yku70 
mutant strain was found to behave like a wild type strain, both of which are in 
agreement with the previous findings.  After confirming that the results obtained 
using this assay is reliable, a yc1d mutant strain was analysed for efficiency of HR.  
The yc1d mutant strain exhibited a twofold reduction in HR efficiency with respect 
to the wild type strain.  Although this is not a dramatic response as observed in a 
rad52 mutant strain, nevertheless it suggests that Yc1d has a role in HR pathway 
(Figure 26, 27).  More importantly, these results were also confirmed using a 
conventional HO endonuclease assay, which measures the HR efficiency in yeast 
cells.  The yc1d mutant strain again exhibited a twofold reduction in HR and when a 
plasmid expressing wild type C1D was introduced, the deficiency was restored back 
to the wild type levels. In conclusion, the results obtained on YC1D so far 
demonstrate that yc1d mutant strains show sensitivity to increased temperature and γ-
irradiation and Yc1d functions in both HR and NHEJ. 
Since both Yc1d and Yku70 act on NHEJ, the effects of disrupting both 
genes were also tested to see whether YKU70 and YC1D genes work together.  If that 
was the case, we would expect to have a more profound effect in the efficiency of 
NHEJ.   Similar to the yc1d and yku70 mutant strains, yc1d-yku70 double mutant 
strain displayed temperature sensitivity for growth at 390C (Figure 30).  The response 
of this double mutant strain to various DNA-damaging agents was rather unexpected.  
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Consistent with a previous report (Boulton and Jackson, 1996), the yku70 mutant 
strain exhibited resistance to DNA damaging agents such as u.v. and γ-irradiation, 
however, showed slight sensitivity to MMS (Figure 31B).  On the contrary, yc1d 
mutants were resistant to MMS and u.v. but slightly sensitive to γ-irradiation (Figure 
22).  It was seen that the yc1d-yku70 double mutant strains behaved similar to the 
yku70 mutant strain (Figure 31A,B and C), thus, exhibiting slight sensitivity to MMS 
but resistance to u.v. and γ-irradiation.  In other words, slight γ-irradiation sensitivity 
of yc1d mutant strain was complemented in double-mutant strains.  At the moment, it 
is not easy to understand how Yku70 deficiency is dominant over Yc1d deficiency. 
We believe that analysis of Yc1d role in other damage response processes such as 
cell cycle, DNA end processing and telomere maintenance will provide important 
clues about the particular response of yc1d-yku70 mutant strain to DNA damaging 
agents. 
When the yc1d-yku70 mutant strains were analysed for NHEJ, it was 
demonstrated that, the double knockouts were even less efficient in DNA end-joing 
with respect to the yc1d or yku70 mutant strains (Figure 32).  This result indicates 
that as long as NHEJ is concerned, YC1D and YKU70 genes are in the same epistasis 
group.  Although we cannot exclude the possibility that this collaboration may be 
through direct interaction of Yku70 and Yc1d proteins, studies performed in 
mammalian systems demonstrated that the human C1D and Ku70 do not interact 
directly (Yavuzer et al., 1998).  Therefore, collaborative work of Yc1d and Yku70 
proteins in NHEJ in yeast, could involve different protein complexes.  Alternatively, 
it is also possible that YC1D could have a general role in RNA and protein stability, 
thus, it may effect the action of Yku70 by regulating the stability of Yku70.  Indeed, 
a recent study, in which 1739 gene products in S.cerevisiae were analysed according 
to protein complexes they form, revealed that YC1D interacts with proteins involved 
in RNA processing (Gavin et al., 2002).   
 It was reported that in eukaryotes, Ku70 acts as a switch between NHEJ and 
HR repair pathways and induces NHEJ while repressing the other (Goedecke et al., 
1999).  In accordance with this report we observed a 1.5 fold increase in the 
efficiency of HR in the yku70 mutant strain (Figure 33).  Interestingly, the yc1d-
yku70 double mutant strain was also 1.5-fold more efficient in HR with respect to the 
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wild type strain (Figure 33).  Although, yc1d mutant strain shows a defect in HR, 
clearly it is not an essential gene in HR and the RAD52 epistasis group of proteins 
plays the major role in homologous recombination.  Therefore, relieving the  
inhibition of Yku70 on this major pathway will lead to an increase on the efficiency 
of HR performed by Rad52 group of proteins.  Under these circumstances, it will not 
be easy to detect the effect of deleting a redundant gene like YC1D.   This hypothesis 
could also be used to explain the complementation of the γ-irradiation sensitivity of 
Yc1d deletion in a yku70 mutant background.   According to the findings on YC1D, a 
hypothetical diagram is shown below to summarize how YC1D may affect the NHEJ 
and HR (Figure 34). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Two main repair pathways in eukaryotes, HR and NHEJ, begin in the same 
way; the ends of the DSB are resected by 5’ to 3’ exonucleases or by a helicase 
coupled to an endonuclease to produce 3’-overhanging DNA tails (Haber, 2000b).  
Therefore, processing of broken DNA ends is critical for repair of DNA-DSBs and 
absence of proteins involved in this process can affect the efficiency of DNA-DSB 
repair pathways.  As previously shown in humans and yeast, Rad50, Mre11, and 
Xrs2 (RMX) complex is involved in processing of broken DNA ends (Haber, 2000a; 
RAD52 
YC1D 
YKU7
NHEJ HR 
Figure 34: Effect of Yc1d on NHEJ and HR 
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Haber, 2000b).  Interestingly, genetic studies have implicated the role of RMX gene 
products in the same NHEJ pathway as Yku70 and Yku80 (Boulton and Jackson, 
1998; Critchlow and Jackson, 1998).  In addition to play a major role in NHEJ, RMX 
complex is also involved in HR, telomere maintenance, mating type switching and 
meiotic recombination (Haber, 2000a).  More recently this complex has also been 
implicated in the suppression of chromosomal rearrengements (Chen and Kolodner, 
1999) and in cell cycle checkpoint signalling (D'Amours and Jackson, 2001; Grenon 
et al., 2001; Usui and Schiebel, 2001).  These findings suggest that the biological 
role of RMX complex is in maintenance of genomic integrity.  Similar to RMX 
complex, Yc1d has dual function in both HR and NHEJ repair pathways, which 
raises the possibility that Yc1d could also have a role(s) in other RMX complex 
related functions.  Indeed, this suggestion coincides with our previous results that 
imply a role for human C1D in preservation of genomic integrity by regulating 
factors involved in DNA repair and recombination (Chapter 5).    
 
 
6.1.  FUTURE PERSPECTIVES 
  
As indicated in the beginning of this section, studies on YC1D provided rather 
useful information on the function of this newly identified gene.  More importantly, 
the data obtained so far strongly suggests that the human and yeast C1D genes are 
functionally homologs.   Therefore, future experiments will be directed towards 
deciphering the other molecules YC1D works with and directly demonstrating that 
the human C1D and YC1D genes are orthologs.  These experiments are summarized 
below:  
 
Expression of hC1D protein under the control of native YC1D promoter: As 
described in the relevant section, by replacing the YC1D coding sequences with the 
human C1D, we expect to detect complementation of phenotypic and functional 
deficiencies of yc1d mutant strains.  This experiment will directly indicate that 
human and yeast C1D genes are evolutionarily conserved.  
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Demonstrating if YC1D is involved in RMX complex-regulated events: Targeted 
disruption of YC1D in mre11, rad50 and xrs2 mutant strains and analysing of double 
mutants for cell cycle arrest, telomere maintenance and 5’-3’ exonuclease activity are 
critically important strategies, to understand whether Yc1d functions in the same 
pathway with RMX complex.  Besides these genetic assays, we also plan to perform 
biochemical interaction studies between RMX complex and Yc1d.  Using 
homologous recombination it is possible to tag the endogenous genes with various 
epitopes, such as GST, HA, Myc or GFP.  By this approach, we will be able to tag 
YC1D and any of the genes in RMX complex and perform immunoprecipitations 
using antibodies raised against various epitopes.   Tagging the endogenous YC1D 
gene with an epitope will also be useful in analyzing the expression pattern of the 
endogenous Yc1d protein.  In S.cerevisiae, mating type-switching status influences 
NHEJ and HR.  Haploid yeast strains perform NHEJ about 10-fold more efficiently 
than diploid strains (Lee et al., 1999).  Previous studies suggest that some genes are 
repressed by the diploid specific a/α factor (Kegel et al., 2001).  Therefore, analysis 
of the expression pattern of Yc1d in haploid and diploid strains could provide 
important clues about the role of Yc1d in DNA-DSB repair.  
 
Analysis of S.pombe C1D: The fission yeast S.pombe provides a good model system 
to study DNA-DSB repair pathways in humans since DNA-DSB repair pathways 
between human and S.pombe are highly conserved.  For instance, similar to humans, 
in S.pombe, the major DNA-DSBs are repaired by NHEJ (Wilson et al., 1999).  
Studying the S.pombe C1D will also be useful, since both TRAX and Translin 
homologs are found in S.pombe.  In chapter 3, we showed that C1D interacts with 
TRAX both in vivo and in vitro and proposed a model for C1D-TRAX interaction.  
According to this model, by regulating TRAX and Translin interaction, C1D assists 
recombination and repair, which are nuclear processes critical for maintenance of 
genomic stability. Therefore, in order to analyse the biological significance of 
TRAX-C1D/ TRAX-Translin interaction, the functions of S.pombe homologs of 
human C1D, TRAX or Translin could be analysed.  
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Introduction
Higher order organization of genomic DNA is one of the
important mechanisms involved in control of cell-type-specific
gene expression. Polypeptides involved in higher order
chromatin folding are non-histone proteins and are tightly
bound to DNA, even after treatment with harsh denaturants
(Neuer et al., 1983). Although the biological functions for
these proteins are still largely obscure, some of them have been
reported to be associated with highly repetitive DNA sequences
and to be involved in targeting a subset of genomic DNA to
the nuclear matrix (Neuer and Werner, 1985; Neuer-Nitsche et
al., 1988; Pfutz et al., 1992; Werner and Neuer-Nitsche, 1989).
The nuclear matrix protein C1D is the first of such non-histone
proteins to have been characterized at the sequence level
(Nehls et al., 1998). Independently, C1D was found to be
associated with the transcriptional repressor RevErb and the
nuclear coreceptors N-Cor and SMRT, indicating that it could
act as a component of the complex involved in transcriptional
repression (Zamir et al., 1997). C1D is also an activator of
DNA-dependent protein kinase (DNA-PK) (Yavuzer et al.,
1998), which plays an important role in DNA double-strand
break (DSB) repair and V(D)J recombination, a process
specific to lymphocytes that is required for development of the
immune system (Smith and Jackson, 1999). Interestingly, C1D
is induced upon g -irradiation and proposed to play a role in
targeting DNA-PK to specific nuclear regions in response to
DNA damage. Indeed, the xrs5 cells deficient in one of the
subunits of DNA-PK, Ku-80, exhibit irregularly shaped nuclear
envelope and altered nuclear matrix compared with their wild-
type controls (Korte and Yasui, 1993; Yasui et al., 1991). In
connection with its role to regulate DNA-PK, C1D has also
been shown to induce apoptosis in a p53-dependent manner
(Rothbarth et al., 1999). Although the physiological function
for C1D is not yet clear, accumulating evidence indicates that
C1D is a multifunctional protein and, possibly by influencing
chromatin structure, is capable of regulating different cellular
events, such as DNA-repair, transcription and apoptosis. 
In an attempt to identify the possible biological functions
of C1D and the nuclear matrix, we have applied the yeast
two-hybrid system (Fields and Song, 1989) to screen for
polypeptides that interact with C1D. This approach has led us
to identify a specific interaction between C1D and a recently
identified protein, Translin-associated factor X (TRAX).
TRAX has been shown to interact with Translin through yeast
two-hybrid screening (Aoki et al., 1997) and exhibits extensive
amino acid homology to Translin. Translin was first identified
as a single-strand DNA binding protein that recognizes
the consensus sequences, ATGCAG and GCCC(A/T)-
(G/C)(G/C)(A/T), found at the breakpoint junctions of various
chromosomal translocations seen in many lymphoid and solid
tumours (Aoki et al., 1995; Chalk et al., 1997). Interestingly,
homologues of TRAX and Translin are found in various other
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The nuclear matrix protein C1D is an activator of the DNA-
dependent protein kinase (DNA-PK), which is essential for
the repair of DNA double-strand breaks (DSBs) and V(D)J
recombination. C1D is phosphorylated very efficiently by
DNA-PK, and its mRNA and protein levels are induced
upon g -irradiation, suggesting that C1D may play a role in
repair of DSBs in vivo. In an attempt to identify the
biological function of C1D, we have employed the yeast
two-hybrid system and found that C1D interacts
specifically with Translin-associated factor X, TRAX.
Although the biological function of TRAX remains
unknown, its bipartite nuclear targeting sequences suggest
a role for TRAX in the movement of associated proteins,
including Translin, into the nucleus. We show that C1D and
TRAX interact specifically in both yeast and mammalian
cells. Interestingly, however, interaction of these two
proteins in mammalian cells only occur following g -
irradiation, raising the possibility of involvement of TRAX
in DNA double-strand break repair and providing evidence
for biological functions of the nuclear matrix protein C1D
and TRAX. Moreover, we show, using fluorescently tagged
proteins, that the relative expression levels of TRAX and
Translin affect their subcellular localization. These results
suggest that one role for C1D may be to regulate
TRAX/Translin complex formation. 
Key words: C1D gene, Nuclear matrix, Translin, TRAX, DNA-PK
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organisms including mouse, fission yeast, frogs, insects and
plants (Devon et al., 2000), suggesting that these molecules
have important biological functions. Indeed, numerous
functions have been proposed for Translin, ranging from
mRNA transport and translational regulation to DNA
recombination and repair. 
In this paper we report that C1D and TRAX are capable of
interacting specifically in yeast and in mammalian cells.
However, in mammalian cells their interaction could be
detected only after g -irradiation and interestingly, only the
dimeric but not the monomeric form of C1D can interact with
TRAX. In addition, C1D and Translin interact with TRAX in
a mutually exclusive fashion, and co-expression of TRAX and
Translin results in their altered subcellular localization. The
potential implications of these results in regard to the
biological roles of C1D and TRAX in DNA repair and
recombination are discussed.
Materials and Methods
Cloning, mutagenesis and sequencing
Wild-type TRAX, Translin and C1D open reading frames (ORFs)
were isolated by PCR with primers placing suitable restriction sites
to the 5 ¢ and 3¢ ends and cloned into various yeast and mammalian
expression plasmids. The yeast expression plasmid is pACT. The
mammalian expression constructs include a HA-epitope (a peptide
derived from influenza haemagglutinin protein)-tagged expression
vector pCMV 5 ¢ 2N3T (kindly provided by T. Kouzarides), and
plasmids expressing various chromophores of the Aequorea victoria
green fluorescent protein (GFP) obtained from Clontech: pEGFP
(enhanced green fluorescent protein), pEYFP (enhanced yellow
fluorescent protein), pECFP (enhanced cyan fluorescent protein) and
pDsRed1 (red fluorescent protein). All other C1D constructs have
been described previously (Yavuzer et al., 1998). MutLZ-Trax (the
mutated LZ motive of TRAX) was generated in two steps. First, the
region between amino acids 1-194 was isolated by PCR with
mismatch primers placing SalI/BamHI sites at the 5¢ end and a BglII
site at the 3 ¢ end. The region between amino acids 194-272 was then
amplified via PCR, using primers that place a BglII site at the 5¢ end
and SalI/BamHI sites at the 3 ¢ end. The two PCR fragments were
digested with SalI/BglII and cloned in a triple ligation into the XhoI
site of pACT. This construct produced a mutant TRAX where a BglII
site is inserted, which changes the 194th amino acid leucine to
arginine and the preceding lysine to serine. The whole fragment was
then cut out with BamHI and cloned into T7-Myc/plink; it was
transcribed and translated in vitro using TnT Coupled Reticulocyte
Lysate system (Promega) to confirm that it gives a similar size product
to wild-type TRAX. Sequencing of PCR fragments, point mutations
and cDNA inserts from positive clones of the two-hybrid screen was
performed with an automatic sequencer (ABI 377, version 2.1.1).
Sequence comparisons were conducted using GenBank database
searches.
Yeast two-hybrid screen
The yeast two-hybrid screen was performed as described previously
using a B-lymphocyte cDNA library in pACT (Harper et al., 1993)
and full-length C1D in fusion with the DNA-binding domain of
bacterial LexA protein (DBD-C1D) (Yavuzer et al., 1998). The
yeast strains and the control plasmids (DBD-Lamin and DBD-
Daughterless) were kindly provided by S. Hollenberg. Saccharomyces
cerevisiae L40 (MATa trp1 leu2 his3 LYS2::lexA-HIS3 URA3::lexA-
lacZ) was grown at 30°C in YPD medium (1% yeast extract, 2%
polypepton and 2% glucose) and was transformed with DBD-C1D.
Human B-lymphocyte cDNA library was then transformed into this
strain using the lithium acetate method. Double transformants were
plated on selective medium lacking Trp, Leu, His, Lys and uracil and
were grown at 30°C for 3 days. Colonies were transferred on
Whatman 40 filters to test for b -galactosidase activity using X-gal (5-
bromo-4-chloro-3-indolyl-b -D-galactopyranoside). Positive clones
were rescued and tested for specificity by mating analysis or
retransforming into L40 together with the control plasmids mentioned
above. For the mating assay, DNA from positive clones was extracted
using glass beads and then transformed by electroporation into the
bacterial strain HB101, which has a defect in the leuB gene that can
be complemented by LEU2 from yeast, and therefore provides
selection of the library plasmids. The transformants were plated onto
M9 medium containing ampicillin and proline and incubated at 37°C
for 24 hours. DNAs of five colonies from each plate were then isolated
by the alkaline lysis method, transformed into the yeast strain AMR70
(MAT a his3 lys2 trp1 leu2 URA3::(lexAop)8-lacZ) and were mated
with the L40 strain carrying the bait plasmid. For liquid
b -galactosidase assays using ONPG (o-nitrophenyl b -D-
galactopyronoside) as a substrate, a yeast colony was grown at 30°C
to mid-log phase (OD600) and the cells were resuspended in Z buffer
(60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4,
pH 7.0) and lysed by freeze-thaw cycles. Seven hundred m l of Z buffer
and 160 m l of ONPG (4 mg/ml) were added to 100 m l of lysate and
incubated at 30°C until a yellow colour appeared. The reaction was
stopped by the addition of 400 m l 1 M Na2CO3 and OD420 of the
samples were read. b -Galactosidase units were calculated according
to the formula: 1000 · OD420/(t· V· OD600) where t is elapsed time (in
minutes) of incubation and V is 0.1 ml · concentration factor.
Ni-NTA pull-down assays
His-tagged C1D was expressed in bacteria and bound to Ni-NTA
column as described previously (Yavuzer et al., 1998). His-tagged
hepatitis-C virus core protein, p16 (kindly provided by Mehmet
Ozturk), was purified under denaturing conditions and immobilized
on Ni-NTA beads. TRAX was transcribed and translated in vitro using
TnT-coupled reticulocyte lysate system (Promega) according to the
manufacturer’s instructions. Ten m g of radiolabelled translation
product and the immobilized fusion proteins were incubated in 200
m l binding buffer (20% glycerol, 100 mM NaCl, 0.1· TE pH 8.0, 0.1%
NP-40, 1 mM DTT, 30 m g BSA) at room temperature for 20 minutes
followed by four washes using wash buffer (20% glycerol, 100 mM
NaCl, 0.1· TE pH 8.0 and 0.5% NP-40). The beads were then
resuspended in 20 m l of 2 · SDS sample buffer, boiled, centrifuged at
10,000 g for 5 minutes and loaded on 10% SDS-PAGE. The gel was
soaked in Amplify solution (Amersham) for 30 minutes, dried and
visualized by autoradiography.
Cell culture, transient transfections and co-
immunoprecipitations
COS 7 cells were maintained in DMEM supplemented with 10% fetal
calf serum and grown at 37°C with 5% CO2 as monolayers. Twenty
four hours before transfections, cells were plated into 35 mm 6-well
plates at a density of 3 · 104. Transfections were performed using
FuGENE 6 reagent (Roche) with 0.5 m g of DNA according to the
manufacturer’s instructions. Cells were harvested 24 hours after
transfection and lysed in lysis buffer (PBS containing 0.5% Triton-X,
5 mM EDTA and protease inhibitor cocktail tablets; Roche, 1873580).
Cells that were subjected to 20 Gy of gamma (Cs137 source) or 50
j/m2 of UV irradiation (Stratagene) were incubated for 1 hour at 37°C
before harvesting. Thirty m l of Protein G agarose beads per sample
was used and washed twice in PBS. The lysates were incubated with
either an anti-GFP (Clontech) or anti-HA monoclonal antibody
(Roche) for 2 hours at 4°C and then with protein G agarose beads for
another 2 hours. The beads were washed five times with PBS followed
by five washes with the lysis buffer. Precipitates were then separated
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by 10% SDS-PAGE and blotted onto nitrocellulose. Western blotting
was performed with anti-GFP antibody or a polyclonal antiserum
raised against the full-length C1D and immunoreactive bands were
visualized using ECL (Amersham) according to the manufacturer’s
instructions. 
Microscopy and microphotography
Vectors expressing C1D, TRAX and Translin in fusion with GFP and
various GFP variants were transiently transfected into COS 7 cells as
described above. Twenty four hours after transfections, expression of
the fusion proteins were examined in the control and g -irradiated
living cells for 24 hours. Fluorescence microscopy was performed on
a Zeiss Axiovert 135TV microscope equipped with a CCD camera
(Hitachi Denshi, Ltd) and appropriate filter sets, and the images were
processed by using OpenLab software (Improvision).
Results
Identification of proteins interacting with the nuclear
matrix protein C1D
A yeast two-hybrid screen was employed in an attempt to
identify proteins interacting with C1D. To this end, we
generated the yeast expression plasmid DBD-C1D, which
directs the synthesis of full-length open reading frame of C1D,
fused C-terminal to the bacterial LexA DNA binding protein.
DBD-C1D was then introduced into the yeast reporter strain
L40 (Hollenberg et al., 1995) that contains both the HIS3 and
lacZ genes under the control of LexA operators. Strain L40
containing DBD-C1D is His– and does not express detectable
b -galactosidase activity, indicating that C1D is
transcriptionally inert when fused to LexA. 
Strain L40 containing DBD-C1D was then transformed with
a human B-lymphocyte cDNA library in the vector pACT. A
total of ~1· 108 transformants were obtained, of which ~3· 103
were capable of growing on medium lacking histidine. Of
these, 280 were found to produce elevated b -galactosidase
activity. False positives were eliminated by using a mating
assay and 120 transformants were identified as containing
cDNAs that conferred a His+, LacZ+ phenotype in a fashion
that was specific to L40 cells expressing the DBD-C1D fusion
protein. The cDNA expression vectors from 80 of these
transformants were then rescued, and sequencing revealed five
cDNA groups, one of which comprised C1D. This finding
served as a positive control for the screening because C1D
homodimerisation has been demonstrated previously (U.Y.,
unpublished). A search of the GenBank database revealed that
a second group of overlapping sequences that derived from the
same cDNA encodes a recently identified protein termed
TRAX (GenBank accession no. X95073) (Aoki et al., 1997). 
C1D interacts with TRAX specifically
To establish the specificity of the two-hybrid interaction
between C1D and TRAX, the full-length open reading frame
of TRAX was expressed in yeast as an activation domain
tagged fusion protein (this fusion is referred to as AD-TRAX).
AD-TRAX was transformed into L40 together with baits
comprising the LexA DNA-binding domain (DBD) alone,
DBD-Lamin, DBD-Daughterless or DBD-C1D; the level of
activity from the integrated LacZ reporter was determined in
each case using the ONPG assay. TRAX interacts specifically
with DBD-C1D given that no interaction is detected with
DBD alone, DBD-Lamin or DBD-Daughterless (Fig. 1). In
reciprocal two-hybrid experiments where C1D was fused to the
activation domain and TRAX to the C-terminal DNA-binding
region of LexA and introduced into the strain L40, a similar
level of b -galactosidase activity was also determined (data not
shown). Therefore, we concluded that C1D and TRAX interact
specifically. 
C1D and TRAX interact in vitro
Next, we determined whether C1D is able to bind TRAX in
vitro. For this, C1D was expressed in E. coli as a His-tagged
fusion protein and was purified by use of Ni-NTA beads.
Hepatitis C core protein, which has a similar size to C1D, was
also expressed and purified under the same conditions as C1D
and was used as control. The immobilized fusion proteins were
then incubated with the in vitro transcribed and translated
TRAX and pull-down assays were performed. As shown in Fig.
2, although no interaction is observed between TRAX and pQE
alone or hepatitis C core protein, a substantial proportion of
the input TRAX (one-tenth) is bound by C1D, indicating that
C1D and TRAX also interact specifically in vitro. 
Fig. 1. C1D and TRAX interact specifically. TRAX fused to the Gal4
activation domain (AD-TRAX) was transformed into the reporter
yeast strain together with DBD alone, DBD-lamin (La), DBD-
Daughterless (Da) or DBD-C1D and interactions were measured by
b -galactosidase activity using ONPG.
Fig. 2. C1D and TRAX interact in vitro. C1D and hepatitis C virus
core proteins (HCV-core/pQE) were expressed in bacteria using the
plasmid pQE30 (Qiagen) and purified by Ni-NTA column under
denaturing conditions. One m g of each of the immobilized fusion
proteins and pQE alone were incubated with In vitro Transcribed and
Translated (IVTT) TRAX product and pull-down assay was
performed. One tenth of the input TRAX was bound by C1D. 
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The putative leucine zipper region of TRAX is involved in
interaction with C1D
TRAX contains a putative leucine zipper (LZ) (Aoki et al.,
1997) motif between amino acids 73-208. Because this motif
may be involved in protein-protein interactions, we tested
whether this region has any role in its interaction with C1D.
We introduced mutations into the putative LZ motif of TRAX
within an otherwise intact full-length protein (this mutant is
termed mutLZ-TRAX). We then subcloned mutLZ-TRAX to a
yeast expression plasmid as a fusion to the Gal4 activation
domain (AD-mutLZ-TRAX) and transformed into strain L40
together with the plasmid expressing DBD-C1D and
determined the b -galactosidase activity. As expected, a
significant activity was observed with AD-TRAX, whereas a
low level of b -galactosidase activity was detected when
mutLZ-TRAX-AD was tested for a two-hybrid interaction with
DBD-C1D (Fig. 3A). To confirm the requirement of the
putative LZ region of TRAX in C1D interaction, we used the
N-terminal region of TRAX (between amino acids 1-210) and
expressed this truncated protein as a fusion with the Gal4
activation domain (AD-N-TRAX) and determined the b -
galactosidase activity. As seen in Fig. 3A lane 2, the truncated
version of TRAX protein, which contains the N-terminal
region including the putative LZ, interacted with C1D as
strongly as the wild-type TRAX protein. 
Because TRAX can interact with both Translin and C1D,
and the putative LZ region is important in its interaction with
C1D, it was important to determine whether the same region
also plays a role in Translin/TRAX interaction. The yeast two-
hybrid assay employed for this purpose showed that the
putative LZ region of TRAX is also important for
TRAX/Translin interaction, as the mutLZ-TRAX did not
interact with Translin (Fig. 3B). However, unlike the
C1D/TRAX interaction, which is mainly governed through the
N-terminal region of TRAX containing the LZ motif,
TRAX/Translin interaction is likely to require the full-length
TRAX protein with an intact LZ region, as neither the N-
terminal nor the C-terminal regions of TRAX alone interacted
with Translin (Fig. 3B, lanes 3,4). Because the mutLZ-TRAX
did not interact with either C1D or Translin, it was important
to check whether it is expressed in yeast. As an HA-epitope
was tagged to the N-terminal region of mutLZ-TRAX, we were
able to detect the protein levels by western blotting in total
yeast extracts, and we showed that the mutLZ-TRAX was
expressed in both of the strains carrying DBD-C1D and DBD-
Translin (data not shown). 
C1D and translin bind to TRAX in a mutually exclusive
manner 
According to the yeast two-hybrid results, TRAX binds to both
C1D and Translin. Therefore, we wanted to determine the
relative interaction between TRAX and C1D or Translin when
three molecules are found together. His-tagged C1D was
immobilized on Ni-NTA beads, and in vitro transcribed and
translated TRAX and Translin were incubated with the
immobilized fusion protein either alone (Fig. 4, lanes 3,4) or
together (lanes 5, 6 and 7). Similar to the previous result (Fig.
2), around 10% of input TRAX was bound to C1D (lane 3),
whereas binding of Translin to C1D was barely detectable (lane
4). When TRAX and Translin were incubated simultaneously
with the immobilized C1D, the binding of TRAX to C1D was
similar to the levels obtained when TRAX was incubated with
C1D alone (compare lanes 3 and 5). By contrast, when TRAX
and Translin were pre-incubated for 1 hour and then added to
the immobilized C1D, only a small fraction of TRAX was able
to bind to C1D (lane 6). When TRAX was incubated with C1D
for 1 hour prior to the addition of Translin (lane 7), binding of
TRAX to C1D was increased almost twofold with respect to
its binding without pre-incubation in the absence of Translin
(compare lanes 3 and 7). Taken together with the fact that both
C1D and Translin require the putative LZ region of TRAX to
bind (Fig. 3), these results would suggest that C1D and
Translin bind TRAX in a mutually exclusive fashion. 
C1D and TRAX interaction is stimulated by g -irradiation
in mammalian cells
Because C1D mRNA and protein levels have been shown to
Journal of Cell Science 115 (1)
Fig. 3. The putative LZ region of TRAX is essential for interactions
with C1D and Translin. (A) Yeast two-hybrid assay was performed
using DBD-C1D and an activation domain (AD) tagged forms of
TRAX; wild-type (WT), N-terminal region containing the LZ motif
(N-Ter) or mutLZ where the LZ region of TRAX has been mutated
within an otherwise intact protein. The interactions were measured
by b -galactosidase activity using ONPG. (B) Constructs as in (A)
were used to detect interaction with the Translin protein expressed as
a fusion to the bacterial LexA protein (DBD-Translin). Mutations
that disrupt the LZ region of TRAX abolish its interaction with
Translin and neither the N-terminal region of TRAX carrying an
intact LZ nor the C-terminal region alone (C-Ter) are sufficient for
interaction with Translin.
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be induced upon g -irradiation (Yavuzer et al., 1998), we
wished to determine whether g -irradiation would affect
TRAX/C1D interaction in mammalian cells in vivo. C1D
protein is insoluble and remains tightly bound to DNA during
whole-cell or nuclear extract preparations and therefore
cannot be detected by western blotting of soluble cell extracts
(Yavuzer et al., 1998). Therefore, COS 7 cells were transiently
transfected with vectors expressing HA-epitope-tagged
version of C1D (HA-C1D) and YFP-tagged TRAX (YFP-
TRAX). Cells expressing YFP only and untransfected cells
were also included as controls. Transfection of cells with
C1D-expression vectors enables the production of sufficient
soluble C1D and thus allows co-immunoprecipitation assays
to be performed (Yavuzer et al., 1998). Twenty four hours
following transfection, 20 Gy of g -irradiation was applied to
a set of transiently transfected cells and after incubating for
an additional hour, lysates were prepared from the irradiated
and unirradiated cells. Immunoprecipitations were performed
with anti-GFP, which also recognizes YFP, or anti-HA
antibodies, followed by immunoblotting with an antibody
against C1D. In both unirradiated and irradiated cells, C1D
monomers (16 kDa) and SDS-resistant dimers (32 kDa)
(Nehls et al., 1998) were detected in immunoprecipitations
using anti-HA antibody followed by immunoblotting with
anti-C1D (Fig. 5A, lanes 1,4). As expected, C1D was detected
in lysates from HA-C1D-transfected cells but not in lysates
from untransfected or YFP-expressing cells (lanes 6 and 5,
respectively). When HA-C1D and YFP-TRAX were
cotransfected and immunoprecipitated with anti-GFP
antibody and probed with anti-C1D antibody, we were not
able to detect C1D interaction with TRAX from unirradiated
cells (lane 2). However, the 32 kDa SDS-resistant C1D
homodimer, but not the 16 kDa monomer, was readily
detectable upon g -irradiation (lane 3), indicating that g -
irradiation induces TRAX/C1D interaction. 
Because g -irradiation results in DNA double-strand breaks,
we next determined whether the interaction between C1D and
TRAX was specific to DNA double-strand breaks or whether
it could also be induced by other types of DNA damage. To
test this, we used UV irradiation (50 j/m2), which is known
to activate mainly the nuclear excision repair (NER)
pathways. COS 7 cells were transiently transfected with
vectors expressing GFP-TRAX and HA-C1D and
immunoprecipitations were performed using antibodies raised
against GFP peptide or HA-epitope. As for controls, lysates
from untransfected and HA-C1D- or GFP-TRAX-transfected
cells were also immunoprecipitated using the same antibodies
Fig. 4. Binding of C1D and Translin to TRAX is mutually exclusive.
C1D was expressed in bacteria and immobilized on Ni-NTA column
as explained in the legend to Fig. 2. IVTT TRAX and Translin
products were incubated with the immobilized C1D either alone
(lanes 3 and 4) or together. TRAX (T) and Translin (t) IVTT
products were incubated simultaneously (S) with the immobilized
C1D for 2 hours before washing (lane 5), TRAX and Translin IVTT
products were pre-incubated (PI) for 1 hour before adding to
immobilized C1D and incubated for another hour (lane 6), IVTT
product of TRAX was incubated with the immobilized C1D (C) for 1
hour and then Translin was added and incubated for an additional
hour (lane 7). The plasmid expressing His only (pQE) was expressed
in bacteria, purified and immobilized under the same conditions as
C1D and was used in lane 8 as a negative control.
Fig. 5. SDS-resistant C1D homodimers interact with TRAX upon g -
irradiation. (A) Transiently transfected COS 7 cells were
immunoprecipitated using the antibodies indicated. For lanes 3-6 the
cells were treated with 20 Gy of ionizing irradiation before lysate
preparation. Western blotting was performed by an anti-C1D
antibody. The monomer and dimer forms of C1D are indicated.
(B) Transiently transfected COS 7 cells were immunoprecipitated
using the indicated antibodies. For lane 3-7, the cells were treated
with 50 j/m2 UV irradiation. The top panel shows the western
blotting using an anti-C1D antibody, and in the bottom panel, the
blot was stripped and reprobed with an anti-GFP antibody to
demonstrate the presence of GFP-TRAX. For each lane,
immunoprecipitations were performed using the cell lysates obtained
from 3· 105 cells.
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(Fig. 5B, lanes 4-7). The immunoprecipitates were then blotted
with an anti-C1D antibody (Fig. 5B, top panel). We were able
to detect the 32 kDa dimeric form of C1D only in cell lysates
from HA-C1D-transfected cells (lane 1). However, C1D was
not detectable when cell lysates from GFP-TRAX- and HA-
C1D-transfected cells were immunoprecipitated with an anti-
GFP antibody (lane 2). In contrast to g -irradiation, treatment
of these double-transfected cells with UV irradiation did not
induce interaction of TRAX with C1D (lane 3). To confirm that
the lack of interaction between C1D and TRAX upon UV
irradiation is not due to the absence of TRAX expression, we
stripped the blot and reprobed with an antibody raised against
GFP-peptide (Fig. 5B, bottom panel). As expected, a protein
of ~60 kDa, which is the expected size for GFP-TRAX protein,
was detected in all the cell lysates from GFP-TRAX-
transfected cells (lanes 2, 3 and 7) but not in lysates from
untransfected or HA-C1D-transfected cells (lanes 1, 4, 5 and
6). We conclude therefore that C1D and TRAX interact in
mammalian cells in response to agents inducing DNA-double
strand breaks but not in response to UV irradiation.
Subcellular localization of C1D, TRAX and Translin
To determine the subcellular localization of Translin, TRAX
and C1D, we expressed these proteins in COS 7 cells as fusions
with different GFP variants either alone or in combination, and
determined the expression patterns in the living cells. The
fluorescence results are shown in Fig. 6A-C with a summary
shown in Fig. 6D. In agreement with previous results (Kasai et
al., 1997; Chennathukuzhi et al., 2001), CFP-Translin when
expressed alone was found to be cytoplasmic in over 90% of
cells examined (Fig. 6Aa). In around 6% of cells however,
CFP-Translin exhibited both nuclear and cytoplasmic
localization. g -Irradiation or other DNA damaging agents that
induce DNA double-strand breaks did not cause any alteration
in its subcellular localization in agreement with previous
observations (Chennathukuzhi et al., 2001). By contrast, YFP-
TRAX was localized to the nucleus in all cells examined,
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Fig. 6. Subcellular localizations of TRAX, Translin and C1D.
(A) Plasmids expressing CFP-Translin, YFP-TRAX and RFP-C1D
were transfected into COS 7 cells and subcellular localizations were
determined in the living cells. Translin was mainly cytoplasmic;
however, 6% of cells exhibited nuclear/cytoplasmic staining (a).
TRAX was nuclear (b) and C1D was mainly nuclear, but a
cytoplasmic staining was also evident (c). (B) COS 7 cells were
double transfected with the indicated plasmids. (a-c) TRAX/C1D
double-transfected cells showing that TRAX is solely nuclear (a)
whereas C1D is showing a nuclear/cytoplasmic staining pattern (b),
and colocalizes with TRAX in the nucleus (c). In TRAX/Translin
double-transfected cells (d-f), TRAX and Translin colocalize in the
cytoplasm and in the nucleus. The middle cell in d and f expresses
TRAX only. In C1D/Translin double-transfected cells (g-i), C1D is
mainly nuclear (g) and Translin is cytoplasmic (h). (C) COS 7 cells
triple transfected with TRAX-, Translin- and C1D-expressing
plasmids. (a-c) A single cell in which a diffuse nuclear/cytoplasmic
staining pattern is observed. In d-f, another field is shown where two
of the cells were triple transfected and in which the upper cell TRAX
and C1D were expressed in the nucleus (d and f) when Translin was
mainly cytoplasmic (e); the lower cell shows a diffuse nuclear-
cytoplasmic staining pattern as in a-c. (D) Summary of the results
demonstrating the percentage of nuclear/cytoplasmic and solely
nuclear localizations of Translin, TRAX and C1D.
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whereas C1D was observed in a diffuse nuclear
(predominantly)/cytoplasmic staining pattern as observed
using anti-C1D antibody (U.Y., unpublished) (Fig. 6Ab and
Fig. 6Ac, respectively). As with Translin, the localization of
TRAX and C1D did not change following g -irradiation (data
not shown). Because Translin exhibited nuclear/cytoplasmic
localization in 6% of the cells when expressed alone, we
wanted to see whether an alteration would occur in its nuclear
localization when expressed together with C1D or TRAX. To
constitute a basal level for the percentage of cells exhibiting
nuclear Translin in double transfections, Translin was co-
expressed with a plasmid expressing YFP only and was found
to show nuclear/cytoplasmic localization in around 10% of the
cells (Fig. 6D). A different picture emerged with TRAX or
C1D double transfections: co-expression of Translin with
TRAX resulted in an almost 3.5-fold increase in the proportion
of cells in which Translin was observed to be nuclear/
cytoplasmic (34%) colocalizing with TRAX, and a striking
alteration in the location of TRAX, with around 58% of cells
expressing TRAX both in cytoplasm and nucleus (compared to
100% nuclear when expressed alone). In 42% of the cells
TRAX was solely cytoplasmic and colocalized with Translin.
Importantly, in these cells where TRAX was cytoplasmic,
Translin was never found to be nuclear. In Fig. 6Bd-f, a
representative area consisting of three cells is shown; two of
the cells contain both TRAX and Translin. In one of the cells,
TRAX and Translin are co-localized to cytoplasm, whereas in
the other, a diffuse nuclear/cytoplasmic staining pattern is
observed. The third cell expresses TRAX only and, as
expected, when Translin is not co-expressed, TRAX is solely
nuclear. This single TRAX-expressing cell in this particular
area also acts as an internal control demonstrating that the
filters used to detect YFP or CFP are highly specific. These
alterations in the compartmentalization of TRAX and Translin
presumably reflect interactions between these two proteins and
indicates that the relative expression levels of these proteins is
important in determining their subcellular localization. g -
Irradiation did not cause a significant alteration in the
subcellular localizations of TRAX and Translin. On the
contrary, when TRAX was expressed with C1D, neither C1D
nor TRAX changed their localizations either before or after g -
irradiation and TRAX stayed in the nucleus (Fig. 6Ba) whereas
C1D showed its usual nuclear/cytoplasmic staining pattern
(Fig. 6Bb), colocalizing with TRAX in the nucleus (Fig. 6Bc).
Co-expression of Translin and C1D (Fig. 6Bg-i) resulted in a
slight increase in the proportion of the cells containing nuclear
Translin (19%); however, once again g -irradiation did not have
any effect on the subcellular localizations of either Translin or
C1D. These results demonstrate that g -irradiation does not
affect the localization of TRAX, Translin or C1D, but the
otherwise nuclear TRAX changes its localization when
Translin is co-expressed and stays in the nucleus when C1D is
co-expressed. 
In cells triple transfected with YFP-TRAX, CFP-Translin
and RFP-C1D expression vectors, we were not able to detect
any significant alteration in the subcellular localizations of
TRAX or Translin compared to TRAX/Translin double-
transfected cells (Fig. 6D). In other words, C1D over
expression did not cause an overall alteration in the localization
of TRAX or Translin. In Fig. 6Cd-f, a group of cells, of which
two were triple transfected, is shown. C1D again exhibits a
nuclear/cytoplasmic staining (Fig. 6Cf), whereas TRAX is
solely nuclear in one of these cells (Fig. 6Cd, upper cell) and
nuclear/cytoplasmic in the lower cell. Translin, however, is also
nuclear/cytoplasmic in this lower cell, but is mainly
cytoplasmic in the upper cell and therefore does not colocalize
with TRAX. In the bottom, left-hand side, a third cell is seen
(Fig. 6Cd,e) which only expresses nuclear/cytoplasmic TRAX
and Translin, and a fourth cell (Fig. 6Ce) expressing Translin
only, again acting as internal controls; this shows that the
different filters used for GFP, YFP or DsRed are specific.
Although in a few cells expression of C1D appears to maintain
TRAX in the nucleus, whereas Translin was mainly
cytoplasmic, the majority of cells showed a nuclear/
cytoplasmic staining (Fig. 6Ca-c), making it difficult to
determine whether TRAX was complexed with Translin or
C1D. However, we noted a slight increase in the percentage of
cell expressing nuclear TRAX or Translin after irradiation in
the presence of C1D, compared to no increase in the double-
transfected cells (Fig. 6D). 
Discussion
The protein and mRNA levels of the nuclear matrix protein
C1D increase upon g -irradiation (Yavuzer et al., 1998). In
addition, C1D interacts with DNA-PK and is an efficient
substrate for this kinase, which plays an essential role in the
repair of DNA double-strand breaks. The interaction between
C1D and DNA-PK is significant in the sense that C1D is the
first substrate identified that is capable of activating DNA-PK
in the absence of free DNA-ends (Yavuzer et al., 1998). These
findings raised the possibility that C1D might play a role in
DSB repair. Given the role of the nuclear matrix in the
regulation of important cellular events, such as DNA
replication, transcription, RNA splicing, topoisomerase
activity, nucleotide excision and DSB repair (Berezney, 1984;
Cockerill and Garrard, 1986; Jackson, 1991; Johnston and
Bryant, 1994; Kaufman and Shaper, 1991; Koehler and
Hanawalt, 1996; Korte and Yasui, 1993; Nelson et al., 1986;
Verheijen et al., 1988; Yasui et al., 1994; Yasui et al., 1991), it
is clearly important to reveal the role of C1D in any of these
events. 
Using the yeast two-hybrid system to screen a human B-
lymphocyte library we showed that C1D can interact
specifically with the Translin-interacting protein, TRAX.
Although the putative LZ region of TRAX is important not
only in interaction with C1D but also in its interaction with
Translin, C1D and Translin show different requirements for
interaction with TRAX outside the LZ region. The N-terminal
region of TRAX that contains an intact LZ region is sufficient
for its interaction with C1D, whereas Translin requires full-
length TRAX with an intact LZ region for interaction.
However, consistent with Translin and C1D sharing an
interaction motif within TRAX, we were able to show that
binding of Translin and C1D to TRAX appears to be mutually
exclusive and that stable interaction between C1D and TRAX
in mammalian cells occurs upon g -irradiation. Although the
biological functions of these proteins are not yet clear, these
findings suggest that both C1D and TRAX might play a role
in the repair of DNA DSBs. 
Cells use various mechanisms to protect their genome
against genotoxic insults. One obvious mechanism is to detect
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the damage and activate DNA repair machinery to repair the
damage before cell division takes place. When the damage is
beyond repair, cells can activate their suicide programs, and via
apoptosis the damaged cell destroys itself. C1D may play a role
in both types of mechanism as overexpression of C1D is
capable of inducing apoptosis in tumour cell lines (Rothbarth
et al., 1999) and C1D interacts with DNA-PK, which has an
established role in double-strand DNA break repair. 
An important feature of tumour cells is that they carry
specific chromosomal abnormalities, including translocations,
that result in the altered expression or structure of cellular gene
products giving rise to functional activation which contributes
to the initiation or progression of cancer (Rabbitts, 1994).
Chromosome translocations in malignant tumours may arise by
several mechanisms. The translocations seen in lymphomas
and leukaemias involve the immunoglobulin or T-cell receptor
genes and the Ig/TCR recombinase signal sequences are
present on both affected chromosomes. In some other
lymphoid malignancies, the breakpoint junctions are
characterized by another consensus sequence, which is
recognized by the Translin protein (Aoki et al., 1995). Translin
recognition site sequences have also been identified in solid
tumours (Chalk et al., 1997) indicating that Translin may be
important in the genesis of chromosomal translocations in
some types of neoplasms. As well as being a sequence-specific
DNA-binding protein, Translin is also capable of binding to
RNA, and the mouse homologue of human Translin, the testis
brain RNA-binding protein (TB-RBP), was identified as a
RNA-binding protein capable of recognizing conserved
elements in the 3 ¢ untranslated regions of specific mRNAs in
brain and testis (Han et al., 1995; Wu et al., 1997; Wu and
Hecht, 2000).
Although the role of TRAX in any of these events is not yet
clear, both human and mouse TRAX can form heterodimers
with Translin/TB-RBP (Aoki et al., 1997; Taira et al., 1998;
Wu et al., 1999) and the TRAX/Translin heterodimer is capable
of binding to both single-stranded DNA and RNA, raising the
possibility that TRAX/Translin heterodimer is multifunctional.
However, little is known about the biological functions of
Translin and TRAX.
Previous data demonstrated that Translin is primarily
cytoplasmic in many cell lineages but it is found in the nucleus
in haematopoietic cell lines. Interestingly, however, treatment
of HeLa cells with mitomycin C or etoposide, agents that
induce DNA double-strand breaks, was reported to cause
translocation of Translin into the nucleus (Kasai et al., 1997).
The subcellular localization of TB-RBP changes in meiotic and
post-meiotic cells (Gu et al., 1998; Morales et al., 1998), but
agents causing DNA DSBs did not affect localization of TB-
RBP (Chennathukuzhi et al., 2001). In agreement with this
latter study, and consistent with Translin containing a REV-like
nuclear export signal (Chennathukuzhi et al., 2001), Translin
was located in the cytoplasm in all but around 6% of cells
where a nuclear/cytoplasmic expression pattern was observed,
and treatment of transfected COS 7 cells with etoposide or g -
irradiation did not induce translocation of Translin into the
nucleus. Why around 6% of cells exhibit a different
localization for Translin is unclear, but these cells may
represent those that have recently undergone mitosis, a point
in the cell cycle when Translin would have access to DNA by
virtue of nuclear envelope breakdown. Following the
completion of mitosis, the nuclear envelope would reform,
causing the Translin that was retained in the nucleus either
being exported to the cytoplasm or degraded. 
In contrast to Translin, and to a previous report indicating
that TRAX is a predominantly cytoplasmic protein
(Chennathukuzhi et al., 2001), our results show TRAX located
in the nucleus in all cells examined (COS7, MCF7 or 3T3 cell
lines), consistent with TRAX containing a nuclear localization
signal (Aoki et al., 1997). However, co-expression of TRAX
and Translin resulted in a different pattern of localization of
both proteins – an increase in the number of cells with a nuclear
Translin and an increase in cells expressing cytoplasmic
TRAX. The changes in localization occurring when TRAX and
Translin are co-expressed are consistent with an interaction
between the two proteins affecting their ability to traffic
between the nucleus and cytoplasm, and they also indicate that
the relative expression levels of TRAX and Translin are likely
to be important in determining their subcellular localization.
Indeed, differences in the levels of endogenous or ectopically
expressed TRAX and Translin in different cell types may
explain why the reported subcellular localization of ectopically
expressed Translin or TRAX may differ. 
Because, in our experimental sytems, g -irradiation did not
have a significant effect in the subcellular localizations of
TRAX, Translin or C1D, the finding that the SDS-resistant
homodimers of C1D and TRAX interact only after g -irradiation
may indicate that a post-translational modification is required
for the interaction. Considering that C1D is phosphorylated by
DNA-PK, it is possible that upon g -irradiation DNA-PK is
activated and phosphorylates C1D, which in turn interacts with
TRAX. DNA-PK was not found to immunoprecipitate with
TRAX from mammalian cells, nor was it able to phosphorylate
recombinant TRAX in vitro (data not shown). However, this
does not exclude the possibility that TRAX could be
phosphorylated by DNA-PK or a related kinase in vivo in
response to DNA damage. Indeed, mouse TRAX has been
found to be phosphorylated in testis germ cell nuclear extracts
where many DNA DSBs are found due to ongoing
recombination events (Chennathukuzhi et al., 2001).
One biological consequence of C1D/TRAX interaction
could be to regulate the Translin/TRAX interaction. In this
regard, we note that TRAX has been shown to enhance the
DNA binding capacity of TB-RBP (Translin), while decreasing
its RNA-binding ability (Chennathukuzhi et al., 2001).
Because interaction with either C1D or Translin appears to
require the putative LZ motif of TRAX, the increased
expression of C1D that occurs in response to g -irradiation
(Yavuzer et al., 1998) (a signal that also triggers the stable
interaction between C1D and TRAX in mammalian cells)
could result in C1D masking the Translin docking site on
TRAX and thereby preventing the Translin/TRAX complex
formation and binding to DNA. Thus, increasing the
C1D/TRAX interaction on g -irradiation might represent a
mechanism to inhibit any unwanted Translin-mediated
recombination events before the damaged DNA is repaired.
Indeed, in our in vitro competition experiments, we showed
that binding of C1D and Translin to TRAX is mutually
exclusive. Importantly, however, if TRAX binds to Translin
first, then it is no longer available to bind to C1D. Therefore,
C1D may act as a regulator of TRAX/Translin complex
formation, rather than regulate the association of any
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preformed TRAX-Translin complex. This is an important
point. Our studies using fluorescently tagged proteins also
failed to identify any dramatic change in subcellular
localization of TRAX, Translin or C1D when expressed in any
combination in response to g -irradiation. This is in agreement
with others (Chennathukuzhi et al., 2001) who also found no
difference in the subcellular localization of Translin in
response to DNA-damaging agents. We suspect that the results
may reflect the relative timing of expression of the proteins in
transfected cells. Thus, in the absence of g -irradiation, C1D
will not interact stably with TRAX and so no significant effect
of C1D on the subcellular localization of TRAX and Translin
would be expected. On g -irradiation C1D would interact with
TRAX, but this association would only inhibit the formation
of new TRAX-Translin complexes. Against the high
background of preformed TRAX-Translin complexes it would
be difficult to detect any change in overall localization of
the fluorescent proteins before the overexpression of C1D
eventually results in apoptosis. Nevertheless, we suspect that
the interaction between C1D and TRAX will represent an
important mechanism regulating the association of TRAX and
Translin and leading to alterations in the relative amounts of
TRAX/Translin targeted to the nucleus. Further studies
dissecting the interaction between C1D, TRAX and Translin
and their requirements for DNA binding should help to address
some of these issues. 
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